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ABSTRACT 
 
Endocytosis is an essential function of eukaryotic cells, providing crucial 
nutrients and playing key roles in interactions of the plasma membrane with the 
environment.  The classical view of the endocytic pathway, where vesicles from 
the plasma membrane fuse with a homogenous population of early endosomes 
from which cargo is sorted, has recently been challenged by the finding of 
multiple subpopulations of endosomes.  These subpopulations vary in their 
content of phosphatidylinositol 3- phosphate (PI3P) and Rab binding proteins.  
The role of these endosomal subpopulations is unclear, as is the role of multiple 
PI3P effectors, which are ubiquitously expressed and highly conserved.  One 
possibility is that the different subpopulations represent stages in the maturation 
of the endocytic pathway.  Alternatively, endosome subpopulations may be 
specialized for different functions, such as preferential trafficking of specific 
endocytosed cargo.  To determine whether specific receptors are targeted to 
distinct populations of endosomes, we have built a platform for total internal 
reflection fluorescence (TIRF) microscopy coupled with structured illumination 
capabilities named TESM (TIRF Epifluorescence Structured light Microscope).  In 
this study, TESM, along with standard biochemical and molecular biological 
tools, was used to analyze the dynamic distribution of two highly conserved Rab5 
and PI3P effectors, EEA1 and Rabenosyn-5, and systematically study the 
trafficking of transferrin.  Rabenosyn-5 is necessary for proper expression of the 
transferrin receptor as well as internalization and recycling of transferrin-
vi
transferrin receptor complexes.  Results of combining TIRF with structured light 
Epifluorescence (SLE) indicate that the endogenous populations of EEA1 and 
Rabenoysn-5 are both distinct and partially overlapping. 
The application of antisense oligonucleotides as potential therapeutic 
agents requires effective methods for their delivery to the cytoplasm of target 
cells.  In collaboration with RXi Pharmaceuticals we show the efficient cellular 
uptake of the antisense oligonucleotide sd-rxRNA® in the absence of delivery 
vehicle or protein carrier.  In this study TIRF, SLE, and biochemical approaches 
were utilized to determine whether sd-rxRNA traffics and functions along specific 
endosomal pathways.  Sd-rxRNA was found to traffic along the degradative 
pathway and require EEA1 to functionally silence its target.  These new findings 
will help define the cellular pathways involved in RNA silencing. 
Neurotransmitter reuptake and reuse by neurotransmitter transport 
proteins is fundamental to transmitter homeostasis and synaptic signaling.  In 
order to understand how trafficking regulates transporters in the brain and how 
this system may be disregulated in monoamine-related pathologies, the 
transporter internalization signals and their molecular partners must be defined.  
We utilized a yeast two-hybrid system to identify proteins that interact with the 
dopamine transporter (DAT) endocytic signal.  The small, membrane associated, 
GTPase Rin was determined to specifically and functionally interact with the DAT 
endocytic signal, regulating constitutive and protein kinase C (PKC) – stimulated 
DAT endocytosis.  The results presented in this study provide new insights into 
vii
functions and components of endocytosis and enhance the understanding of 
endocytic organization. 
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CHAPTER I 
 
INTRODUCTION 
 
The internalization and subsequent sorting of endocytosed 
macromolecules is an important determinant in processes like cellular 
development, immunological response, neurotransmission, cell-cell 
communication, signal transduction and homeostasis [1,2].  Uptake into cells can 
be classified based on the type of internalization including pinocytosis, 
phagocytosis, clathrin-mediated and clathrin-independent endocytosis and 
endocytosis through lipid rafts.  Eukaryotic cells are highly compartmentalized 
structures with functionally distinct membrane-bound compartments.  Proteins 
and other macromolecules are targeted to specific intracellular routes through 
plasma membrane-derived transport vesicles that are directed to recycling or 
degradation compartments.  For example, the epidermal growth factor (EGF) 
receptor (EGFR), upon binding its ligand, EGF, is internalized and shuttles 
through the early endosome to lysosomes for degradation.  Conversely, the 
transferrin (Tf) receptor (TfR) is constitutively internalized through the early 
endosome to the recycling endosome and back to the cell surface.  Therefore, 
the intracellular fate of a protein molecule is primarily dictated by its endocytic 
route.  The mechanism by which these sorting decisions are made is an 
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important question in membrane trafficking with implications for understanding 
pathogen invasion of host cells. 
 
Aberrant trafficking and disease 
The endocytosis and trafficking of membranes and proteins is a 
fundamental cellular process that impacts human diseases.  Mutations that affect 
trafficking of receptors are associated with disease, for example mutations in the 
low-density lipoprotein (LDL) receptor (LDLR) that impair its function lead to 
familial hypercholesterolemia [3,4].  LDL is the carrier by which cholesterol is 
safely transported through the circulatory system.  High blood cholesterol levels 
increase the formation of arterial plaques that cause heart attacks and stroke 
thereby necessitating the removal of excess cholesterol from circulation.  High 
affinity for LDL as well as the ability to internalize and recycle LDL renders the 
LDLR essential for the cellular metabolism of cholesterol.  At the cell surface, the 
LDLR binds LDL from the blood plasma at neutral pH (7.4).  Once internalized, 
the acidic pH of endosomes (5.5) causes release of the LDL from its receptor.  
The receptor recycles to the plasma membrane while the LDL is degraded [5].  
Patients with familial hypercholesterolemia suffer from early onset coronary heart 
disease and atherosclerosis [6].  The J D mutation, a class IV mutation found in 
familial hypercholesterolemia patients, in the LDLR is a single tyrosine to 
cysteine point mutation at position 807 of the cytoplasmic domain of the receptor.  
This mutation inhibits the recruitment of clathrin and prevents the endocytic 
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machinery from interacting with the receptor thereby impeding LDLR-LDL 
internalization [7].  Aberrant transport processes are found in a number of other 
diseases such as tuberculosis infection [8], non-insulin dependent diabetes 
mellitus [9], Alzheimer’s disease [10], and cancer [11,12]. 
 
Small GTPases 
Two fundamental molecules in endocytic trafficking are small molecular 
weight GTP-binding proteins (GTPases) and phosphoinositides [13-17].  The 
nature of these molecules bring both molecular specificity and plasticity to 
endosomal membranes, thereby distinguishing various endocytic membranes 
and allowing endocytic material to traffic to specific cellular destinations (Figure 
1.1).  Small GTPases act as molecular switches regulating the steps involved in 
vesicle carrier formation, movement, and fusion with target membranes.  GTP 
binding proteins cycle between the GDP-bound inactive state and the GTP-
bound active state.  This process is catalyzed by guanine nucleotide exchange 
factors (GEFs) and GTPase-activating proteins (GAPs), respectively, and allows 
for the activation of GTPases specifically at sites where their function is required. 
Members of the Rab family of small GTPases are master regulators of protein 
trafficking that coordinate vesicular transport between different endocytic 
organelles.  Distinct Rab proteins have been identified that are specifically 
associated with a particular organelle or pathway.  These small GTP binding 
proteins regulate vesicular membrane transport in both the endo- and exo-cytic 
3
 Figure 1.1. Organelle specific distribution of Rab proteins and 
phosphoinositides.  PI(4)P is present at the Trans Golgi Network (TGN) and 
plasma membrane.  PI(4,5)P2 is present on the plasma membrane (PM) and on 
invaginating clathrin-coated pits.  PI(3)P is specifically present on early 
endosomes (EE).  PI(3,5)P2 is present on late endosomes (LE).  Rab5 and 
Rab4 are localized to early endosomes.  Recycling endosomes (RE)  are a 
collection of Rab4 and Rab11 positive tubules.  Late endosomes are recognized 
by the presence of Rab7.  Figure modified from Vicinanza et al. Cell Mol Life 
Sci. 2008 Sep;65(18):2833-41. Review. 
 
Rab5 
Rab4 
Rab4 
Rab11 
Rab7 
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pathways.  Their active forms serve in cargo selection as well as in the formation 
of scaffolds for vesicle budding, cytoskeletal transport, and targeted membrane 
fusion.  For instance, Rab5 is localized to early endosomes and is essential for 
plasma membrane to early endosomal transport as well as early endosome 
fusion [18-21], while Rab7 regulates the transport from early to late endosomes 
and from late endosomes to lysosomes, and Rab11 is enriched in recycling 
endosomes [17,22] while Rab4 controls recycling from the early endosome 
directly to the plasma membrane [23-25].  Three major populations of early 
endocytic Rab microdomains have been observed by electron and fluorescent 
microscopy [26].  These three domains are Rab5 positive, Rab5/Rab4 positive, 
and Rab4/Rab11 positive and are the major regulators of the endocytic recycling 
pathway [26]. 
Specific kinases can phosphorylate phosphatidylinositol at the 3, 4, or 5 
positions of the inositol ring to generate different phosphoinositide species.  
Phosphoinositide species are relegated to distinct subcellular compartments 
through both localized synthesis and rapid turnover, brought about through 
specific kinases and phosphatases, respectively [27,28].  Different 
phosphoinositide species bind specific phosphoinositide binding domains 
including FYVE, pleckstrin homology (PH), and PHOX homology (PX) domains.  
Found in 40 mammalian proteins, several of which are implicated in membrane 
trafficking [29], the conserved FYVE domain was named after the first four 
proteins discovered to contain this motif: Fab1, YOTB, Vac1, and EEA1 [30].  
5
The FYVE domain is characterized for its ability to bind PI3P, the phospholipid 
enriched on early endocytic membranes. Phosphoinositides function as cellular 
compartment identifying molecules while also providing the means to alter 
compartment identity.  Other proteins facilitate the spatial and temporal 
regulation of phosphoinositide conversion.  For example, Rab5 regulates 
phosphatases that convert PI(4,5)P2, on vesicles internalized from the plasma 
membrane, to phosphatidylinositol 3-phosphate (PI(3)P) on early endosomes 
[31].  This process facilitates membrane transport while maintaining compartment 
identity. 
 
Rab5 effector proteins 
The function of Rab5 in regulating organelle motility and fusion between 
clathrin coated vesicles and early endosomes (heterotypic fusion) and fusion 
between early endosomes (homotypic fusion) occurs through recruitment of 
effector proteins.  In many cases Rab effector proteins are evolutionarily 
conserved such as the mammalian Rab5 effectors Rabenosyn-5 and EEA1 [32]. 
Upon Rab5 activation, its effector hVps34 results in localized production of 
PI(3)P.  The increase in PI(3)P concentration through its synthesis by the Rab5 
effector hVps34, a class III PI3-kinase [15,33], generates the lipid environment 
necessary for the recruitment of downstream effector proteins containing FYVE 
or PX domains such as EEA1 [30,34], Rabenosyn-5 [32], and Rabankyrin-5 [35-
37], that can interact with PI(3)P on endosomal membranes [38-40].  The 
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concomitant presence of activated Rab5 and PI(3)P is essential for recruitment of 
FYVE-finger domain containing Rab5 effectors and tethering factors like EEA1 
and Rabenosyn-5 which require PI(3)P for localization and subsequent 
recruitment of SNARE proteins for fusion of endosomal vesicles [32,41,42].  
These complexed local events provide the functional platform for homotypic and 
heterotypic fusion events and the presence of numerous effector proteins with 
multiple Rab binding capabilities may provide a mechanism for sorting 
internalized cargo to distinct cellular compartments.  In conjunction with the 
FYVE-finger containing PI(3)P effector Smad2 Anchor for Receptor Activation 
(SARA), a functional platform is generated which mediates signal transduction 
events.  SARA, by interacting with internalized TGFβ-Receptor-II, is necessary to 
phosphorylate Smad2, subsequently propagating the TGFβ signal. [43]. 
 
EGFR and TfR trafficking 
Current models of endocytic trafficking suggest that internalized cargo 
(receptors, nutrients, pathogens, growth factors) is incorporated into vesicles 
formed at the plasma membrane.  These vesicles may form via clathrin or non-
clathrin mediated endocytosis.  Once internalized, these cargo-containing 
vesicles fuse with a homogenous population of early endosomes marked by 
EEA1.  The early endosome is the intracellular location at which cargo is then 
sorted for lysosomal degradation or delivery to the plasma membrane [44-48].  
TIRF microscopy, in conjunction with molecular and biochemical techniques, 
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were utilized by our laboratory to examine the sorting and early stages of 
endocytosis of two classically trafficking ligands, EGF and Tf, to determine the 
mechanism by which these molecules sort to their respective fates at the level of 
the early endosome [49].  The EGFR is a transmembrane glycoprotein receptor 
widely expressed in many cells types and responsible for growth, proliferation, 
differentiation, and other biological responses [12,50-53].  EGF ligand binding to 
the EGFR induces receptor dimerization and activates EGFR through tyrosine 
transphosphorylation [54] and stimulates its internalization.  Activated EGF-
EGFR complexes are trafficked through a series of endocytic compartments and 
finally the lysosome for degradation [2,55,56].  Studies on the TfR, with its unique 
internalization and recycling, have advanced understanding of the intricacies of 
the sorting pathways of endocytosed molecules.  Cells utilize the iron bound to Tf 
circulating in blood plasma upon Tf internalization.  At neutral extracellular pH 
(7.4), di-ferric-Tf binds to its receptor, internalizes through clathrin coated pits, 
and fuses with an endosome.  The acidic environment of the endosome (pH 5.5) 
causes the release of iron from the Tf while the apo-Tf remains bound to its 
receptor [57].  The intact apoTf-TfR complex is efficiently recycled from 
endosomes to the cell surface via the juxtanuclear recycling endosome or by 
direct recycling from early endosomes [58] where, at neutral pH, apo-Tf is 
released and the TfR is free to bind more di-ferric-Tf [59].  Wortmannin treatment 
results in partial inhibition of TfR recycling [60,61] possibly because the recycling 
endosomal pathway requires PI3-K while the fast recycling pathway does not. 
8
The endocytic system is energetically essential.  Cells internalize greater 
than 25% of their plasma membrane per hour [62].  Tf cycles from and back to 
the extracellular space in 2-3 minutes [63] and more LDL particles are 
internalized from the extracellular space and degraded than can be accounted for 
by new LDLR protein synthesis [64].  Thus the endocytic system allows for the 
remodeling and reuse of membranes that could not be otherwise reconstituted by 
de novo synthesis. 
Under physiological conditions, simultaneous addition of EGF and Tf to 
COS cells resulted in low levels of associated cargo molecules as observed by 
TIRF microscopy [49].  EGF and Tf bind to their receptors located in distinct 
plasma membrane regions and are incorporated into different endocytic vesicles 
[49].  EGF enters the cell through small, peripheral structures (Figure 1.2).  The 
internalized EGF rapidly and specifically associates with EEA1 within 4-5 minutes 
of EGF addition to cells regardless of signal intensity (Figure 1.3B) [49].  In 
contrast, Tf enters the cell through concentrated patches found throughout the 
cell membrane in addition to areas of diffuse signal and rapidly traffics to the 
juxtanuclear region (Figure 1.2).  These results strongly indicate that different 
machineries exist to control internalization and sorting occurs not only at the level 
of the endosome, but also the plasma membrane [49].  These and other findings 
support the notion that endosomes exist as functionally distinct heterogeneous 
populations [26,65-67].  It has been suggested that PI3K utilizes different 
effectors at apical and basolateral endosomes in polarized cells [68].  In 
9
 Figure 1.2. Binding and internalization of EGF and Tf in COS-7 cells. 
COS-7 cells grown on coverslips were placed in KRH buffer at 35°C, and 
exposed to 50ng/ml Alexa-Fluor568-EGF and 20µg/ml Alexa-Fluor488-Tf. 
Image capture was started immediately after ligand addition. Background 
is pseudo colored in yellow to enhance low level signal. Colocalized 
signal (arrows) is pseudo colored in white.  Figure from Leonard D et al. 
J Cell Sci 2008;121:3445-3458. 
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 Figure 1.3. EEA1 and Rabenosyn-5 schematic.  A.  Topology and selected 
effector binding regions of EEA1.  B.  COS-7 cells expressing GFP-EEA1 were 
imaged by TIRF microscopy during continuous incubation with 50ng/ml 
Alexa568-EGF for the times indicated.  Depicted is the specific colocalization of 
EGF with EEA1.  Image from Mechanisms of Endocytic Sorting: a 
dissertation by Deborah Marie Leonard 2006.   C.  COS-7 cells expressing 
GFP-EEA1 were imaged by TIRF microscopy during continuous incubation with 
10µg/ml Alexa568-Tf for the times indicated.  Depicted is the transient nature of 
the colocalization of Tf with EEA1.  Image from Leonard et al. J Cell Sci 
2008;121:3445-3458.  D. Topology and selected effector binding regions of 
Rabenosyn-5. 
A. 
B. 
C. 
D. 
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polarized Drosophila wing cells, Rabenosyn-5 is required for the formation of 
actin bundles at the apical membrane, while in the basolateral region it is 
required for the formation of large endosomes [68].  In MDCK cells, EEA1 is 
found localized to basolateral endosomes where it may confer directionality of 
fusion events [69] suggesting functional differences between endosomal 
populations.  
Given that Tf-TfR containing vesicles do not show a rapid, specific 
interaction but rather a minor transient association with EEA1 (Figure 1.3C) [49] 
and only 20% localization with WDFY2, another PI(3)P binding FYVE domain 
protein localized to endosomes proximal to the plasma membrane [65], we chose 
to examine the role of another FYVE domain protein in early endocytosis, 
Rabenosyn-5 (Figure 1.3D).  Rabenosyn-5 has been suggested to interact with 
Eps homology domain (EHD) proteins and promote endosomal recycling to the 
plasma membrane, however its role in endocytosis has not been investigated 
[70].  Given that Rabenosyn-5 is first recruited through its Rab5 and FYVE 
binding domains, this data suggests that Rabenosyn-5 has the potential to be 
recruited to early endosomes where it receives cargo then transitioned to the 
endocytic recycling compartment.  Specifically Rabenosyn-5 has been implicated 
in bridging the transition from Rab5 to Rab4 compartments in the recycling of the 
TfR [41].  Given that Rabenosyn-5 is an effector protein capable of forming 
multivalent interactions and that transport of cargo along the endocytic pathway 
could be mediated by coordinated and sequential action of discrete Rab 
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membrane domains, Rabenosyn-5 may help to coordinate the transport of cargo 
along the endocytic recycling pathway. 
 
High resolution population based studies 
In recent years, microscopy techniques such as TIRF have allowed 
simultaneous imaging of two fluorophores in real time.  TIRF has been 
particularly important in elucidating cellular processes of endo- and exocytosis.  
With the advent of TIRF, for the first time, an approximately 300nm depth from 
the coverslip could be selectively illuminated without exciting fluorophores in the 
entire three dimensional volume of the cell [71].  The caveats of TIRF microscopy 
systems are 1) that most offer two wavelength excitation and 2) positional 
relationships between structures cannot be determined.  Due to the former 
caveat, the systematic analysis of multiple endosomes with respect to a ligand or 
multiple ligands with respect to endosomes has been absent.  The latter caveat 
is a result of the brightness of an object in the TIRF zone being due to either its 
size or its distance from the coverslip. 
While high capture rates and non-invasive imaging makes wide field 
fluorescence light microscopy highly advantageous, a disadvantageous aspect of 
light microscopy is the limitation imposed by the diffraction limit of light.  Light can 
only be focused to a diameter of approximately half the wavelength of the emitted 
light.  Visible light wavelengths range from 400-700nm meaning the diffraction 
limit for imaging under these conditions is 200-350nm.  With the diffraction limit of 
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approximately 200nm, significantly larger than subcellular structures, multiple 
objects less than 200nm apart appear as one.  Thus, in order to visualize and 
systematically analyze the transfer of endocytic cargo from one compartment to 
another within the early endocytic pathway we developed a three fluorophore 
TIRF system.  To provide the spatial resolution required to identify the topological 
organization of endocytic intermediates or compartments involved in cargo 
transfer, we coupled epifluorescence structured light (ESL) to this TIRF system.  
Structured-illumination microscopy is a method of wide field fluorescence 
microscopy that achieves resolution beyond the diffraction limit of light [72].  By 
combining TIRF and ESL we will be able to determine the position of endosomes 
relative to the cell surface.  The microscopy platform we have developed allows 
the detection of the precise position of endosomes relative to the plasma 
membrane during the uptake of cargo.  Axial resolution is maximized by 
concurrently applied TIRF and ESL allowing us to address the fundamental 
question of whether different internalization mechanisms deliver cargo into 
distinct subsets of early endosomes.  Chapter 2 utilized this new microscopy 
platform, TESM (TIRF Epifluorescence Structured light Microscope, illustrated in 
Figure 1.4), to investigate the endocytosis of the transferrin receptor with respect 
to endocytic domains in real time. 
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 Figure 1.4.  Overview and schematic of TIRF and Epifluorescence 
Structured light Microscope (TESM).  Instrument layout showing four lasers 
(L1, 491nm; L2, 561nm; L3, 660nm; L4, 808nm), shutters (S1, S2, S3, S4) 
mirrors (M1, M2, M3, M4) and dichroic mirrors (D1, D2), beam splitters (BS1, 
BS2), neutral density filters on the TIRF beam path (ND1) and the 
epifluorescence beam path (ND2), lenses (L1, L2, L3), and filter wheel (FW). 
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Trafficking of self-delivering small interfering RNA 
RNA interference (RNAi) is a naturally occurring cellular process in 
eukaryotes affecting post-transcriptional gene silencing.  The multi-step RNAi 
pathway is initiated by double stranded RNA (dsRNA) and results in sequence-
specific mRNA degradation.  A crucial component of the immune response to 
foreign genetic material such as bacteria and viruses is RNAi.  The endosomal 
pathway could link RNAi machinery to innate immunity.  Non-cell autonomous 
gene silencing is a novel mechanism of intracellular communication and, 
potentially, viral defense that requires RNAi silencing signals to travel between 
cells.  Many [73-75] but not all [76,77] organisms can communicate RNAi 
silencing between cells.  One possible evolutionary advantage of systemic RNAi 
is an antiviral defense.  It is known that systemic RNAi acts as an antiviral 
defense mechanism in plants and recently HIV-1 was shown to elicit nucleic acid-
based immunity in human cells [78].  In addition to the naturally occurring 
process, short duplexes (21 nucleotides) of chemically synthesized siRNAs 
introduced into mammalian cells also result in efficient sequence-specific gene 
silencing [79].  Conversely, long dsRNA, those greater than 30 nucleotides, elicit 
an interferon mediated anti-viral response in mammalian cells [80].  The ability of 
siRNA to induce targeted silencing of genes has the potential to be harnessed to 
treat human diseases by specifically silencing genes that lead to disease. 
Challenges to any RNAi therapeutic model include successful delivery and 
entry of siRNAs into a cell type of interest.  RXi Pharmaceuticals developed a 
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novel class of self delivering RNAi compounds (sd-rxRNA®) that do not require a 
delivery vehicle for cellular uptake.  Sd-rxRNA is a hydrophobically modified 
hybrid of conventional RNAi and antisense compounds resulting in a unique 
class of RNAi compounds with improved drug-like properties compared to 
traditional siRNAs with the potential to be utilized as therapeutics.  A detailed 
understanding of the mechanism of sd-rxRNA uptake will allow the development 
of RNAi compounds that target tissues of interest with efficient intracellular 
uptake.  Within Chapter 3 I investigate the endocytic route utilized by sd-rxRNA 
following exposure to cells and components of the endocytic pathway required 
for functional silencing by targeted sd-rxRNA. 
 
Molecular mechanisms of dopamine transporter trafficking 
Dopaminergic neurotransmission plays a pivotal role in motor control, 
cognition, and rewarding behaviors in the central nervous system.  Synaptic 
dopamine (DA) levels are stringently controlled by DA reuptake mediated by the 
sodium- and chloride- dependent plasma membrane DA transporter (DAT).  DAT 
is potently inhibited by psychostimulants, and blocking DA uptake with these 
agents increase extracellular DA levels and enhances postsynaptic signals 
[81,82].  Consequently, the number of active DATs at the plasma membrane is 
directly linked to the efficacy of DA signaling and psychoactive drug targeting.  
Extensive evidence demonstrates that DAT is not a static membrane protein; 
rather, it robustly traffics to and from the cell surface via the endocytic pathway 
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[83-86].  Moreover, DAT surface levels are dynamically regulated by altering 
transporter trafficking kinetics through both protein kinase C (PKC) activation and 
exposure to amphetamine [81,87-89].  To date, the molecular mechanisms 
governing DAT endocytic trafficking are not well defined. 
We recently reported that DAT carboxy terminal residues 587-596 encode 
endocytic signals required for basal and PKC-accelerated DAT endocytosis 
[90,91].  We sought to identify proteins that interact with the DAT endocytic signal 
and may play a role in basal and PKC-accelerated DAT internalization.  We 
utilized the hSOS rescue yeast two-hybrid system, which allows bait-target 
interactions at or near the plasma membrane, mimicking the expected 
interactions of proteins with DAT during endocytic events.  Using the DAT 587-
596 domain as bait in a screen against the human substantia nigra library, we 
identified the small plasma membrane associated GTPase, Rin/Rit2, as a 
candidate DAT-interacting protein.  Rin is a 25kDa GTPase that directly binds the 
C-terminal domain of calmodulin and may play a role in activation of PKC 
through interactions with the PDZ binding domain of Par6 [92,93].  Given that 
DAT activity is regulated by both PKC and CamKII [94], and that Rin is coupled 
to both of these pathways, it is likely that Rin could play a role in PKC-regulated 
DAT trafficking.  As discussed in Chapter 4, cellular, in vitro, and biochemical 
approaches were utilized to investigate the role of Rin in DAT trafficking. 
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CHAPTER II 
 
RABENOSYN-5 DEFINES THE FATE OF THE TRANSFERRIN RECEPTOR 
FOLLOWING CLATHRIN-MEDIATED ENDOCYTOSIS 
 
ABSTRACT 
Cell surface receptors and other proteins internalize through diverse 
mechanisms at the plasma membrane, and are sorted to different destinations.  
Different subpopulations of early endosomes have been described, raising the 
question of whether different internalization mechanisms deliver cargo into 
different subsets of early endosomes.  To address this fundamental question we 
developed a microscopy platform to detect the precise position of endosomes 
relative to the plasma membrane during the uptake of ligands.  Axial resolution is 
maximized by concurrently applied total internal reflection fluorescence (TIRF) 
and epifluorescence structured light.  We found that transferrin receptors are 
selectively delivered from clathrin-coated pits on the plasma membrane into a 
specific subpopulation of endosomes enriched in the multivalent Rab and 
phosphoinositide binding protein Rabenosyn-5.  Depletion of Rabenosyn-5, but 
not of other early endosomal proteins such as EEA1, resulted in impaired 
transferrin uptake and lysosomal degradation of transferrin receptors.  These 
studies reveal a critical role for Rabenosyn-5 in determining the fate of transferrin 
receptors internalized by clathrin-mediated endocytosis, and more broadly, a 
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mechanism whereby the delivery of cargo from the plasma membrane into 
specific early endosome sub-populations is required for its appropriate 
intracellular traffic. 
 
INTRODUCTION 
The endocytic pathway is known principally for its role in the uptake of 
receptors and ligands [47,95-97] and increasingly is being recognized as critical 
in other aspects of cell physiology.  For example, the control of cellular growth 
through mammalian target of rapamycin signaling involves associations with late 
endosomal membranes [98,99], and microRNA regulatory mechanisms are 
associated with endosomal/lysosomal membranes [100-102].  Thus, it is 
necessary to understand how the distinct membrane compartments of the 
endocytic pathway form, traffic internalized ligands, and serve as scaffolds for the 
assembly of regulatory complexes. 
In the classical view of the endocytic pathway [44-48], internalizing 
cargoes are incorporated into vesicles formed by clathrin-mediated or other 
mechanisms of endocytosis at the plasma membrane.  These vesicles fuse with 
a homogenous population of early endosomes from which cargo then is sorted to 
different destinations.  However, recent results demonstrate that genetic 
networks involved in the early trafficking of the transferrin (Tf) and EGF receptors 
(TfR and EGFR, respectively) differ from each other substantially [103] and find 
that EGF and Tf populate different subsets of vesicles almost immediately after 
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addition to live cells at physiological temperature [49].  Further evidence for early 
endosome heterogeneity is found in studies in which endosomes display different 
motilities and different phosphoinositide effector complements [65,66,104].  
These results suggest that different populations of early endosomes exist, raising 
the possibility that different ligands may be directed specifically from the plasma 
membrane into particular early endosome classes rather than internalizing into a 
common early endosome. 
The TfR has been studied extensively to define mechanisms involved in 
receptor-mediated endocytosis [47,105].  This receptor concentrates in clathrin-
coated membrane regions [106], from which it enters the endosomal system.  
Iron bound to Tf is released at the low pH of the endosomes, and the TfR 
recycles to the plasma membrane and releases iron-free Tf.  To visualize directly 
the movement of TfRs from clathrin-coated membrane structures into specific 
early endosome subpopulations, we developed a microscopy platform capable of 
simultaneously detecting three different fluorophores using total internal reflection 
fluorescence (TIRF).  Because TIRF images confound intrinsic fluorescence 
brightness with axial position, the true position of an endosome relative to the 
plasma membrane can be obtained only if its actual brightness is known.  Thus, 
we concurrently determined the in focus brightness of the endosomes in the 
TIRF field using Epifluorescence structured light (ESL) [107,108].  The 
combination of TIRF and ESL microscopy (TESM) provides the precise 
localization of endosomes relative to the cell surface. 
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Among key endosomal components implicated in early endosome fusion 
are proteins such as early endosome antigen 1 (EEA1) [109,110], adaptor 
protein phosphotyrosine interaction (APPL1) [67], and Rabenosyn-5 [32].  Their 
function is controlled by small GTPases, such as Rab4 and Rab5, and lipids such 
as phosphatidylinositol 3-phosphate [31,38,111].  To determine the role of 
endosomes containing these proteins, we imaged each one simultaneously with 
clathrin and Tf.  We found distinct endosome subpopulations enriched in these 
markers residing at different regions within the TIRF zone.  Tf is internalized from 
clathrin-coated regions at the plasma membrane into endosomes containing 
Rabenosyn-5.  Depletion of Rabenosyn-5, but not of EEA1, results in TfR 
missorting and extensive degradation, coupled with alterations in clathrin 
dynamics.  These results reveal the importance of Rabenosyn-5 in early 
endosomal trafficking of cargo internalized through clathrin-mediated 
mechanisms and suggest that specific endosome populations are involved in the 
trafficking of cargo entering through distinct plasma membrane internalization 
pathways. 
 
RESULTS 
Flux of Tf from the Plasma Membrane through the Endosomal System 
To visualize the movement of Tf from clathrin-enriched plasma membrane 
regions into the endosomal system, Tf-DyLight-649 was added to cells 
cotransfected with TagRFP-T-clathrin and EGFP-tagged Rabenosyn-5, APPL1, 
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or EEA1.  Cells were imaged at 1 Hz (one frame/s) continuously for 15 min: 5 
min before the addition, 5 min in the presence, and 5 min after the removal of Tf-
DyLight-649.  Figure 2.1A illustrates one time frame of the resulting 900-image 
set, taken 1 min after the addition of Tf. To analyze these complex time-lapse 
image sets systematically, we used the method illustrated in Figure 2.1B and 
further described in Experimental Procedures.  This method identifies all 
individual structures within the image and measures the relative amount of Tf 
specifically associated with them at each time point.  In this example, images of 
TagRFP-T-clathrin (Figure 2.1B, Top, Unprocessed) are first convolved using a 
difference of Gaussians (DOG) filter to eliminate the diffuse signal originating 
from out of focus or auto fluorescence (Figure 2.1B, Top, DOG).  The pixel of 
highest intensity within each region is identified (Figure 2.1B, Top, MIP) and is 
mapped on the unprocessed clathrin image (Figure 2.1B, Middle Left). A 5 × 5 
pixel square (25 pixels) surrounding this pixel is outlined (Figure 2.1B, Middle 
Right), and its mean intensity [clathrin (in)] is recorded.  From this value, the 
mean intensity of a one-pixel-wide frame (24 pixels) surrounding the square 
(Figure 2.1B, Middle Right, hatched regions) is subtracted [clathrin (out)], thus 
subtracting the local background.  The positions of the maximum intensity pixels 
(MIPs) derived from the clathrin image are mapped onto the corresponding 
unprocessed Tf image (Figure 2.1B, Bottom), and the same calculation is 
performed.  Thus, Tf has a positive value only if the signal detected within the 5 × 
5 pixel region is higher than that of the immediate surrounding region.  The ratio 
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 Figure 2.1. Dynamics of Tf flux into Rabenosyn-5 enriched endosomes. A. 
Cells co-expressing EGFP-Rabenosyn-5 (green) and TagRFP-T-Clathrin (red) 
were exposed to Tf-DyLight-649 (blue). Representative frames of images taken 
immediately before (t=0) and 60 seconds after addition of Tf (t=60s). B. A 
representative unprocessed image (top, left) of TagRFP-T-Clathrin was 
smoothed using a difference of Gaussians as described in the Methods (DOG, 
top, center), and the maximum intensity pixel (MIP) of each region identified 
(MIP, top, right) and mapped onto the unprocessed Clathrin (Clath, center, left) 
and Transferrin (Tf, bottom left) images. Areas of 5x5 pixels (in) and a 
surrounding 1 pixel-wide frame (out) were delineated around each MIP in each 
image (center and bottom right). C. The average ratio of (Tf(in) - Tf (out))/
(Clath(in) - Clath(out)) and (Tf(in) - Tf (out))/(Rbsn(in) - Rbsn(out)) of all 
maximum intensity pixels at each time point was calculated and normalized to a 
maximum of 1. D. Percent of Tf pixels colocalized with Clathrin (red) or 
Rabenosyn-5 (green) over time. Spikes seen upon addition and removal of Tf 
are due to temporary focus shifts, which recover rapidly. This experiment was 
repeated 4 times with similar results (Table. 2.1). E. Representative images 
showing Tf associating with clathrin-enriched regions (red arrows) and 
subsequently with Rabenosyn-5 endosomes (green arrows).  
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of the values obtained [Tf (in) − Tf (out)/clathrin (in) − clathrin (out)] for each 
region then is calculated, and the mean of all regions in the image is plotted for 
each time point (Figure 2.1C).  In the same cell, the trafficking of Tf into 
Rabenosyn-5–containing endosomes is measured similarly.  The data (Figure 
2.1C) are fit into a kinetic model, described in detail in the experimental 
procedures “Curve Fits to Ratio Data” section, that incorporates known constants 
for Tf binding to the TfR, the concentration of free ligand, and the amount of Tf 
associated with clathrin. 
Tf associates rapidly and saturably with clathrin-containing regions, 
displaying kinetic constants consistent with binding to the TfR (Table 2.1) [112-
114].  Interestingly, Tf is detected almost immediately within Rabenosyn-5–
enriched regions, with virtually no time elapsing between the detection of Tf in 
clathrin-coated regions and its detection in Rabenosyn-5 endosomes, and 
continues to accumulate in these endosomes as long as free Tf is present.  
When Tf is removed from the medium, it disappears rapidly from clathrin-
enriched regions because of transfer into the endosomal pathway (Table 2.1).  
Strikingly, the rate of exit of Tf from clathrin-containing membrane regions 
(0.0053 ± 0.002/s, mean ± SEM, n = 4), is indistinguishable from its rate of entry 
into Rabenosyn-5–enriched endosomes (0.0037 ± 0.002/s, mean ± SEM, n = 4) 
(Table 2.1), implying that Tf internalized via clathrin-coated pits could be 
delivered almost directly into Rabenosyn-5–containing endosomes. 
We then calculated the net amount of Tf colocalizing with clathrin and 
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Table 2 1.  Kinetic constants for transferrin trafficking through Clathrin and 
Rabenosyn-5 
 
  
 
Tabl  S1  Kin ti  nsta ts f  tr f rr n tr fi ki  thou  cl thr n  
nd r ben y  
experiment 
Tf/clathrin 
t1 t2 A1 Tfconc k(empty) 
1 303 647 0.19534 7.18E-08 0.01062 
2 297 622 0.11696 4.44E-08 0.00534 
3 316 664 0.56492 1.51E-08 0.00123 
4 296 624 0.22226 2.67E-08 0.00407 
      mean 303.6 637.2 0.24078 6.32E-08 0.00538 
std.err. 3.6 8 0.08408 2.55E-08 0.00152 
tau(sec.)         185.9 
experiment 
Tf/rabenosyn 
 
B1 k(in) k(empty) k(fill) 
1 
 
2.5159 0.00593 0.00681 0.00037639 
2 
 
0.4234 0.10487 0.03356 0.00136871 
3 
 
2.9916 0.01162 0.0055 0.00897243 
4 
 
5.5213 0.01227 0.00589 0.00406776 
       mean 
 
2.86305 0.03367 0.01294 0.00369632 
std.err. 
 
1.04703 0.02377 0.00688 0.00192386 
tau(sec.)       77.3 270.5 
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Rabenosyn-5 over time (Figure 2.1D).  Approximately 70– 80% of Tf colocalized 
with clathrin within 2 min of exposure and then decreased because of increasing 
accumulation in endosomes.  The amount of Tf colocalizing with Rabenosyn-5 
increased in parallel, reaching ∼40% of the signal, such that >80% of Tf can be 
accounted for as colocalizing with either clathrin or Rabenosyn-5 4–5 min after 
addition.  Thus, both the kinetics (Figure 2.1C) and the net amount measured 
(Figure 2.1D) indicate that the majority of Tf proceeds from clathrin-coated 
pits/vesicles into Rabenosyn-5– containing endosomes.  Visual inspection of the 
images reveals numerous events consistent with this model, where Tf is seen 
moving from clathrin-enriched regions of the plasma membrane into endosomes 
containing Rabenosyn-5 localized in the immediate vicinity (Figure 2.1E). 
If indeed Tf can be delivered preferentially and rapidly to Rabenosyn-5-
enriched endosomes, there may be a high degree of proximity between clathrin-
coated plasma membrane regions and Rabenosyn-5-containing endosomes. 
TIRF imaging alone cannot be used to determine the positional relationship 
between these structures, because the brightness of an object can result from 
either its size or its distance from the cell surface (coverslip).  Thus, to determine 
the topological relationship between clathrin-coated regions and endosomes, we 
concurrently obtained ESL images, which provide the actual intensity of 
fluorescent structures within the field. TIRF (Figure 2.2A, TIRF) and ESL (Figure 
2.2A, ESL) images of GFP-clathrin and endogenous Rabenosyn-5 were obtained 
and were used to derive high-resolution 3D maps (TESM) of the position of 
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Figure 2.2. Localization of Rabenosyn-5 enriched endosomes and 
Clathrin relative to the cell surface. COS-7 cell expressing EGFP-
Clathrin and stained with antibodies to endogenous Rabenosyn-5 imaged 
with TIRF and epifluorescence structured light (ESL), and the resulting z- 
maps derived by TESM. Rightmost panels are enlargements of the section 
indicated. Lower panels are the overlapped images of Clathrin (green) and 
Rabenosyn-5 (red), displayed in XY orientation, and YZ orientation of the 
section indicated. Arrows indicate the differing depths within the cell at 
which Rabenosyn-5 containing endosomes detected in the TIRF zone are 
found.  
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endosomes relative to the cell surface, as described in detail in Experimental 
Procedures.  In these images, objects closest to the plasma membrane are 
displayed as blue, and those furthest away from the plasma membrane are 
displayed in red.  Numerous endosomes containing Rabenosyn-5 are as 
proximal as clathrin-enriched regions to the cell surface.  Similar information was 
obtained when clathrin and Rabenosyn were compared directly in overlapped 
TIRF and ESL images displayed in XZ orientation.  Bright objects visible in ESL 
often are less visible in TIRF because of their distance from the cell surface, and 
objects highly visible in TIRF actually may be dimmer objects that are very close 
to the cell surface.  These images demonstrate that Rabenosyn-5–enriched 
endosomes are in close proximity to clathrin-enriched regions at the cell surface, 
indicating that the topological organization of this pathway could accommodate a 
transfer from clathrin-coated pits/vesicles into these endosomes. 
To determine whether the delivery of Tf into Rabenosyn-5-containing 
endosomes is specific, we analyzed the relationship between Tf internalization 
and other endosome classes.  Recently it has been shown that in cells 
expressing the constitutively active V12G mutant of H-Ras, clathrin-mediated 
endocytosis gives rise to a set of endosomal intermediates containing the protein 
APPL1 [104].  As others have reported previously [67,104], we found APPL1 on 
small vesicles at the periphery of the cell image, whereas clathrin-enriched 
regions are present throughout (Figure 2.3A, Upper).  Several of the APPL1-
containing structures localize close to clathrin (Figure 2.3A, Lower), consistent 
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 Figure 2.3. Tf flux into APPL1-enriched endosomes.  A. 
Epifluorescence images of COS-7 cells co-expressing EGFP-APPL1 
(green) and TagRFP-T-Clathrin (red). Region of the cell showing APPL1 
localizing to small vesicles at the cell periphery in proximity to clathrin. B. 
Quantification of the ratio of (Tf(in) - Tf (out))/(Clath(in) - Clath(out)) and 
(Tf(in) - Tf (out))/(APPL(in) - APPL(out)) plotted as the mean of all regions 
at each time point over time. Spikes seen upon addition and removal of Tf 
are due to temporary focus shifts, which recover rapidly. C. Quantification 
of Tf colocalization with clathrin (red) or APPL1 (green) over time, n=3. D. 
Representative image at 5 minutes following addition of Tf. Arrows in the 
overlapped image indicate the areas where clathrin, APPL1, and Tf 
colocalize. E. Representative image of EGFP- APPL1 and TagRFP-T-
Rabenosyn-5 co-expressing COS-7 cell 5 minutes following addition of Tf. 
Arrow in overlapped image indicates the area where APPL1, Rbsn, and Tf 
colocalize.  
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Table 2.2.  Kinetic constants for transferrin trafficking through Clathrin 
and APPL1 
 
  
 
          
  
 
 
     
      
      
      
      
            
      
          
 
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
        
 
    
 
 
    
         
 
 
 
 
Tab e S  inet c constants for transferrin trafficking though clath in  
and PPL  
experiment 
Tf/clathrin 
t1 t2 A1 Tfconc k(empty) 
1 316.733 623.785 0.33306 2.89E-08 0.0039488 
2 322.342 656.389 0.17782 1.06E-07 0.0207115 
3 313.38 621.008 0.12156 2.83E-07 0.0097476 
4 298.298 629.488 0.41734 5.46E-09 0.0043682 
      mean 312.688 632.667 0.26244 1.06E-07 0.009694 
std.err. 5.14 8.101 0.0683 6.28E-08 0.0039025 
tau(sec.)         103.2 
experiment  
Tf/APPL1 
 
B1 k(in) k(empty) k(fill) 
1 
 
2.37253 0.0140693 0.0078423 0.00375113 
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with the hypothesis [104] that APPL1-containing endosomes are derived from 
clathrin-coated vesicles.  Tf occupied APPL1-containing structures at a rate 
similar to the rate at which it entered Rabenosyn-5 endosomes (Figure 2.3B and 
Table 2.2), but the net amount of Tf localizing to APPL1-enriched endosomes 
was almost negligible (Figure 2.3C).  In addition, only APPL1 endosomes closest 
to clathrin colocalized with Tf (Fig. 3D, overlap, white pixels), and these 
endosomes also contained Rabenosyn-5, as visualized in cells coexpressing 
EGFP-APPL1 and TagRFP-T-Rabenosyn-5 (Figure 2.3E).  Thus, Tf does not 
internalize through endosomes containing only APPL1. 
 
Functional Role of Rabenosyn-5 in TfR Internalization 
To examine the function of Rabenosyn-5 in Tf trafficking, we analyzed the 
effects of siRNA-mediated depletion.  Rabenosyn-5 protein decreased 48 h after 
transfection and was undetectable after 72 h (Figure 2.4A, Top).  Surprisingly, 
TfR levels were decreased markedly in response to Rabenosyn-5 knockdown, 
with the decline beginning 48 h after transfection (Figure 2.4A, Middle).  This 
effect was specific to the TfR, because GAPDH (Figure 2.4 A and B), or other 
elements of the endocytic pathway, such as clathrin, EEA1, and APPL1, and 
other receptors, such as the EGFR, were not affected (Figure 2.4B).  To 
determine whether other components of the early endocytic pathway would lead 
to similar changes in TfR levels, we compared the effects of Rabenosyn-5 and 
EEA1 depletion.  Depletion of EEA1 did not result in TfR degradation; instead, a 
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 Figure 2.4. Time course and effect of Rabenosyn-5 depletion on levels 
of endocytic proteins. A. Cells were transfected with scrambled (Sc) or 
Rabenosyn-5-directed (Si) oligonucleotides, and at the time points 
indicated or at 72 h and (B) analyzed by western blotting for the proteins 
indicated (Rabenosyn-5 = Rbsn; Transferrin receptor = TfR; Clathrin 
heavy chain = Clath; EGF Receptor = EGFR). C. Cells were transfected 
with scrambled (Sc), two different EEA1-directed (SiEEA1 a,b) 
oligonucleotides, or Rabenosyn-5-directed (Si Rbsn) and at 72 h analyzed 
by Western blotting for the proteins indicated. D. Representative TIRF (top 
panels) and epifluorescence (EPI, bottom panels) images of endogenous 
TfR in cells transfected with scrambled (Sc) or Rabenosyn-5- directed (Si) 
oligonucleotides for 72 hours. Epifluorescence images are auto scaled for 
illustration purposes to reveal the region of maximal TfR concentration. d. 
Quantification of the mean intensity of endogenous TfR in TIRF and EPI 
images.  
 
 
5µm 
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small but detectable increase in TfR levels was observed (Figure 2.4C).  These 
results demonstrate that Rabenosyn-5 and EEA1 have fundamentally different 
roles in Tf trafficking and are consistent with a previously proposed role of EEA1 
in trafficking toward the lysosomal pathway [49].  To determine whether 
Rabenosyn-5 depletion would, in addition to decreasing total levels, affect the 
cellular distribution of the TfR, we performed immunofluorescence analysis.  A 
marked decrease in endogenous TfR levels was visible in the TIRF zone (Figure 
2.4D, Upper Left), with remaining receptors detected by epifluorescence in the 
juxtanuclear region (Figure 2.4D, Lower Left). Quantification of the image 
intensity revealed a 75% decrease in TfR intensity in TIRF. These results reveal 
that the absence of Rabenosyn-5 results in a depletion of the TfR population 
found in the cell periphery at steady state. 
 To examine further how Rabenosyn-5 depletion affects TfR trafficking, we 
examined its internalization and recycling rates.  Tf internalization was reduced 
markedly in cells depleted of endogenous Rabenosyn-5, and this defect could be 
rescued by transfection of exogenous EGFP-tagged Rabenosyn-5 (Figure 2.5). 
The binding of Tf to the cell surface (Figure 2.6A) and the net amount 
internalized (Figure 2.6B) were decreased significantly in cells depleted of 
Rabenosyn-5, consistent with the decrease in total and surface TfR levels 
detected by Western blotting and TIRF imaging.  However, the rate of individual 
receptor internalization, assessed from the ratio of bound to internalized Tf 
(Figure 2.6C), was not significantly different, suggesting that the lack of 
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 Figure 2.5. Inhibition of Tf uptake by Rabenosyn-5 knockdown is 
rescued by wild-type EGFP-Rabenosyn-5 expression. Cells were 
exposed to scrambled (Sc) or Rabenosyn-5 directed siRNA 
oligonucleotides (Si) for 72 hr, without or with co-transfection of non-
siRNA resistant wild-type EGFP-tagged Rabenosyn-5 (RbsnWT) or a 
mutant in which the C2H2 N terminal zinc finger was disrupted by 
mutation of Cysteine residues 16 and 19 to serine (RbsnC16,19S). 
Transferrin was added for 10 min, and cells fixed and imaged. A. 
Representative cells. B. Quantification of average Tf fluorescence 
intensity in 10 fields of cells acquired with a 20x objective. Statistical 
analysis was done using two tailed student t- tests   
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 Figure 2.6. Effect of Rabenosyn-5 depletion on Tf trafficking.  Cells 
were transfected with scrambled (Sc) or Rabenosyn-5-directed (Si) 
oligonucleotides, and at 72 h the cell surface binding (A), internalization 
(B) internalization rate (C) and recycling rate (D) were measured using 
HRP-labeled Tf and chemiluminescence as described in the Experimental 
Procedures. Plotted are the means and SEM of three experiments. 
Statistical significance was calculated using two-tailed Student t-test for 
each time point as indicated. E. Cells were transfected with EGFP-clathrin 
and treated with scrambled (Sc) or Rabenosyn-5 siRNA (Si) for 72 hr. Tf-
DyLight-649 was added and removed 300s later, and shown are images 
obtained at the time points indicated. Images were smoothed as described 
in Figure 2.1, and binary renditions generated to visualize all signal 
present. Pixel overlap is rendered in yellow. Arrows point to structures 
containing transferrin but devoid of clathrin.  
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Rabenosyn-5 does not directly impair the very early steps of TfR recruitment into 
clathrin-coated vesicles.  In contrast, the recycling of TfR to the plasma 
membrane, assessed by the release of previously internalized Tf (Figure 2.6D), 
was markedly decreased by Rabenosyn-5 depletion.  The major difference in 
recycling rate was seen in the first 15 min, suggesting that the rapid recycling 
pathway of the TfR [47] is affected preferentially.  To compare the biochemical 
results to events at the single-cell level, Tf uptake and recycling were visualized 
by TIRF in cells expressing GFP-clathrin (Figure 2.6E).  In both control and 
Rabenosyn-5–depleted cells, Tf associates immediately with clathrin-enriched 
regions of the membrane, such that at early time points (0–30 s) virtually all the 
Tf signal colocalizes with clathrin (Figure 2.6E, Top, yellow). Subsequently, 
vesicular structures appear that contain Tf but lack clathrin (Figure 2.6E, arrows, 
red).  At 30 s after washing these structures are likely to represent both uncoated 
internalizing vesicles and vesicles involved in rapid recycling of Tf; the latter 
gradually predominate with increasing time following removal of Tf from the 
medium (Figure 2.6E, t = 240 s after washing). Recycling vesicles were greatly 
reduced in cells depleted of Rabenosyn-5, consistent with the finding of a slowed 
rapid recycling rate seen in the cell population (Figure 2.6D). 
To begin to define the mechanisms by which Rabenosyn-5 depletion leads 
to a decrease in TfR levels, we first examined whether its effects were exerted at 
the transcriptional or post-transcriptional level.  Translation of the TfR is 
regulated through sequences in the 3′ and 5′ untranslated regions (UTRs) of its 
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mRNA.  To study the regulation of TfR levels independently of translational 
control, we measured the levels of TfR-EGFP expressed from a plasmid lacking 
the regulatory sequences present in the endogenous TfR mRNA (Figure 2.7A). 
Endogenous and GFP-tagged expressed TfR levels were reduced equally in 
response to Rabenosyn-5 depletion, ruling out an effect of this protein on 
transcriptional or translational control of TfR expression.  Although the majority of 
the TfR undergoes recycling after internalization, a larger proportion may be 
targeted to the lysosome for degradation in the absence of Rabenosyn-5 [115].  
Consistent with this possibility, exposure of cells to Bafilomycin A1, an inhibitor of 
acidification and lysosomal degradation, resulted in increased TfR levels (Figure 
2.7B), and this effect was more pronounced in Rabenosyn-5–depleted cells. 
Together these results suggest a model in which, in the absence of Rabenosyn-
5, the TfR is missorted into endosomes that direct cargo toward lysosomal 
degradation (Figure 2.7C). 
In addition to decreased TfR levels and Tf recycling, Rabenosyn-5-
depleted cells also displayed alterations in clathrin dynamics. Both the number of 
GFP-clathrin regions detected by TIRF (Figure 2.8A) and their average size 
(Figure 2.8B) were significantly greater in cells depleted of Rabenosyn-5. 
Analysis of endogenous clathrin was consistent with the results seen for GFP-
clathrin, revealing an increase in the intensity of clathrin signal in the TIRF zone 
and the perinuclear region (Figure 2.8 C and D).  Because no difference in total 
clathrin was detected by Western blotting (Figure 2.4B), and there is a significant 
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 Figure 2.7.  Mechanism of TfR loss in response to Rabenosyn-5 
depletion. A. Western blotting of TfR in cells transfected with TfR-GFP 
and treated with scrambled (Sc) or Rabenosyn-5 siRNA (Si) for 72 hr 
after transfection. GAPDH is used as a loading control. B. Cells were 
transfected with scrambled (Sc) or Rabenosyn-5-directed (Si) 
oligonucleotides, and at 48 hr treated with or without 100nM Bafilomycin 
A1 (Baf). After 24 hr lysates were harvested and analyzed by Western 
blotting and immunofluorescence for the TfR. C. In this model, TfR is 
internalized into endosomes marked by Rabenosyn-5, which are 
juxtaposed to clathrin-coated plasma membrane regions, from which it is 
rapidly recycled to the plasma membrane. A small fraction of TfR may be 
directed into EEA1-enriched endosomes, which are destined for 
lysosomal degradation. In the absence of Rabenosyn-5, clathrin-coated 
structures accumulate and their cargo enters lysosome- directed 
pathways, resulting in low recycling rates.  
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 Figure 2.8.  Effect of Rabenosyn-5 depletion on Clathrin 
Distribution. Cells were transfected with EGFP-clathrin and treated 
with scrambled (Sc) or Rabenosyn-5 siRNA (Si) for 72 hr. The number 
(A) and size (B) of clathrin regions in the TIRF zone was determined 
from binary renditions of smoothed images such as those depicted in 
Figure 2.6E. Results are the means and SEM of regions from 8-10 cells. 
C. Representative TIRF (top panels) and epifluorescence (bottom 
panels) images of endogenous clathrin in cells transfected with 
scrambled (Sc) or Rabenosyn-5- directed (Si) oligonucleotides for 72 
hours. D. Quantification of the mean intensity of endogenous clathrin in 
TIRF and epifluorescence (EPI) images. Results are the means and 
SEM of 8-10 cells. Statistical significance was calculated using two-
tailed Student t-test.  
 
5µm 
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pool of cytoplasmic unassembled clathrin in these cells (not illustrated), these 
results suggest that Rabenosyn-5 depletion leads to an increase in the proportion 
of total cellular clathrin assembled on both the plasma membrane and the trans-
Golgi network.  Although more work is required to understand their mechanistic 
basis, these findings further suggest a possible direct interaction between 
clathrin, or associated molecules, and Rabenosyn-5 on endosomes, possibly 
facilitating the delivery of cargo to the specific endosome subpopulation 
containing this protein. 
 We and others have previously found that the EGF receptor, which is 
largely degraded after internalization, quantitatively enters EEA1-enriched 
endosomes [49,116], suggesting that these endosomes are part of an endocytic 
route directing ligands to the lysosome for degradation.  As suggested by 
knockdown of EEA1 (Figure 2.4C) and treatment with Bafilomycin A1 (Figure 
2.7B) a significant amount of TfR appears to be targeted for degradation, 
therefore we asked the question of whether a fragment of internalized Tf might 
be directed into endosomes containing EEA1.  Analysis of Tf uptake was 
performed in cells co-expressing EGFP-Rabenosyn-5 and TagRFP-T-EEA1.  
The rate with which Tf enters EEA1-enriched endosomes is slower than that at 
which it enters Rabenosyn-5 containing endosomes (Figure 2.9C), and the 
amount of Tf associated with EEA1-enriched endosomes was significantly 
smaller than that associated with Rabenosyn-5 enriched endosomes at any time 
point analyzed (Figure 2.9B).  Images obtained from these cells were consistent 
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 Figure 2.9.  Relative flux of Tf through EEA1-enriched and Rabenosyn-5-
enriched endosomes.  A.  Representative images of Tf-DyLight-649 uptake 
into cells co-expressing EGFP-Rabenosyn-5 (green) and TagRFP-T-EEA1 (red). 
Arrows depict Rabenosyn-5 endosomes co-localizing with Tf, arrowheads depict 
EEA1 endosomes co-localizing with Tf at times following addition of Tf indicated 
in seconds.  B.  Quantification of the percent of Tf co-localized with endosomes 
containing Rabenosyn-5 (green) and EEA1 (red).  C.  Quantification of the ratio 
of [Tf(in)-Tf(out)]/[Rbsn(in)-Rbsn(out)] and [Tf(in)-Tf(out)]/[EEA1(in)-EEA1(out)] 
plotted as the mean of all regions at each time point over time from cells co-
expressing EGFP-Rabenosyn-5 and TagRFP-T-EEA1. 
A. 
B. C. 
5µm 
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with the quantitative analysis; as seen before, Tf accumulated in Rabenosyn-5 
labeled endosomes rapidly (Figure 2.9A, arrows), while EEA1-containing 
endosomes remained unoccupied.  At later time points, Tf was found to 
colocalize with EEA1-containing endosomes (Figure 2.9A, arrowheads).  These 
results indicate that a small but significant amount of Tf traffics into EEA1 
endosomes, possibly reflecting the fragment of the receptor population being 
targeted for lysosomal degradation at steady state. 
 
Topological organization of endosomes containing EEA1 and Rabenosyn-5 
 Several lines of evidence presented here and published by others suggest 
that EEA1 and Rabenosyn-5 mediate different endocytic trafficking functions.  
For example, knockdown of Rabenosyn-5 [70], but not of EEA1 [49], affects Tf 
recycling, and knockdown of EEA1 impairs EGF degradation.  Data presented in 
Figure 2.2 shoes that Rabenosyn-5 enriched endosomes are juxtaposed to 
clathrin enriched regions at the cell surface and the evidence presented in Figure 
2.9 suggests the potential for a topological relationship whereby EEA1 enriched 
endosomes are more distal from Rabenosyn-5 enriched endosomes.  While 
overexpressed Rabenosyn-5 and EEA1 co-localize extensively under conditions 
where Rab5 is simultaneously over expressed [32] to our knowledge an analysis 
of the distribution of endogenous EEA1 and Rabenosyn-5 in the absence of Rab 
overexpression has not been performed.  To obtain the topological relationship 
between Rabenosyn-5 endosomes and EEA1 endosomes we simultaneously 
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obtained TIRF and ESL images.  Figure 2.10 illustrates the distribution of EEA1-
containing and Rabenosyn-5 containing endosomes in the TIRF zone (Figure 
2.10, TIRF) and in the three dimensional volume of the cell using ESL (Figure 
2.10, ESL).  By combining the TIRF and ESL images (Figure 2.10, TESM), a 
three dimensional map of the position of these endosomes within ~400nm from 
the plasma membrane was generated.  These images reveal a population of 
endosomes containing Rabenosyn-5 but no EEA1 localized close to the plasma 
membrane (Figure 2.10, blue objects) compared to endosomes containing EEA1.  
When EEA1 and Rabenosyn-5 are expressed as fusion proteins with either 
EGFP or TagRFP-T, the distinct identity of endosomes containing these markers 
is also apparent (Figure 2.11).  Both TIRF and ESL projected images reveal the 
presence of endosomes containing EEA1, Rabensoyn-5, or both.  TESM also 
reveals Rabenosyn-5 enriched endosomes localized closer to the plasma 
membrane, as seen for the endogenous protein.  Thus, expression of the tagged 
version of these molecules mimics their endogenous distribution.  These studies 
suggest the Rabenosyn-5 endosomes are part of an endocytic route directing 
cargo for recycling.  These pathways also appear to be spatially separated with 
Rabenosyn-5 endosomes residing closer to the plasma membrane than EEA1 
endosomes.  The results shown here suggest that sorting of internalized cargo 
proceeds through the delivery of cargo from the plasma membrane into 
specialized endosomal populations characterized by their topological 
organization relative to the plasma membrane. 
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 Figure 2.10. Topology of Rabenosyn-5 and EEA1-enriched endosomes.  A. 
COS-7 cell stained with antibodies to endogenous Rabenosyn-5 and EEA1 
imaged with TIRF, epifluorescence structured light (ESL), and TESM.  Right, 
Enlarged image of section indicated.  B. and C. The number and size, 
respectively, of endosomes containing EEA1, Rabenosyn-5 (Rbsn) or both 
(coloc) in the TIRF zone*p >0.05, n=5 cells.  D. and E.  The number and size, 
respectively, of endosomes containing EEA1, Rbsn or both (coloc) found by 
SLE at proximal (0) and distal (+2.5µm) points relative to the plasma membrane 
*p >0.05, n=5, two-tailed student t-test.  #p>0.05, n=5, one-tailed student t-test.  
A. 
B. D. 
C. E. 
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 Figure 2.11.  Topology of Expressed Rabenosyn-5 and EEA1-enriched 
endosomes.  COS-7 cell co-expressing EGFP-Rabenosyn-5 and TagRFP-
T-EEA1 analyzed by TIRF, ESL, and TESM. 
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DISCUSSION 
A large amount of evidence has demonstrated that internalization from the 
plasma membrane proceeds through clathrin-dependent and -independent 
mechanisms [95] and that variation exists within these mechanisms, whereby, for 
example, certain subpopulations of clathrin-coated pits may capture different 
receptor types preferentially [114,117].  Until recently it was thought that these 
diverse internalization mechanisms delivered cargo into a homogenous 
population of early endosomes from which sorting to different destinations 
occurred.  However, recent genetic and imaging results have suggested that 
early endosomes may not be functionally homogeneous, displaying differences in 
composition, cargo enrichment, and motility [49,65,66,103,104].  The findings of 
varied internalization mechanisms at the plasma membrane and of different 
endosome subpopulations raise the question of whether different internalization 
mechanisms are associated with distinct endosome subtypes. 
To address this question, we investigated whether the TfR, internalized 
through clathrin-mediated endocytosis, would be delivered to a specific 
endosome subpopulation.  This investigation required the use of a platform that 
could detect three fluorophores simultaneously with high temporal and spatial 
resolution in live cells and analytical methods to generate quantitative models 
from resulting complex images.  By simultaneously monitoring clathrin and early 
endosome markers, it was possible to visualize Tf internalizing from clathrin-
coated membrane structures into endosomes containing specific markers.  The 
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resulting images and kinetic models derived from quantitative analysis indicated 
that Tf enters endosomes containing Rabenosyn-5 almost immediately following 
its entry through clathrin-coated structures.  By enhancing axial resolution in the 
TIRF zone by combining TIRF and ESL, it was found that Rabenosyn-5–enriched 
endosomes reside closest to clathrin-enriched structures at the plasma 
membrane, providing a topological framework for delivery of Tf into this specific 
endosome population. 
The results discussed above led us to test the hypothesis that Rabenosyn-
5 might be functionally involved in the movement of TfR from clathrin-coated 
structures into endosomes.  Biochemical and morphological analysis revealed 
impairment in rapid TfR recycling following internalization and a marked increase 
in TfR degradation.  In conjunction, the dynamics of clathrin at the plasma 
membrane appear altered, with the size and number of clathrin-enriched regions 
being increased.  Clathrin-enriched regions at the plasma membrane are larger 
than individual clathrin-coated pits and vesicles and are likely to represent areas 
of enhanced formation of these structures [106,112,114].  Thus, an increase in 
their size and number may reflect a delay in the movement of clathrin-coated 
vesicles away from the plasma membrane or a delay in their uncoating and 
fusion with endosomes (Figure 2.6C).  These results are consistent with previous 
findings of impaired formation of early endosomes in Drosophila and 
Caenorhabditis elegans lacking Rabenosyn-5 [118,119] and with previous results 
in mammalian cells indicating a role for this protein in receptor recycling 
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[32,70,106].  Moreover, a direct role of Rabenosyn-5 in clathrin-mediated 
internalization may explain the mechanism by which dominant negative mutants 
of Rab5, which interacts with Rabenosyn-5 [120], impair Tf uptake [19]. 
Beyond identifying Rabenosyn-5 as an important regulator of TfR entry 
into the endosomal pathway, the data shown here suggest that sorting in general 
may occur through delivery of cargo into specific endosome subpopulations that 
maintain a defined topological organization relative to sites of endocytosis. 
Results by others also are consistent with the concept that diverse endocytic 
mechanisms are associated with specific endosomal subtypes. For example, 
work by Zoncu et al. [104] indicates that EGFR is internalized via 
macropinosomes that rapidly acquire APPL1 and subsequently acquire WD 
repeat and FYVE domain-containing protein 2 (WDFY2) and EEA1.  We [49] and 
others [116] also have observed that EGF is internalized from the plasma 
membrane into EEA1-containing endosomes and have found relatively low 
colocalization of internalizing Tf with EEA1 [49,105,121].  Moreover, knockdown 
of EEA1 leads to a detectable increase in TfR levels (Figure 2.4) and to an 
impairment of EGFR degradation [49], in stark contrast to the effect of 
Rabenosyn-5 knockdown in decreasing TfR levels.  These results support a 
model in which EEA1 and Rabenosyn-5 have fundamentally different roles in 
endosomal traffic:  Endosomes containing EEA1 appear to capture cargo 
destined to lysosomes, whereas endosomes containing Rabenosyn-5 capture 
cargo destined for recycling (Figure 2.6C). 
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Despite these different functions, many endosomes containing both 
Rabenosyn-5 and EEA1 are found deeper within the cell [41], but how these 
endosomes arise is not clear.  In one possible model, endosomes formed from 
larger portions of the membrane, such as EGF-containing macropinosomes that 
acquire EEA1 [104,122], also may acquire Rabenosyn-5 in conjunction with 
endosomal clathrin for the purpose of fully retrieving cargo that is not destined for 
the lysosomal pathway, as has been shown to occur for E-cadherin [123].  
Alternatively, EEA1 may associate with Rabenosyn-5– enriched endosomes to 
retrieve cargo destined for degradation.  This association is likely to vary with the 
levels of phosphatidylinositol 3-phosphate and Rab5 unoccupied by Rabenosyn-
5.  Thus, cargoes such as EGF, which increase the activity of PI3 kinases and 
activate Rab5 [124], would be expected to promote binding of EEA1 to 
Rabenosyn-5–containing endosomes.  Activation of Rab5 also would be 
expected to result in enhanced EEA1 binding and more extensive colocalization 
of Rabenosyn-5 and EEA1 on the same endosomal surface, as indeed is 
observed in cells over-expressing wild-type or persistently active Rab5 [41]. 
In summary, the visualization of the initial steps of endocytosis using a 
multimodal imaging platform that improves axial resolution in TIRF and the use of 
analysis protocols that generate quantitative models from complex imaging data 
have identified Rabenosyn-5 as a key element in clathrin-mediated endocytosis 
and the initial node of Tf sorting.  Further experiments with additional ligands and 
endosomal components will allow generation of quantitative, testable models for 
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the molecular mechanisms underlying receptor internalization into the endocytic 
pathway. 
 
EXPERIMENTAL PROCEDURES 
Cell culture and transfection – COS-7 cells were maintained in DMEM 
(Invitrogen) supplemented with 100U/ml penicillin streptomycin (Invitrogen), 0.1 
mg/ml normocin (InvivoGen) and 10% fetal bovine serum (Atlanta Biologicals) at 
37°C 5% CO2.  Cells were plated at a density of 1x105 cells per well of a 6 well 
cell culture plate and grown for 24 hours.  These cells were transfected with 1µg 
DNA using calcium phosphate and grown for 24 hours, plated on glass coverslips 
(Thomas Scientific 25 circle #1.5), grown for an additional 24 hours.  Live 
imaging was done in KRH buffer (125M NaCl, 5mM KCl, 1.3mM CaCl2, 1.2mM 
MgSO4, 25mM HEPES, 2.5% BSA and 2mM sodium pyruvate) pH 7.4. 
 
RNAi – Rabenosyn-5 and EEA1 RNAi duplexes with a sense sequence of 
5’UUUGAUGUCACUGCCAACCAAAGAA 3’ and 5’ 
AGGACCAAAAGAUCCAGAACCUUGA 3’, respectively, were designed and 
synthesized by RXi Pharmaceuticals.  A second oligonucleotide to EEA1, with 
the sense sequence 5′-AACUUGCUACUGAAAUUGCAGUU-3′ (designated “a” in 
Figure 2.6D) was obtained from Dharmacon.  One day before transfection cells 
were plated in antibiotic-free medium in a six-well cell-culture plate at a density of 
1×105 cells per well.  Cells were transfected using 5µL of Lipofectamine 
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RNAiMAX (Invitrogen) according to the manufacturer’s instructions with a final 
concentration of 10 nM siRNA. 
 
Reagents – Polyclonal EEA1 antibody was produced in chickens by injecting N- 
terminal 6-His-tagged fusion protein of human EEA1 residues 32-218.  Polyclonal 
clathrin antibody was produced in rabbits by injecting the last 15 amino acids of 
the clathrin heavy chain.  Polyclonal Rabenosyn-5 antibody was produced in 
rabbits by injecting residues 137-784 of human Rabenosyn-5.  Additional 
antibodies were obtained as follows:  APPL1 and GAPDH from Cell Signaling 
Technologies; TfR from Invitrogen, and EGFR from Millipore.  Unconjugated, 
DyLight-649– and DyLight-488–conjugated human Tf were obtained from 
Jackson Immunoresearch. 
 
Plasmids – TagRFP-T in pcDNA3 and TagRFP-T-clathrin were gifts from Roger 
Y. Tsien (University of California at San Diego, La Jolla, CA) and Michael W. 
Davidson (Florida State University, Tallahassee, FL), respectively.  The TagRFP- 
T expression vector was constructed as described [125].  GFP-clathrin was a gift 
from J. H. Keen (Thomas Jefferson University, Philadelphia, PA).  The cDNA 
clone 40034008 for human Rabenosyn-5 was obtained from American Tissue 
Culture Collection and was cloned in frame with EGFP or TagRFP-T at the N 
terminus of the protein using standard techniques.  GFP-EEA1, from which 
TagRFP-T-EEA1 was subcloned, was described previously [126].  APPL1 [127] 
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was cloned in frame with EGFP and TagRFP-T at the N terminus of the protein 
using standard techniques.  Human TfR in plasmid cDNA was a gift from Tim 
McGraw (Weill-Cornell Medical College, New York, NY).  Human TfR cDNA was 
subcloned in frame with EGFP in the Clontech pEGFP-N1 vector at the XhoI and 
BamHI restriction sites. 
 
TIRF/Epi-fluorescence Structure-illumination Microscope (TESM) optical system 
– A custom- built microscope system, TESM, simultaneously combines Total 
Internal Reflection Fluorescence and wide-field epifluorescence modes and 
incorporates structured illumination in the epi mode for fast optical sectioning and 
enhanced spatial resolution.  Briefly, two Cobolt diode pumped solid state 
(DPSS) 100mW lasers produce 491 nm and 561 nm light.  A 120mW diode laser 
from Blue Sky Laser produces 660 nm light.  The three beams were combined 
using mirrors and dichroics before being split by a 50/50 beam cube and coupled 
into a single mode fiber for the TIRF illumination path and a beam expander for 
the epi-illumination path.  The output of the lasers and the epi and TIRF channels 
was controlled by a set of five computer-controlled shutters.  The output of the 
TIRF fiber was collimated by a lens and the fiber was positioned using a 3 axis 
translation stage to adjust focus and input TIRF angle.  The epi beam passed 
through a Ronchi ruling that was moved by a computer controlled Physik 
Instruments translation stage.  A modified Olympus IX71 microscope was used 
and the TIRF and epi beams were combined and directed into the microscope 
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using a 50/50 beam splitter at the lower illumination port.  TIRF illumination was 
introduced though the edge of an Olympus TIRF 60X objective with an NA of 
1.49 at an angle set to visualize 100-200 nm from the coverslip.  A Physik  
Instruments PIFOC was used for fine focus control.  The Ronchi ruling in the epi 
path was positioned so that the internal optics of the microscope and the 60X 
objective formed an image of the ruling at the sample.  Light is collected and 
relayed through a triple bandpass filter cube and an output filter wheel onto a 
1004x1002 Andor iXon 885 emCCD camera, which was binned at 2x2. The 
electron multiplier gain was set at 10.  The Olympus IX71 microscope was 
contained in a heated chamber held at 35°C.  
 
TESM imaging hardware and software – TESM acquisition system uses the 
following components:  Super Micro workstation (SYS-7045A-WTB, San Jose, 
CA) with two 2.33GHz E5410 Xeon processors with 16GB of ram running Fedora 
13x86_64; Instrutech ITC-18 data acquisition system with a USB-18 adapter 
(Heka, NY); 250GB system drive (ST3250310NS, Seagate), two 750GB data 
drives (ST3750330NS, Seagate) and one 1TB backup drive (ST31000340NS, 
Seagate). The two 750GB drives are in a RAID-0 configuration.  mManager by 
USCF (http://www.micro-manager.org/) was used as the acquisition software. 
mManager was extended with three additional hardware device adapters 
developed or modified by the UMass Medical Biomedical Imaging Group. The 
Andor camera device adapter was ported to the 64 bit Linux operating system.  A 
56
new Cobolt adapter (https://valelab.ucsf.edu/~nico/MMwiki/index.php/Cobolt) 
controls the laser power and other settings.  A new ITC18 adapter 
(https//valelab.ucsf.edu/~nico/MMwiki/index.php/ITC18), controls the ITC18 
(Heka, NY) (http://www.heka.com/physio/equipment/interfaces/itc18.html). All 
changes and new software was contributed back to mManager.  The ITC18 
adapter is the heart of the imaging system and allows for high speed triggering of 
the camera in synchronization with 5 shutters (2 x UniBlitz VMM-D3, Vincent 
Associates, Rochester, NY), 1 filter wheel (Lambda 10-2, Sutter, Novato, CA), 
and 2 pifocs (Physik Instrumente, Irvine, CA). 
 
TIRF time series imaging – The TIRF time series protocol used three lasers 
emitting at 491 nm and 561 nm, with 525/50- and 590/50-nm emission filters, 
respectively, and 660 nm, with >690 nm emission.  By using four-color (blue, 
green, orange-red, far-red) 0.2-µm TetraSpeck microspheres (Invitrogen), it was 
determined that the focus (and magnification) of the green (525 nm) and red (590 
nm) emission were identical, whereas the far-red (690 nm) focus was shifted by 
500 nm.  Correspondingly, the focus of the microscope was shifted by this 
amount using a PIFOC objective scanner (Physik Instruments) when acquiring 
the far-red images. 
 
TESM 3-D imaging – The same lasers and emission filters were used in the 
TESM imaging protocol as in TIRF alone.  Typically, each set of images 
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contained one TIRF image followed by three structured light images.  The grating 
was moved by one-third of a period (∼2 ms) between each image.  The period of 
the grating was 500 line-pairs/in; with the 60X objective, the first-order period at 
the specimen was measured to be 0.456 microns, and no higher orders were 
observable.  The focus was adjusted by 0.1 microns between every set of 
images for a total range of 10 microns. 
 
TIRF image analysis – For quantitative image analysis, TIRF time series images 
were first smoothed by performing a temporal running average of three time 
points to reduce noise with a negligible effect on data.  Next, the background 
fluorescence for each image was calculated as the mean intensity in a region of 
interest (typically 21x21 pixels) outside the cell and subtracted from all pixels. 
 
Segmentation of vesicles from background.  To generate images in which 
vesicles or other fluorescence structures can be analyzed without interference 
from diffuse fluorescence, images then were convolved with a DOG filter 
consisting of (i) a small 2D Gaussian spot with a unit area (σ = 150 nm) that 
acted as a vesicle-matched detector ( i.e., an approximation to a near-diffraction 
limited spot) and (ii) a larger, inverted 2D Gaussian spot (σ = 300 nm) with 
negative unit area that estimated and subtracted the local background. The 
Gaussian smoothed images were thresholded visually (global threshold) to select 
for pixels belonging to objects (e.g., vesicles) and to eliminate areas devoid of 
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signal but containing noise. 
 
Colocalization.  For colocalization analysis, image sets dual labeled or triple 
labeled with Tf-DyLight 649 were processed as above.  For each label, its 
globally thresholded image was used to generate a binary image by setting the 
intensity of all positive-value pixels to one and all other pixels to zero. 
Colocalization was determined by two-way or three-way binary image overlap 
among the labels. Colocalization values are reported as the percent of pixels that 
are colocalized with a given label. Given a pair of 2D binary images of labels “A” 
and “B,” the colocalization of B with A at time t is 
100·ΣxΣy(A(x,y,t)·B(x,y,t))/ ΣxΣyB(x,y,t) 
Images of two-way and three-way colocalization are displayed using the running-
averaged, background-subtracted images (colored as green and red or as green, 
red, and blue), with the colocalized pixels (defined above) shown as white, as 
indicated by the accompanying color wheels (Figures 2.1 and 2.3) [128]. 
 
Transferrin Trafficking.  To analyze the trafficking of Tf, the thresholded-DOG 
time series image of an endocytic marker (clathrin, Rabenosyn-5, APPL, EEA1) 
was analyzed to identify individual objects (spots, vesicles) and their central 
(x,y,t) positions in every time point by finding all 2D intensity maxima (pixels 
brighter than their eight neighbors) and thresholding the maxima to eliminate 
spurious peaks.  The average local fluorescence within a 5x5 pixel region 
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centered at each (x,y,t) position was obtained in both the running- averaged, 
background-subtracted endocytic marker image and the corresponding Tf image.  
From this value, the average fluorescence of a one-pixel- wide frame surrounding 
the 5x5 pixel region was subtracted (e.g., Figure 2.1B).  The fluorescence ratio of 
Tf to endocytic marker was calculated for each object position, and the mean 
ratio and SE for each time point was calculated (typically there were hundreds of 
objects in each time point) and plotted (e.g., Figures 2.1C and 2.3B).  The 
fluorescence ratio was used as an estimate of the (relative) Tf concentration 
associated with each object (both signals should be in roughly some proportion 
to the amount of surface membrane) while also correcting for the exponential 
decrease in fluorescence brightness with increasing depth in TIRF.  Additionally, 
the kinetics of trafficking of Tf through clathrin, Rabenosyn-5, and APPL1 were 
modeled, and the models were fit to the ratio time-course data to determine rates 
of entry/filling and exiting/emptying of Tf for each endocytic marker.  Details of 
the kinetic models and fitting are given in the curve fits to ratio data below. 
 
Curve fits to ratio data – The Tf/Clathrin ratio data were fit with a simple kinetic 
model: 
 
koff  
Tf + clathrin ↔ Tf-clathrin → ? 
                                                 kon                kempty 
 
The TfR is modeled as having two binding sites for Tf, one low affinity and one 
high affinity.  TfRs are assumed to be in instantaneous, steady-state 
colocalization with clathrin, independent of binding Tf, therefore clathrin is a 
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proxy for TfR. Tf/Clathrin is [Tf-Clathrin] (times a scale factor).  The extracellular 
[Tf] is stepped from zero to a constant concentration, and the increase in the total 
Tf-TfR, and therefore Tf-clathrin, is proportional to 1-e-k·t where k is the sum of 
the on and off rates for Tf plus a rate kempty, the rate at which Tf apparently 
disassociates from clathrin objects.  This may be because Tf in fact disassociates 
from a clathrin object, or a Tf-clathrin object disappears from the TIRF imaging 
zone (and is replaced by a clathrin-alone object, preserving the steady state). 
Conversely when the [Tf] is stepped back to zero, the Tf-clathrin decreases as  
e-k·t where kon·[Tf] is now zero since [Tf] is zero.  The two Tf binding sites are 
assumed to be independent, so the equations for the ratio, R(t)clathrin are: 
R(t ≤ tadd)clathrin = 0 
R(tadd < t ≤ twash)clathrin = A·{(1-e-k1·t) + (1-e-k2·t)}/2 
R(t > twash)clathrin = R(twash)clathrin·{e-k1·t + e-k2·t}/2 
where A is an arbitrary constant to match the ratio data amplitude, and 
k1 = k1on·[Tf] + k1off + kempty  
k2 = k2on·[Tf] + k2off + kempty 
The equations for R(t)clathrin were fit to the ratio data using a Levenberg–
Marquardt least-squares fit algorithm, with tadd, twash, [Tf], A, and kempty as 
parameters. [Tf] is either a constant (tadd< t < twash) or 0. Tf binding rate constants 
used are k1on=1.0·105 M-1s-1 and k1off=3.2·10-3 s-1, and k2on=8.3·105 M-1s-1 and 
k2off=1.0·10-3 s-1 [129]. 
The Tf-rabenosyn (or Tf-APPL) ratio data were fit with a similar model, except  
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that for the association of Tf with rabenosyn-5, we assume that the Tf must pass  
 
through the clathrin pathway to be available to taken up in rabenosyn-5 vesicles. 
 
Tf-clathrin + Rbsn → clathrin + Tf-Rbsn → ? 
                            kfill                                         kempty 
where kfill = kon·[Tf-clathrin]·[Rbsn] 
 
This yields the differential equations for the change in rabenosyn-5 
d[Rbsn]/dt = kempty·[Tf-Rbsn] – kon·[Rbsn]·[Tf-clathrin] 
d[Tf-Rbsn]/dt = kon·[Rbsn]·[Tf-clathrin] - kempty·[Tf-Rbsn] 
[Rbsn]+[Tf-Rbsn] is assumed to be constant. We used R(t)clathrin (see above) as 
the [Tf-clathrin] driving the association with rabenosyn-5 at time t , yielding 
d[Rbsn]/dt = kempty·[Tf-Rbsn] – kon·[Rbsn]·R(t)clathrin  
d[Tf-Rbsn]/dt = kon·[Rbsn]·R(t)clathrin – kempty·[Tf-Rbsn] 
[Tf-Rbsn](t) is related to the observed ratio by an unknown scale factor, i.e., 
R(t)rabenosyn = B·[Tf- Rbsn](t). The system of ordinary differential equations was 
numerically integrated (for a given B, kon and kempty) using the ODE function of 
Scilab (http://www.scilab.org/) producing [Tf-Rbsn], and hence R(t)rabenosyn. Initial 
conditions were [Rbsn] =1 and [Tf-Rbsn]=0.This function was fit to the Tf- 
rabenosyn-5 ratio data using the L-M method, with B, kon and kempty as 
parameters (i.e., the ODE solver was called interatively with different values for 
B, kon and kempty until R(t)rabenosyn. matched the Tf/rabenosyn-5 ratio data 
sufficiently closely. 
For each 3-color experiment (Tf, clathrin, rabenosyn-5 or APPL), the ratio time 
courses of Tf/clathrin and Tf/rabenosyn-5 were calculated as describe above. 
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First, R(t)clathrin was fit to the Tf/clathrin ratio. Then R(t)rabenosyn was fit to the 
Tf/rabenosyn ratio using the resulting R(t)clathrin. While R(t)clathrin is not a 
concentration, it is only the product kfill (not kon) that matters. As kfill is not constant 
over time, for each experimental data set a “near-steady-state” value of kfill was 
calculated at t=twash. 
 
TESM 3-D image analysis – Optical sectioned images of epifluorescence were 
produced from the structured illumination data sets according to the method of 
Tony Wilson [108].  Briefly, at each focal position and for each emission 
wavelength, a single optical section image, I, was computed from a triplet of 
images acquired sequentially with the illumination grating shifted by one-third 
period each time (I0/3, I1/3, I2/3) as  
I = [(I0/3 – I1/3)2 + (I1/3 – I2/3)2 + (I2/3 – I0/3)2]1/2 
 
Colocalization.  Optical section images of endogenous proteins (antibody-labeled 
and fixed) were convolved with a 2-dimensional DOG filter with the positive unit 
area Gaussian sigma = 75nm, and the negative unit area Gaussian sigma=150 
nm. Selected focal positions of the DOG images were used to generate binary 
images as described above.  Colocalization between proteins was determined by 
two or three way binary image overlap. 
 
TESM Z-position maps.  False colored maps of axial (z) position of fluorescence 
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were created from the combination of TIRF and optical section images. TIRF 
images confound “intrinsic” fluorescence brightness with axial position.  If the 
actual brightness is known then the axial position can be recovered.  The 
Epifluorescence- structured illumination optical section images were used as 
indicators of actual in-focus fluorescence brightness.  Briefly, the 3-D TIRF 
images of both 491 and 561 nm illuminations were inspected to determine a 
single, nearest to the coverslip (in 100 nm steps) plane of best focus, z0, of all 
the visible structures.  The TIRF and the optical section image stacks at both 
wavelengths were then segmented to span from z0-2 to z0+4, or 700 nm of 
depth, and a single “extended focus” image of both TIRF and epifluorescence 
was made by maximum intensity projection of these 7 planes, yielding a set of 
four images [491ITIRF, 491Iepi, 561ITIRF, 561Iepi]. These images were thresholded to 
excluded areas devoid of signal. 
Because there is a microscope system dependent and illumination wavelength 
(λ) dependent difference in excitation efficiency between the TIRF and epi-
illumination paths (the emission path is the same), there is a scale factor λK 
relating the intensity of the TIRF image λITIRF to the epi image λIepi.  If the e−1 
penetration distance d of the TIRF evanescent field is known, then image Z of 
axial positions of fluorescent sources in the field can be calculated as 
Z=-λd·ln[λK·λITIRF /λIepi]  
Z=-λd·ln[λITIRF /λIepi]  + (-d·ln[λK]) 
Z=-λd·ln[λITIRF /λIepi] + λz0 
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The value of z0 depends on d and K and is constant as long as the microscope 
set up is constant.  There is an axial apparent offset between the wavelengths 
ΔZ = (491Z0-561Z0).  This offset was determined empirically using dual-color 
microspheres and is described below in calibration of TESM using dual labeled 
beads. 
 
Calibration of TESM using dual labeled beads –To validate the combined use of 
SLE and TIRF to determine the position of endosomes within the depth of the 
TIRF zone (z-map), apparent differences in z-position due to wavelength 
differences in the TIRF vs. SLE between the green and red excitation and 
emission paths must be distinguished from real positional differences.  To 
determine the differences in z-position attributable to specific fluorophore 
wavelengths, dual (green/red) labeled beads (Tetraspec, Invitrogen) were 
embedded in agarose and dried onto the coverslip, mimicking a cell milieu with 
fluorescent vesicles at different positions.  Beads were then imaged in TIRF and 
SLE, identified in the SLE reconstruction, and processed to calculate their z-
position as z = -d * ln [ I(TIRF) / I(SLE) ], using d=132 nm for green and d=150 
nm for red.  These values were derived from the emission wavelengths (~530 nm 
and ~590 nm) and the setting of the TIRF angle micrometer. 
Figure 2.12 shows the positions of the beads calculated using the fluorescence in 
red vs the fluorescence in green. Larger z (to the right and up) is farther from the 
coverslip.  The slope of the data was 0.99, indicating that the relative d values 
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Figure 2.12.  Calibration of z-map position using dual labeled beads. 
The zmap images of the cel s were obtained by taking the 
 -d * ln [ I(TIRF) / I(SLE) ] in the whole image calculated pixel by pixel  and 
masked by thresholding the SL(561) image. The calibration of the z-depth 
colorbar was based on the use of a ~64 degree TIRF angle. The 
calculation of the depth penetration of TIRF is  
d = wl / [ 4*pi* sqrt(n1^2 sin()^2 - n2^2)] 
where wl is the emission wavelength center (520nm) and n1 = 1 52 (glass) 
and n2 = 1.33 (water).  
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are correct.  The intercept is the offset between the colors attributable to 
wavelength.  The TIRF and ESL images of beads in the 561 wavelength are 
shown on the right.  The raw images in the 491 wavelength were virtually 
indistinguishable, and the obtained z- maps of the same beads reveal very good 
correspondence between the two wavelengths when the offset is incorporated 
into the calculation. 
 
Biochemical measurement of Tf trafficking – Cells were treated with scrambled 
(control) or Rabenosyn-5 siRNA as described.  At 48 hours knockdown cells 
were replated on black 96 well plates at a density of 1.5x104 cells per well and 
cultured for an additional 24 hours at 37°C 5% CO2.  Serum Tf was removed by 
incubation in DMEM (Invitrogen) supplemented with 1% ovalbumin (Sigma) for 1 
hour at 37°C 5% CO2.  To determine the number of TfR on the cell surface, cells 
were incubated on ice with DMEM supplemented with 1% ovalbumin containing 
10µg/ml peroxidase-conjugated human transferrin (Tf-HRP) (Jackson 
ImmunoResearch).  After 2 hours cells were washed and peroxidase activity was 
detected using SuperSignal ELISA Pico Chemiluminescent Substrate (Pierce) 
using a Tecan Safire2.  To measure internalization rates, cells were incubated at 
37°C with DMEM containing 1% ovalbumin and 10µg/ml Tf-HRP.  At the times 
indicated in each figure cells were placed on ice and washed three times with 
chilled PBS supplemented with 5% ovalbumin and three times with neutral pH 
buffer supplemented with 1% ovalbumin.  Half the wells were then exposed to 
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chilled pH 2.0 buffer (500mM NaCl, 0.2N glacial acetic acid, pH 2.0) for 5 
minutes at 4°C.  Cells were washed twice with neutral pH buffer and once with 
PBS, and chemiluminescence detected as described above.  Internalized Tf was 
defined as the difference in signal between acid washed (internalized) and non-
acid washed (total) wells.  To measure recycling rates, cells were incubated at 
37°C 5% CO2 for 2 hours in DMEM supplemented with 1% ovalbumin containing 
10µg/ml Tf-HRP.  Cells were washed once with PBS supplemented with 5% 
ovalbumin and incubated in pH 5.0 butter (150mM NaCl, 50mM MES, pH 5.0) at 
room temperature for 2 minutes.  Cells were washed three times with prewarmed 
efflux media (DMEM supplemented with 100µM desferoxamine and 10µg/ml 
human transferrin).  At the times indicated media was removed and 
chemiluminescence in the media detected as described above.  In each 
experiment values obtained in the presence of a 200-fold excess of unconjugated 
human transferrin were subtracted to obtain specific signal.  Means and SEM are 
for three independent experiments performed in quadruplicate. 
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CHAPTER III 
 
ROUTES OF SIRNA INTERNALIZATION AND ENDOSOMAL COMPONENTS 
REQUIRED FOR SILENCING 
 
ABSTRACT 
Effective intracellular delivery of siRNA is a major obstacle in antisense 
oligonucleotide drug development.  Using chemically modified and 
phosphorothioated sd-rxRNA®, we describe the efficient delivery and identify the 
endocytic mechanisms of a proprietary self-delivering siRNA.  Sd-rxRNA is 
actively internalized into Rabenosyn-5 and EEA1 positive endosomes and 
knockdown of EEA1 inhibits sd-rxRNA silencing indicating EEA1 plays a crucial 
role in the initial uptake of self delivering siRNA.  The sd-rxRNA enter and 
function through the lysosomal degradative pathway and remain separate from 
the endocytic recycling pathway.  Taken together, these data suggest that sd-
rxRNA is internalized into specific populations of endosomes and the presence of 
EEA1 is required for silencing of the sd-rxRNA target. 
 
INTRODUCTION 
RNA interference (RNAi) is a naturally occurring cellular process in 
eukaryotes whereby double stranded RNA (dsRNA) association with the RNA 
induced silencing complex (RISC) targets complementary messenger RNA 
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(mRNA) sequences and silences target genes.  RNAi is regarded as a 
revolutionary discovery in biology, jointly awarding scientists Craig C. Mello and 
Andrew Z. Fire the Nobel Prize in Physiology or Medicine in 2006.  RNAi is a 
naturally occurring, highly conserved, cellular process in eukaryotes by which 
short dsRNA results in sequence-specific gene silencing through mRNA 
degradation [130,131].  The RNAi pathway (Figure 3.1) is first initiated by Dicer, 
an enzyme that cleaves dsRNA into shorter dsRNA fragments known as small 
interfering RNAs (siRNAs) [132].  The approximately 20 nucleotide length siRNA 
is composed of guide strand, which is incorporated into RISC, and a passenger 
strand that is degraded [133].  The catalytic component of the RISC complex is 
Argonaute-2 (Ago2).  Ago-2 will cleave guide strand RNA complementarily paired 
to mRNA.  The cleavage of mRNA prevents this mRNA from being translated, 
thereby silencing the gene.  Cytoplasmic bodies, also called processing bodies 
(P-bodies) and GW-bodies, are the specific sites of mRNA degradation where 
Ago-2 and GW182 are localized [134].  GW182 is required for P-body stability 
and RNAi gene silencing as knockdown of GW182 disrupts P-body formation and 
impairs silencing by siRNA [135].  The discovery that small chemically 
synthesized siRNAs introduced into mammalian cells also results in efficient 
sequence-specific gene silencing [79] launched the potential for this process to 
be harnessed as a therapeutic.  While the use of RNAi as a therapeutic strategy 
is intellectually exciting, successful RNAi compound delivery faces many clinical 
obstacles. 
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 Figure 3.1. RNA mediated silencing. Short RNAs derived from Dicer cleavage 
of dsRNA are incorporated into multiprotein effector complex, RISC, to target 
mRNA degradation (RNAi).  Argonaute (AGO) proteins bind short RNAs and 
‘shepherd’ them to appropriate effector complexes. Target nucleic acids are 
shown in blue, short RNAs in red, proteins and enzyme complexes as ovals.  
Figure modified from Matzke & Matzke PLoS Biol. 2004 May;2(5):E133. Epub 
2004 May 11.  
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Successful delivery to and entry into the cells of interest are major 
challenges in the use of siRNA as a therapeutic.  Potential caveats of 
systemically administered siRNA therapies are degradation by nucleases found 
in blood, clearance of siRNA from circulation by the kidneys, cellular targeting, 
passing through the plasma membrane into the cytoplasm, and uptake by RNAi 
machinery.  The negative charge of siRNA molecules means that the negatively 
charged cell membrane poses a great barrier for siRNA uptake.  As a result, lipid 
carriers, nanoparticles, cholesterol modifications, antibodies, or other methods 
must overcome the barrier of the plasma membrane.  Once a delivery vehicle 
has promoted cellular uptake of siRNA, the siRNA must then be able to associate 
with RNAi machinery. 
In plants RNAi is initiated by dsRNA [136] that can be transported to 
distant cells through the phloem [137].  Studies in Drosophila S2 cells show that 
when scavenger receptors are knocked down, internalization of dsRNA 
decreases by over 90% [138].  Further evidence for dsRNA internalization by 
scavenger receptors comes from expression studies in CHO cells.  CHO cells 
stably expressing Drosophila scavenger receptors were able to take up 
substantially more dsRNA than control cells [138].  These studies indicate that 
scavenger receptors could be mediating endocytosis of dsRNA, however dsRNA 
associating with a lipid or growth factor and being internalized through a carrier’s 
endocytic pathway has not been ruled out. 
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Systemic RNAi defective-1 (SID-1) is a transmembrane protein in C. 
elegans that localizes to the cell periphery and is necessary for cells to import 
dsRNA and for silencing by external dsRNA [139].  Studies of exogenous SID-1 
expressed in Drosophila S2 cells confirmed that SID-1 mediates cellular uptake 
of dsRNA at a much lower dsRNA concentration than these cells are normally 
able to internalize [140].  A mammalian homolog of C. elegans SID-1, SidT1, 
when overexpressed has been shown to localize to the cell membrane and 
enhance siRNA uptake and increases gene silencing in human pancreatic 
ductoral adenocarcinoma cells [141].  Knockdown of endogenous SidT1 resulted 
in decreased lipoprotein-associated cholesterol-siRNA uptake in primary mouse 
hepatocytes [142]. 
A genetic screen in Drosophila S2 cells revealed that components of RNAi 
and endocytic machinery are required for uptake and processing of dsRNA [143].  
Genes required for RNAi silencing include Dicer, Argonaute-2 (Ago-2), clathrin 
heavy chain, Rab7, and vacuolar H+-ATPase [143].  Dicer and Ago-2 are both 
part of the RNAi machinery.  Dicer specifically cleaves dsRNA to generate 
microRNA and it has been shown that knocking out Dicer impairs microRNA 
processing [144,145].  Ago-2 is an essential component of RISC involved in 
mRNA cleavage and RNAi is impaired in cells lacking Ago-2 [146].  The 
surprising results of this screen were the components of the endocytic 
machinery.  Clathrin heavy chain is required for clathrin mediated endocytosis 
while Rab7 is a known regulator of late endocytic traffic [147].  The vacuolar H+-
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ATPase is required for maturation of multivesicular bodies (MVB) [148], late 
endosomes whose membranes have internally budded resulting in the 
accumulation of multiple luminal vesicles.   
MVBs can proceed along the degradative pathway and fuse with 
lysosomes, degrading their cargo.  Alternatively, MVBs can fuse with the plasma 
membrane, releasing their accumulated luminal vesicles as exosomes [149].  
Exosomes have been shown to contain functional microRNAs (miRNAs) 
[150,151] that can be taken up by other cells [151], suggesting a role for MVBs in 
the RNAi pathway. 
A potential functionally important link between the RNAi machinery and 
the endosomal pathway was published in back-to-back manuscripts in 2009 
[100,101].  Membrane fractionation of monocytes on density gradients found 
GW182, Ago-2, and a mature miRNA localized to the MVB fraction [100].  
Additionally, knockdown of hepatocyte growth factor-regulated tyrosine kinase 
substrate (Hrs), a component of the endosomal sorting complex required for 
transport (ESCRT) pathway, which blocks MVB formation, inhibited miRNA 
silencing [100,101]. 
Taken together this data suggests that the RNAi machinery is localized to 
multivesicular endosomes found within the degradative pathway.  In order to 
function, siRNA must reach the cell of interest, cross the plasma membrane, and 
traffic into the degradative pathway where it can be loaded into RISC to function.  
Utilizing a fluorescently tagged self-delivering siRNA we employed TIRF 
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microscopy and biochemical techniques to define the endosomes through which 
siRNA traffics and if the presence of those endosomal populations is required for 
functional silencing. 
RNAi technology can be utilized to treat human diseases by shutting down 
genes that are known to lead to disease.  RXi Pharmaceuticals is a 
pharmaceutical company pursuing the development and commercialization of 
RNAi based therapeutics for the treatment of human diseases.  RXi 
Pharmaceuticals developed a novel class of self-delivering RNAi compounds (sd-
rxRNA®) that is a proprietary technology that enables efficient cellular uptake in 
the absence of a delivery vehicle.  Sd-rxRNA are chemically modified asymmetric 
RNA duplexes with a short duplex region of 11-15 base pairs and a fully 
phosphorothioated single stranded tail (Figure 3.2). 
 
RESULTS 
Utilizing TIRF microscopy sd-rxRNA was added to COS-7 cells and 
imaged at 1 Hz (one frame/second) continuously for 20 minutes.  Figure 3.3A 
illustrates a time series from the image set.  Within minutes of exposure to sd-
rxRNA the cells have internalized the oligo into punctate structures.  A caveat to 
previous studies of oligo transport has been the question of whether or not oligos 
are internalized through interactions with lipid binding proteins in the medium.  To 
test whether or not sd-rxRNA requires the presence of a carrier protein for 
internalization we added it to COS-7 in a buffered solution lacking carrier 
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 Figure 3.2. sd-rxRNAs are chemically modified to improve cellular uptake. 
The favorable pharmacokinetic (PK) properties of antisense oligonucleotides 
(ASOs) are believed to be based on the ability of a fully phosphorothioated 
single-stranded oligonucleotide to bind proteins and enter cells and tissues. Use 
of minimal length asymmetric RNAi compounds enable merging favorable PK 
properties of ASOs with the potency and duration of effect advantages, resulting 
from an RNAi mechanism of action. These compounds usually have a guide 
strand of 19 nucleotides and a passenger strand of 11-15 nucleotides, thus 
making an asymmetric compound with a 6-12 nucleotide single-stranded 
phosphorothioate tail. In addition, sd-rxRNA compounds are heavily modified 
with stabilizing and hydrophobic modifications (e.g. sterol), which confer 
stability, reduced inflammatory response and efficient cellular uptake . This 
complex chemical structure is essential for cellular delivery but does not 
interfere with the ability of the oligonucleotides to be efficiently recognized by 
the RNA Induced Silencing Complex (RISC) and induce RNAi.  Figure 
provided by RXi Pharmaceuticals.  
 
<15 bp duplex 6 nt & longer  tail 
= standard and modified bases 
= phosphorothioate linkages 
= various hydrophobic moieties 
= other hydrophobic linkages 
= phosphodiester linkages 
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 Figure 3.3. Efficient cellular uptake of sd-rxRNA by COS-7 cells. COS-7 
cells were imaged by TIRF microscopy in the presence of 0.25µM sd-rxRNA.  A. 
Time course demonstrates that sd-rxRNA is internalized in punctate structures 
within 10 minutes of exposure.  B.  Sd-rxRNA is efficiently internalized in the 
absence of any carrier proteins. 
A. 
B. 
5µm 
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proteins.  Figure 3.3B demonstrates that there was no change in sd-rxRNA 
internalization in the absence of carrier protein.  To determine that internalization 
of sd-rxRNA is a specific endocytic process, we compared uptake of sd-rxRNA 
with that of the membrane dye FM4-64.  FM4-64 is a lipophilic styryl, membrane 
selective, dye used as a marker for endocytosis [152,153].  As shown in Figure 
3.4 FM4-64 is enriched in vesicles lacking sd-rxRNA.  Given that sd-rxRNA is 
hydrophobically modified, this data suggests that sd-rxRNA is not being 
internalized by pinocytosis or fluid phase uptake at fatty areas of the membrane. 
To address the question of which components of the endosomal system 
traffic sd-rxRNA, we added it to cells transfected with GFP-EEA1, GFP-
Rabenosyn-5, GFP-APPL1, or GFP-WDFY2.  Cells were imaged at 1 Hz 
continuously for 15 minutes.  After 5 minutes of exposure to sd-rxRNA any 
unbound oligo was washed out of the bath.  Figure 3.5A illustrates the same time 
frame of the resulting image set.  While no association was found between sd-
rxRNA and APPL1, and minimal between sd-rxRNA and WDFY2, significant 
amounts of the oligo were found in both EEA1 and Rabenosyn-5 enriched 
regions (Figure 3.5B). 
Recent data from our laboratory indicate that Rabenosyn-5 is a crucial 
component of the endocytic recycling system involved in determining the 
recycling versus degradation fate of cargo internalized through clathrin coated 
pits while EEA1 captures cargo destined for lysosomal degradation [49,154].  In 
light of these findings we visualized the uptake of sd-rxRNA in conjunction with 
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Cy3-sd-rxRNA FM4-64 Overlay 
 Figure 3.4. Cellular uptake of sd-rxRNA by COS-7 differs from fluid phase 
uptake.  COS-7 were simultaneously exposed to 0.25µM sd-rxRNA (red) and 
0.5µg/ml FM4-64 (blue) and imaged by TIRF microscopy. 
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 Figure 3.5. sd-rxRNA localizes to 
specific endosomal populations.  
A. COS-7 cells expressing GFP-
EEA1, GFP-Rabenosyn-5, GFP-
APPL1, or GFP-WDFY2 were 
exposed to 0.25µM sd-rxRNA and 
imaged by TIRF microscopy.  
Background has been pseudo 
colored yellow.  Arrows highlight 
areas of colocal izat ion.  B.  
Q u a n t i f i c a t i o n o f s d - r x R N A 
colocalized with Rabenosyn-5 (red) 
or EEA1 (green) over time. n=4 
A. 
B. 
5µm 
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the recycled ligand transferrin (Tf) and the degraded ligand epidermal growth 
factor (EGF).  As depicted in the single frames of Figure 3.6, sd-rxRNA 
associates specifically with EGF while there is virtually no sd-rxRNA found in Tf 
positive regions.  Given the abundance of the Tf signal in these cells, the 
association between sd-rxRNA and Tf was more closely examined by structured 
light Epifluorescence (SLE).  With standard Epifluorescence in Figure 3.7 there is 
association between Tf and sd-rxRNA within the out of focus signal in the 
perinuclear region.  When this signal is removed by imaging with high resolution 
SLE there is a negligible association between sd-rxRNA and Tf (Figure 3.7, 
insert).  Conversely to the Tf data, when EGF and sd-rxRNA are added to COS-7 
cells and imaged over time, the uptake of these two compounds is quite similar 
and shows specific overlap (Figure 3.8).  This data suggests that sd-rxRNA 
follows an endocytic route similar to that of EGF, which is known to specifically 
and rapidly associate with EEA1 positive endosomes (Figure 3.9A).  Closer of 
examination of sd-rxRNA internalization into GFP-EEA1 transfected cells reveals 
that the vast majority of punctate internalized oligo localizes to EEA1 positive 
endosomes (Figure 3.9B).  Consistent with sd-rxRNA trafficking along the EGF 
positive EEA1 positive degradative pathway, sd-rxRNA is found localized to 
acidified vesicular structures as indicated by positive association with Lysotracker 
(Figure 3.10). 
To examine the function of EEA1 in sd-rxRNA trafficking, we analyzed the 
effects of siRNA-mediated EEA1 depletion.  COS-7 cells were treated with 
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Ligand sd-rxRNA Overlay 
 Figure 3.6. sd-rxRNA localizes EGF positive endosomes.  A.  COS-7 cells 
were simultaneously exposed to 0.25µM sd-rxRNA and 50ng/ml Alexa488-EGF 
or 0.25µM sd-rxRNA  and 10µg/ml Tf-DyLight-488 and imaged by TIRF 
microscopy.  Background has been pseudo colored yellow.  Arrows highlight 
areas of colocalization.  B.  Quantification of sd-rxRNA colocalization with 
EGF (black) or Tf (grey) over time.  n=3-8 
A. 
B. 
5µm 
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 Figure 3.7. Transferrin and sd-rxRNA trafficking pathways differ.  COS-7 
cells treated with 0.25µM sd-rxRNA  and 10µg/ml Tf and imaged by 
epifluorescence and structured light epifluorescence.  Yellow pixels indicate 
colocalization. 
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 Figure 3.8. EGF and sd-rxRNA trafficking pathways are similar. 
COS-7 cells were simultaneously exposed to 0.25µM sd-rxRNA and 
50ng/ml Alexa488-EGF and imaged by TIRF microscopy.  White pixels 
indicate colocalization. 
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EGF-­‐Alexa568
GFP-­‐EEA1
Ti
m
e 
Cy3-­‐sd-­‐rxRNA
GFP-­‐EEA1
 Figure 3.9. Visual comparison of EGF and EEA1 colocalization and 
sd-rxRNA and EEA1 colocalization.  A. COS-7 cells expressing GFP-
EEA1 were imaged by TIRF microscopy in the presence of 50ng/ml 
Alexa568-EGF.  White pixels indicate colocalized regions.  B. COS-7 cells 
expressing GFP-EEA1 were imaged by TIRF microscopy in the presence 
of 0.25µM Cy3-sd-rxRNA.  White pixels indicate colocalized regions. 
A. B. 85
Lysotracker-Alexa488 Cy3-sd-rxRNA Overlay 
Figure 3.10. sd-rxRNA localizes to acidified vesicles.  COS cells 
treated for 20 hours with sd-rxRNA were stained with lysotracker. 
5µm  5µm  5µm  
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control and siRNA specific to EEA1.  Once knockdown of EEA1 had reduced 
protein to virtually undetectable levels (Figure 3.11B) sd-rxRNA specific to 
MAP4K4 (M4K4) was added to these cells and the ability of M4K4-sd-rxRNA to 
silence M4K4 was assessed by quantitative real time PCR (qRT-PCR).  As 
shown in Figure 3.11A under control conditions M4K4-sd-rxRNA is able to 
reduce M4K4 mRNA expression by 50% while in EEA1 knockdown cells 
attenuated this effect in a dose dependent manner.  Knockdown of M4K4 by 
M4K4-sd-rxRNA was not inhibited in Rabenosyn-5 knockdown cells (Figure 
3.11C) suggesting that EEA1 is specifically required for functional knockdown by 
sd-rxRNA.  These results were confirmed with the use of a second sd-rxRNA 
targeting cyclophilin B (PPIB).  As shown by immunoblotting in Figure 3.11D, 
siRNA depletion of EEA1 followed by treatment of these and control cells with 
PPIB-sd-rxRNA resulted in a marked decrease of PPIB protein levels in control 
transfected cells which was significantly inhibited in EEA1 knockdown cells. 
To begin to determine the mechanism by which sd-rxRNA enters COS-7 
cells we examined the ability of M4K4-sd-rxRNA to function in the absence of 
SidT1.  Consistent with previous reports of low SidT1 expression in kidney [142], 
SidT1 is expressed at low levels COS-7 cells.  Nonetheless, siRNA depletion of 
SidT1 followed by administration of M4K4-sd-rxRNA resulted in attenuated 
silencing at low concentrations of M4K4-sd-rxRNA (Figure 3.12). 
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Control 
EEA1 KD 
Control 
EEA1 KD 
Rbsn KD 
 Figure 3.11. Loss of EEA1 impairs silencing by sd-rxRNA. COS-7 were 
treated with control, EEA1, or Rabenosyn-5 siRNA for 72 hours followed by 2 
hour treatment with sd-rxRNA targeting MAP4K4 (M4K4).  RNA was harvested 
24 hours followed sd-rxRNA treatment and qRT-PCR was run to determine the 
relative expression of M4K4 mRNA.  A.  There is a dose dependent inhibition of 
M4K4-sd-rxRNA in EEA1 knockdown cells.  B.  Western blot showing the 
amount of EEA1 and Rabenosyn-5 protein remaining after their respective 
knockdowns.  C. Knockdown of EEA1, but not Rabenosyn-5, inhibits silencing 
by M4K4-sd-rxRNA.  D.  COS-7 cells were treated with control (Scr), or EEA1 
siRNA for 72 hours followed by 72 hour treatment with 2µM control sd-rxRNA or 
sd-rxRNA targeting cyclophilin B (PPIB).  Lysates were harvested and 
immunoblots were probed for PPIB and GAPDH as a loading control. 
A. B. 
C. 
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 Figure 3.12. Loss of SidT1 impairs silencing by sd-rxRNA. COS-7 were 
treated with control (white) or SidT1 (black) siRNA for 72 hours followed by 2 
hour treatment with sd-rxRNA targeting MAP4K4 (M4K4).  RNA was harvested 
24 hours followed sd-rxRNA treatment and qRT-PCR was run to determine the 
relative expression of M4K4 mRNA.  There is a dose dependent inhibition of 
M4K4-sd-rxRNA in SidT1 knockdown cells. 
[M4K4-sd-rxRNA] 
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DISCUSSION 
Self-delivering siRNAs are of great therapeutic value because of their 
enhanced stability and efficient cellular uptake in the absence of a delivery 
vehicle.  Understanding of the mechanisms by which these antisense 
oligonucleotides are taken up by target cells is of extreme importance.  Recent 
work suggests scavenger receptors [138] or SID-1 transporter [139-142] are 
responsible for oligonucleotide uptake.  Several components of the endocytic 
pathway are required for siRNA silencing suggesting endocytic vesicles are 
critical for siRNA entry into cells.  To better understand the endosomal pathway 
by which oligonucleotides enter the cell we studied the uptake of a proprietary 
system of self-delivering siRNA.  The results of the present study indicate 
endosomal localization of sd-rxRNA is distinct from fluid phase endocytosis 
suggesting a regulated mechanism of uptake.   
TIRF microscopy demonstrates sd-rxRNA is taken up by COS-7 cells and 
transferred to Rabenosyn-5 and EEA1 positive endosomes, suggesting 
antisense oligonucleotides traffic through a specific endosomal pathway. 
Previously we’ve shown that Rabenosyn-5 is required for endocytic recycling of 
the TfR [154], however sd-rxRNA positive structures are distinct from Tf 
containing endosomes indicating that antisense oligonucleotides do not enter the 
endocytic recycling pathway.  Sd-rxRNA colocalize with EGF containing 
endosomes, which require trafficking through EEA1 positive endosomes to be 
degraded in lysosomes and suggests antisense oligonucleotides follow a 
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lysosomal degradative pathway.  Sd-rxRNA entry into both Rabenosyn-5 and 
EEA1 is consistent with the finding that endosomes containing both Rabenosyn-5 
and EEA1 are found deeper within the cell [41].  Interestingly depletion of the 
PI(3)P endosomally localized protein Hrs [155] results in impaired EGFR 
degradation [156] and diminished miRNA silencing [101].  This is consistent with 
our findings that early sorting of sd-rxRNA to the lysosomal pathway is required 
for efficient silencing.  Furthermore, EGF traffics through EEA1 positive 
endosomes and knockdown of EEA1 impairs EGFR degradation [49], similar 
reduction in EEA1 levels impairs targeted sd-rxRNA silencing suggesting sd-
rxRNA and EGF follow the same degradative pathway. 
SID-1 is a dsRNA channel required for systemic RNAi in C. elegans and to 
ask if a similar mechanism is present in mammals we investigated the function 
SidT1, the mammalian homolog of SID-1.  Knockdown of SidT1 resulted in a 
reduction in silencing of the target of sd-rxRNA and suggests SidT1 may play a 
key role in sd-rxRNA uptake.  Further studies are needed to address the role of 
SidT1, and possibly additional proteins, in sd-rxRNA internalization. 
In addition to their implications in oligonucleotide uptake, scavenger 
receptors have been shown to be involved in the uptake of bacterial pathogens 
[157].  Additionally, RNA viruses such as Semliki Forest virus are known to use 
the endocytic pathway for viral pathogenesis [158].  Lastly, RNA silencing by 
siRNA has been show to protect both plants and invertebrates from viral infection 
[159].  Taken together these data suggest the antisense oligonucleotide uptake 
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pathway may have a role in the innate immune response and provide protection 
in the spread of viral infections. 
Self-delivering siRNA represents a powerful potential therapeutic with 
seemingly limitless applications.  Unfortunately little is known regarding how 
siRNA molecules enter the cell.  A better understanding of the endocytic 
machinery governing sd-rxRNA entry could lead to more effective therapeutic 
siRNA delivery. 
 
EXPERIMENTAL PROCEDURES 
Cell culture and transfection – COS-7 cells were maintained in DMEM 
(Invitrogen) supplemented with 100U/ml penicillin streptomycin (Invitrogen), 0.1 
mg/ml normocin (InvivoGen) and 10% fetal bovine serum (Atlanta Biologicals) at 
37°C 5% CO2.  Cells were plated at a density of 1x105 cells per well of a 6 well 
cell culture plate and grown for 24 hours.  These cells were transfected with 1µg 
DNA using calcium phosphate and grown for 24 hours, plated on glass coverslips 
(Thomas Scientific 25 circle #1.5), grown for an additional 24 hours.  Live 
imaging was done in KRH buffer (125M NaCl, 5mM KCl, 1.3mM CaCl2, 1.2mM 
MgSO4, 25mM HEPES, 2.5% BSA and 2mM sodium pyruvate) pH 7.4.  Carrier 
free live imaging was done in KRH buffer without BSA (125M NaCl, 5mM KCl, 
1.3mM CaCl2, 1.2mM MgSO4, 25mM HEPES and 2mM sodium pyruvate) pH 7.4. 
 
RNAi – Rabenosyn-5 and EEA1 RNAi duplexes described previously [154], and 
92
Sid1 (Sid no. 1 as described previously [142] along with non-targeting control 
duplexes were designed and synthesized by RXi Pharmaceuticals.  One day 
before transfection cells were plated in antibiotic-free medium in a six-well cell-
culture plate at a density of 1×105 cells per well.  Cells were transfected using 
5µL of Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s 
instructions with a final concentration of 10 nM siRNA.  Cy3-conjugated 
scrambled and MAP4K4 sd-rxRNA and cyclophilin B sd-rxRNA were designed 
and synthesized by RXi Pharmaceuticals.  Cells were treated with sd-rxRNA in 
DMEM. 
 
Reagents – Polyclonal EEA1 and Rabenosyn-5 antibodies were described 
previously [154].  GAPDH antibody was obtained from Cell Signaling 
Technologies.  Cyclophilin B antibody was obtained from Abcam.  Unconjugated 
and DyLight-488–conjugated human Tf were obtained from Jackson 
Immunoresearch.  EGF-Alexa-488, Lysotracker-488, and FM4-64 were obtained 
from Invitrogen. 
 
Plasmids – GFP- Rabenosyn-5, GFP-EEA1, GFP-APPL1, and GFP-WDFY2 
were previously described [65,126,127,154].  
 
TIRF/Epi-fluorescence Structure-illumination Microscope (TESM) optical system, 
TESM imaging hardware and software, TESM 3-D imaging, and image analysis – 
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were described previously [154]. 
 
Quantitative RT-PCR – Total RNA was extracted using TRIzol reagent 
(Invitrogen).  For quantitative mRNA analysis, 1µg of the total RNA was reverse-
transcribed by using an iScript cDNA synthesis kit (Bio-Rad).  10% of each 
reverse transcriptase reaction was subjected to quantitative real-time PCR 
analysis using an iQ SYRB Green supermix kit and real-time PCR detection 
system following the manufacturer’s instructions (MyiQ, Bio-Rad).  β2-
microglobulin was used as an internal housekeeping gene.  Relative gene 
expression was calculated by the 2-ΔΔCT method [160]. 
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CHAPTER IV 
 
THE PLASMA MEMBRANE-ASSOCIATED GTPase RIN INTERACTS WITH 
THE DOPAMINE TRANSPORTER AND IS REQUIRED FOR PROTEIN KINASE 
C-REGULATED DOPAMINE TRANSPORTER TRAFFICKING 
 
ABSTRACT 
Dopaminergic signaling and plasticity are essential to numerous CNS 
functions and pathologies, including movement, cognition, and addiction.  The 
amphetamine- and cocaine-sensitive dopamine (DA) transporter (DAT) tightly 
controls extracellular DA concentrations and half-life.  DAT function and surface 
expression are not static but are dynamically modulated by membrane trafficking. 
We recently demonstrated that the DAT C terminus encodes a PKC-sensitive 
internalization signal that also suppresses basal DAT endocytosis.  However, the 
cellular machinery governing regulated DAT trafficking is not well defined.  In 
work presented here, we identified the Ras-like GTPase, Rin (for Ras-like in 
neurons) (Rit2), as a protein that interacts with the DAT C-terminal endocytic 
signal.  Yeast two-hybrid, GST pull down and FRET studies establish that DAT 
and Rin directly interact, and colocalization studies reveal that DAT/Rin 
associations occur primarily in lipid raft microdomains.  Coimmunoprecipitations 
demonstrate that PKC activation regulates Rin association with DAT. 
Perturbation of Rin function with GTPase mutants and shRNA-mediated Rin 
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knockdown reveals that Rin is critical for PKC-mediated DAT internalization and 
functional downregulation.  These results establish that Rin is a DAT-interacting 
protein that is required for PKC-regulated DAT trafficking.  Moreover, this work 
suggests that Rin participates in regulated endocytosis. 
 
INTRODUCTION 
Presynaptic neurotransmitter reuptake facilitated by plasma membrane 
transporters is the primary mechanism terminating synaptic transmission. 
Dopamine transporter (DAT) terminates DA signaling and thus is central to 
controlling extracellular DA levels in the brain [161].  DAT is the primary target for 
therapeutic agents such as methylphenidate (Ritalin) and bupropion (Wellbutrin), 
as well as the addictive psychostimulants amphetamine and cocaine, whose 
actions inhibit DAT function [162].  Recent knock-in transgenic mouse studies 
demonstrated that DAT availability is paramount to establishing the rewarding 
properties of cocaine [163], and aberrant DAT function was reported recently in a 
subgroup of attention-deficit hyperactivity disorder (ADHD) patients [164]. 
Moreover, DAT+/− and DAT−/− mice are hyperlocomotive and exhibit significant 
DA depletion in tissue stores [165,166].  Thus, mechanisms that regulate DAT 
plasma membrane availability are likely to have a significant impact on DA 
signaling and the availability of DAT to interact with therapeutic and addictive 
drugs. 
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A wealth of data demonstrates that DAT activity is acutely downregulated 
by protein kinase C (PKC) activation, resulting in DAT trafficking to, and 
sequestering in, endosomal vesicles [81,87].  Work from our laboratory 
established that DAT C-terminal residues 587–596 encode endocytic regulatory 
domain that modulates both basal and PKC-enhanced DAT internalization rates 
[90,91].  The DAT N terminus is also central to regulating DAT endocytic 
trafficking [167], and Nedd4–2-mediated ubiquitination in this domain is critical for 
PKC-mediated DAT sequestration [86,168].  A variety of proteins have been 
identified that interact with DAT, including PICK1 [169,170], Hic-5 [171], 
synaptogyrin-3 [172], and calcium/calmodulin-dependent kinase II (CaMKII) [94]. 
However, none of these identified DAT-interacting proteins are mechanistically 
linked to PKC-regulated DAT internalization.  In the current study, we sought to 
identify proteins that (1) interacted with DAT endocytic regulatory residues 587–
596 and (2) were required for PKC-regulated DAT trafficking.  A yeast two-hybrid 
screen identified the Rin (for Ras-like in neurons) GTPase as a candidate DAT-
interacting protein. Using biochemical, cellular imaging, and knockdown 
approaches, we determined that Rin interacts directly with DAT in a PKC-
regulated manner and is required for PKC-mediated DAT internalization. 
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RESULTS 
Rin is a DAT-interacting protein 
We previously identified a 10 amino acid region encoded in hDAT C-
terminal residues 587–596 that is required for PKC-regulated DAT internalization 
[91] and that negatively regulates basal DAT endocytic rates [90].  Our major aim 
in the current study was to identify proteins that interacted with the hDAT 
residues 587–596 (FREKALAYAIA) and that were mechanistically integral to 
PKC-regulated DAT trafficking.  Using this sequence as bait, we used the hSOS 
rescue system to screen a human substantia nigra cDNA library.  The advantage 
of this approach is that library cDNAs are myristylated and thereby anchored at 
the plasma membrane, whereas baits are cloned in-frame with the Ras guanine 
nucleotide exchange factor, hSOS.  Thus, interactions between bait and library 
prey occur at or near the plasma membrane, mimicking circumstances during 
DAT endocytic trafficking.  Screens take place in the temperature-sensitive 
mutant yeast strain cdc25H, which lacks Ras signaling and is unable to grow at 
the restrictive temperature.  Protein–protein interactions localize hSOS to the 
plasma membrane, activate Ras signaling, and rescue the temperature-sensitive 
phenotype.  In our initial studies, we attempted to use the entire DAT C terminus 
as bait.  However, this bait alone was capable of rescuing growth in the absence 
of library coexpression and was thus deemed unsuitable as bait in the library 
screen.  However, the FREKLAYAIA sequence (hDAT residues 587–596) alone 
did not rescue yeast growth (data not shown) and was therefore used as bait in 
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the screen.  We isolated four clones that rescued yeast growth at the restrictive 
temperature.  Sequence analysis revealed that clone H19 corresponded to the 
small neuronal GTPase Rin, also known as Rit2.  Retransforming purified hRin 
plasmid with the DAT 587–596 bait also yielded a positive interaction and 
confirmed the protein–protein interaction (data not shown). 
We first investigated whether Rin was expressed in dopaminergic cells, to 
determine whether there was a physiologically relevant context for cellular 
DAT/Rin interactions.  Immunoblots revealed a single 25 kDa immunoreactive 
band in catecholaminergic cells lines and neuronal tissues, including the rat 
pheochromocytoma PC12, the human neuroblastoma SK-N-MC, as well as in rat 
striatum (Figure 4.1A).  In addition to its neuronal expression, we also detected 
Rin in rat muscle and liver, primary cultured rat astrocytes, and mouse embryonic 
kidney cells, as well as in non-neuronal cell lines HeLa, COS-1, CHO, IMCD3, 
and HEK293 (Figure 4.1A).  Given that the mRNA expression of Rin is reported 
to be restricted to neuronal tissue [173], we were concerned that the anti-Rin 
antibody might be also detecting Rit, the closest homolog of Rin.  Because both 
proteins are 25 kDa and could not be distinguished on the basis of 
electrophoretic mobility, we used Rin and Rit GFP fusion proteins to test for this 
possibility.  Both constructs were expressed in PC12 cells and exhibited the 
expected molecular weight shift, as confirmed by immunoblotting with anti-GFP 
antibodies (Figure 4.1D).  However, the anti-Rin antibody only detected GFP–Rin 
and not GFP–Rit (data not shown), confirming its specificity.  Thus, Rin protein 
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Figure 4.1. Rin is expressed in PC12 cells and rat striatum and 
specifically coimmunoprecipitates with DAT. A. Rin expression in 
catecholaminergic tissue, noncatecholaminergic tissue, and cell lines. Top: 
Twenty micrograms of PC12, HEK293, CHO, and SK-N-MC lysate and 150 µg 
of rat striatal and cerebellum lysate.  Bottom: 30µg of glial, PC12, HeLa, COS, 
and IMCD3 lysates were resolved by SDS-PAGE and immunoblotted with 
mouse anti-Rin antibodies. B. Coimmunoprecipitations. DAT was 
immunoprecipitated from equivalent amounts lysate from PC12 cells 
transfected with either vector (−) or DAT (+). Control immunoprecipitations 
were performed using anti-TfR antibodies or with Protein A/G beads alone. 
Bead eluents (Bead) and 110th supernatant volumes (Sup) were resolved by 
SDS-PAGE and immunoblotted with an anti-Rin antibody. Representative blots 
are shown (n = 3). C. Coimmunoprecipitations from rat striatal synaptosomes. 
Immunoprecipitations were performed with solubilized rat striatal 
synaptosomes using Protein A beads coated with rabbit anti-DAT antibodies or 
rabbit IgG alone. Eluents were resolved by SDS-PAGE, and immunoreactive 
bands were detected with the indicated antibodies. A representative blot is 
shown (n = 2).  D. Immunoblot of PC12 cells and PC12 cells transfected with 
YFP-Rin. 
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appears to be expressed in neuronal, as well as non-neuronal, tissues and cell 
lines. 
We next asked whether DAT and Rin interact in mammalian cells. 
Coimmunoprecipitations using an antibody directed against the DAT N terminus 
isolated Rin from DAT-PC12 cell lysates, confirming that Rin associates with 
DAT in mammalian neuroendocrine cells (Figure 4.1B).  Rin 
coimmunoprecipitated with DAT specifically and was not isolated from 
nontransfected PC12 cells, with antibodies directed against the transferrin 
receptor, or when empty Protein A/G beads were used (Figure 4.1B).  We also 
detected DAT/Rin interactions when DAT was immunoprecipitated from rat 
striatal synaptosomes (Figure 4.1C), confirming that the DAT/Rin interaction 
occurs in brain.  It should be noted that we were unable to detect the DAT/Rin 
interaction when a C-terminus-directed anti-DAT antibody was used for 
immunoprecipitation, despite quantitative DAT pull down (data not shown). 
Moreover, we were not able to perform the reciprocal coimmunoprecipitation, 
because the available Rin antibody does not effectively immunoprecipitate Rin. 
Although the Rin monoclonal antibody recognizes a single band on 
immunoblots, it does not recognize Rin in situ, nor does it immunoisolate Rin 
from cell lysates.  Furthermore, our attempts to raise rabbit anti-peptide 
antibodies against Rin domains divergent from its homolog Rit did not yield 
immunoreactive sera.  Therefore, we used CFP-tagged Rin to ask whether DAT 
and Rin colocalize in cells and, if so, in what cellular regions.  In PC12 cells 
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cotransfected with CFP–Rin and DAT, staining was clearly detected as a ring 
around the cell perimeter (Figure 4.2A), consistent with its predicted plasma 
membrane localization.  CFP–Rin was also detected primarily at the cell 
perimeter (Figure 4.2A), consistent with reports that it localizes to the plasma 
membrane [174].  We observed substantial DAT and Rin colocalization at the 
plasma membrane, and DAT and Rin colocalization was limited to discrete foci 
within the plasma membrane (Figure 4.2A, arrowheads).  We also observed 
areas in which DAT did not appear to colocalize with Rin (Figure 4.2A, arrows). 
DAT is distributed between lipid raft and non-raft microdomains within the plasma 
membrane [175-177], and we asked whether the focal distribution of DAT/Rin 
colocalization correlated with the expression of DAT in membrane microdomains. 
To answer this question, we coexpressed DAT and CFP–Rin and labeled lipid 
rafts with Alexa Fluor 594-conjugated CTX, which specifically labels membrane 
rafts via binding to GM1 ganglioside [178].  Cells were then fixed, and DAT and 
CFP–Rin were stained as described in Experimental Procedures, using Alexa 
Fluor 488- and Alexa Fluor 405-conjugated secondary antibodies to visualize 
DAT and Rin in the green and blue channels, respectively (Figure 4.2B, C). 
Visually we observed striking colocalization of DAT and Rin in CTX-positive 
regions (Figure 4.2C, arrowheads).  We then quantitatively compared the 
percentage of DAT/Rin colocalization in CTX-positive versus CTX-negative 
regions.  At virtually all the thresholds tested, there was more DAT/Rin 
colocalization in rafts than in non-rafts (n = 16).  Only at a very few extreme 
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Figure 4.2.  DAT and Rin colocalization at the plasma membrane is 
enriched in lipid raft microdomains. Immunofluorescence. PC12 cells 
were cotransfected with DAT and CFP–Rin and were fixed and stained as 
follows. A. Cells were stained with anti-DAT and anti-GFP antibodies and 
imaged as described in Materials and Methods. Boxes indicate an 
enlargement of the areas indicated with white boxes in the merged 
images. B. Cells were labeled with Alexa Fluor 594–CTX and were 
subsequently stained with anti-DAT and anti-GFP antibodies and imaged 
as described in Materials and Methods. C. Enlargement of the boxed 
areas from images in B. Arrows indicate DAT-immunoreactive pixels that 
colocalize with neither Rin (blue) nor CTX (red). Arrowheads indicate foci 
of DAT/Rin colocalization that also colocalize with CTX. D. Average data. 
DAT/Rin colocalization in CTX-positive (+CTX) and CTX-negative (−CTX) 
cell regions was measured at 10 independent thresholds per channel, as 
described in Materials and Methods. Average data at the median 
threshold are expressed as percentage ± SEM DAT/Rin colocalization. *p 
< 0.0001, significantly different from −CTX, paired t test; n = 16. 
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thresholds for a few cells (data not shown) was DAT/Rin colocalization higher (by 
a small amount) in CTX-negative regions than in CTX-positive regions.  Analysis 
at the median threshold values for each cell revealed significantly more DAT/Rin 
colocalization in raft versus non-raft populations (80.1 ± 2.4% in CTX-positive vs 
57.0 ± 4.9% in CTX-negative regions; p < 0.0001, paired t-test; n = 16). 
To further evaluate whether DAT and Rin directly interact in living cells, we 
used FRET microscopy [178] using the three-filter method [179] as described by 
Feige et al. [180], which achieves quantitative visualization of protein 
oligomerization in intact cells and which generates NFRET images.  The results are 
shown in Figure 4.3 and Table 4.1.  To provide a reference for membrane protein 
oligomerization, we coexpressed CFP- and YFP-tagged DAT, which have been 
shown to homo-oligomerize by both biochemical approaches [181-184] and 
FRET microscopy in various cell lines [181,183,184] and transfected neurons 
[172].  In addition, we used SERT tagged with CFP and YFP on its cytoplasmic N 
and C termini, respectively (C-SERT-Y), i.e., a transporter construct predicted to 
produce a strong homotypic FRET signal [172].  Coexpressing C-DAT and Y-
DAT or C-SERT-Y resulted in enriched plasma membrane fluorescence and, as 
expected, robust NFRET signals (18.89 ± 0. 1.16, n = 23 and 48.39 ± 2.54, n = 28, 
respectively; Figure 4.3B, Table 4.1).  Similarly, expressing fluorescently tagged 
Rin proteins resulted in predominant plasma membrane fluorescence (Figure 
4.3A).  Coexpression of CFP–DAT and YFP–Rin resulted in an NFRET value of 
17.54 ± 1.30 (n = 24; Figure 4.3A, B), which was significantly higher than 
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Figure 4.3.  Rin and DAT oligomerization as demonstrated by FRET 
microscopy in intact cells. HEK293 cells were transiently transfected 
with cDNAs encoding CFP- or YFP-tagged proteins as indicated, and 
epifluorescence microscopy was performed 2 d after transfection. A. The 
first and second columns show images obtained with CFP and YFP filter 
sets, respectively; the third column displays a corrected and normalized 
FRET image (NFRET) established with PIXFRET. A look-up table of the 
color code used is presented in the last column. All images shown are 
representative of three to seven experiments. In all images, background 
fluorescence was subtracted. B. Averaged data. Normalized FRET 
efficiencies (NFRET values) are given for cells expressing the following 
constructs: C-Rin and membrane-bound YFP (membr-YFP; n = 15), Y-
DAT and membr-CFP (n = 25), C-TfR and Y-Rin (n = 20), C-Rin and Y-
Rin (n = 16), C-SERT and Y-Rin (n = 27), C-rGAT1 and Y-Rin (n = 30), C-
DAT and Y-Rin (n = 24), C-Rin and Y-DAT (n = 20), C-DAT and Y-DAT (n 
= 23), and C-TfR and Y-TfR (n = 37). All values were analyzed by one-
way ANOVA with Dunn's multiple comparison test. *p < 0.001, 
significantly different from (YFP–DAT and membr-CFP), (CFP–Rin and 
YFP–Rin), and (Rin and membr-YFP). **p < 0.001, significantly different 
from (CFP–TfR and YFP–Rin), (CFP–Rin and YFP–Rin), and (Rin and 
membr-YFP). See Table 1 for statistical analysis of complete dataset. 
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FRET Pair #1 FRET Pair #2 Significant?
CFP–DAT$ YFP–Rin CFP–SERT$ YFP–Rin Yes*
CFP–DAT$ YFP–Rin CFP–rGAT1$ YFP–Rin Yes*
CFP–DAT$ YFP–Rin CFP–TfR$ YFP–TfR NS
CFP–DAT$ YFP–Rin CFP–TfR$ YFP–Rin Yes*
CFP–DAT$ YFP–Rin CFP–Rin$ YFP–Rin Yes*
CFP–DAT$ YFP–Rin YFP–DAT$membr-CFP Yes*
CFP–DAT$ YFP–Rin CFP–Rin$membr-YFP Yes*
CFP–DAT$ YFP–Rin CFP–Rin$ YFP–DAT NS
CFP–DAT$ YFP–Rin CFP–DAT$ YFP–DAT NS
CFP–SERT$ YFP–Rin CFP–rGAT1$ YFP–Rin NS
CFP–SERT$ YFP–Rin CFP–TfR$ YFP–TfR Yes*
CFP–SERT$ YFP–Rin CFP–TfR$ YFP–Rin NS
CFP–SERT$ YFP–Rin CFP–Rin$ YFP–Rin NS
CFP–SERT$ YFP–Rin YFP–DAT$membr-CFP NS
CFP–SERT$ YFP–Rin CFP–Rin$membr-YFP NS
CFP–SERT$ YFP–Rin CFP–Rin$ YFP–DAT Yes**
CFP–SERT$ YFP–Rin CFP–DAT$ YFP–DAT Yes*
CFP-rGAT1$ YFP–Rin CFP–TfR$ YFP–TfR Yes*
CFP-rGAT1$ YFP–Rin CFP–TfR$ YFP–Rin NS
CFP-rGAT1$ YFP–Rin CFP–Rin$ YFP–Rin NS
*p# 0.001, **p# 0.05, one-way ANOVA with Dunn’s multiple comparison test.
Table 4.1.  Statistical analysis of NFRET values 
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fluorescent Rin proteins (p < 0.001, one-way ANOVA with Dunn's multiple 
comparison test) and not significantly different from either coexpressed CFP–
DAT and YFP–DAT or CFP–Rin and YFP–DAT.  This confirms that DAT and Rin 
interact in living cells and that the different fluorescent tags do not influence the 
signal.  To control for the possibility of nonspecific FRET of fluorescent proteins 
in the plasma membrane, we tested whether Rin would generate significant 
FRET interaction with membrane anchored YFP; coexpression with CFP–Rin 
yielded an NFRET value of 5.40 ± 0.49 (n = 15; Figure 4.3B), which was 
significantly less than any DAT/Rin combination (p < 0.001).  Apparently, this 
membrane-attached YFP can serve as a weak acceptor for CFP fluorophores 
attached to proteins integral to membranes; indeed, some spurious FRET signal 
was visible during coexpression with CFP–DAT, but only in a cytosolic 
compartment (data not shown); therefore, the transitional interaction most likely 
occurred in the endoplasmic reticulum.  Importantly, Rin proteins do not interact 
with themselves as revealed by an NFRET value of 6.24 ± 0.90 (n = 16; Figure 
4.3B). 
We next asked whether the interaction of Rin with DAT was specific to 
DAT or whether it extended either to other SLC6 transporters or generally to 
proteins that are rapidly endocytosis, such as the transferrin receptor (TfR).  To 
test potential Rin interaction with other SLC6 neurotransmitter transporters, we 
coexpressed Rin with either fluorescently tagged rat GABA (CFP–GAT1) or 
human serotonin transporter (CFP–SERT).  Interestingly, CFP–GAT1 and CFP–
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SERT did not interact with YFP–Rin (NFRET values of 6.55 ± 0.64 and 7.58 ± 0.77, 
respectively; Figure 4.3A, B).  Neither condition differed significantly from the 
CFP–Rin and membrane YFP negative control, and rGAT1 and Rin were 
significantly less than from DAT and Rin (p < 0.001) and from the positive control 
CFP–TfR and YFP–TfR (NFRET value of 18.53 ± 0.96) (p< 0.001) but not from 
hSERT and Rin (NFRET value of 7.58 ± 0.77; n = 27), respectively (Figure 4.3B). 
To test for Rin interactions with rapidly internalizing surface proteins, we 
coexpressed of YFP–Rin with CFP–TfR.  This condition resulted in an 
NFRET value of 6.35 ± 0.83, which was significantly less that DAT/Rin FRET pairs 
and not significantly greater than fluorescent Rin proteins or membrane-anchored 
fluorescent proteins with either DAT or Rin (Figure 4.3B).  Lack of a significant 
TfR/Rin FRET signal was not attributable to inability of fluorescently tagged TfR 
to form FRET pairs, because CFP–TfR and YFP–TfR coexpression resulted in 
an NFRET value of 18.5 ± 0.96, which was significantly greater than fluorescent 
TfR with Rin and is consistent with the known TfR homodimerization (Figure 
4.3B) [185]. 
We next tested whether DAT/Rin interactions relied specifically on the 
DAT C terminus.  To test this, we performed in vitro pull-down assays, using a 
GST fusion protein expressing DAT C-terminal residues 587–617 to probe PC12 
cell homogenates lacking DAT expression.  The GST–DAT 587–617 fusion 
protein was sufficient to isolate Rin from PC12 homogenates, whereas GST 
alone was not (Figure 4.4A).  Moreover, GST–DAT 587–617 recovered Rin from 
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Figure 4.4.  Rin interacts with DAT C terminus.  GST pull-down assays. 
PC12 homogenate was incubated with either GST or GST–DAT 587–617, 
1 h, 37°C. Complexes were isolated with glutathione agarose, and Rin 
was detected by immunoblot as described in Materials and Methods. A. 
Rin is isolated with the DAT C terminus but not GST alone. B. 
Concentration dependence. GST–DAT 587–617 was incubated with 
increasing concentrations of PC12 homogenate, 1 h, 37°C, followed by 
isolation of complexes with glutathione agarose. Top, Representative 
immunoblot probed for Rin. Bottom, Averaged data. Results are expressed 
as percentage maximal Rin signal versus log PC12 homogenate 
concentration (milligrams per milliliters) and were fit to a sigmoidal dose–
response curve (r2 = 0.98, n = 3). 
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PC12 homogenates in a concentration-dependent manner (Figure 4.4B). 
Together with our yeast two-hybrid co-IP and FRET data, these results 
demonstrate that DAT and Rin directly interact in mammalian cells and brain and 
that their interaction is mediated by the DAT C terminus, which encodes the 
FREKLAYAIA sequence used as bait in the original yeast two-hybrid screen. 
 
PKC activation regulates DAT and Rin interactions 
Our previous studies demonstrated that DAT residues 587–596 
(FREKLAYAIA) encode elements that control DAT endocytic rates in a PKC-
sensitive manner [90].  Specifically, 587–589 (REK) residues are required for 
PKC-induced increases in DAT internalization.  Moreover, mutating residues 
587–590 accelerates basal DAT endocytic rates, suggesting that a negative 
regulatory mechanism controls DAT endocytic rates.  Therefore, we asked 
whether DAT associations with Rin were regulated by PKC activation and 
whether residues in the 587–590 region played a role in DAT/Rin interactions. 
PC12 cells stably expressing either wild-type DAT or the DAT 587–590(4A) 
mutant were treated with 1 µM PMA, 30 min, 37°C, and DAT/Rin interactions 
were assessed by coimmunoprecipitation and immunoblot.  PKC activation 
significantly increased wild-type DAT/Rin interactions to 183.6 ± 16.5% of basal 
DAT/Rin interactions (p < 0.005, Student's t test; n = 4) (Figure 4.5A).  PMA-
induced increases in wild-type DAT/Rin interactions were blocked when cells 
were preincubated with the PKC inhibitor BIM (Figure 4.5A), demonstrating that 
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Figure 4.5.  DAT/Rin interactions are regulated by PKC activation and 
are sensitive to DAT C-terminal residues 587-590.  A–C. 
Coimmunoprecipitations. PC12 cells stably expressing either wild-type 
DAT (A) or DAT 587–590(4A) (B) were pretreated with either 1 µM BIM or 
vehicle, 20 min, 37°C, followed by treatment with either vehicle or 1 µM 
PMA, 30 min, 37°C. Cells were lysed, and DAT was immunoprecipitated 
from equivalent amounts of cellular protein. Immunoprecipitants were 
resolved by SDS-PAGE and immunoblotted for both DAT and Rin. Left, 
Representative immunoblots. Right, Averaged data. Rin signals from 
nonsaturating bands were normalized to DAT signals and are expressed 
as percentage vehicle signal ± SEM. *p < 0.002, significantly different from 
vehicle control (one-way ANOVA with Tukey's multiple comparison test; n 
= 4). C. Basal Rin interaction with wild-type versus 587–590(4A) DAT. Left, 
Representative immunoblot. Right, Averaged data. Rin signals from 
nonsaturating bands were normalized to DAT signals and expressed as 
percentage wild-type signal ± SEM. *p < 0.0005, significantly different from 
wild-type DAT (Student's t test; n = 3). D. GST pull downs. GST fused to 
either wild-type or DAT 587–590(4A) C termini were induced and isolated 
on glutathione sepharose as described in Materials and Methods. 
Equivalent amounts of GST–DAT fusion proteins were incubated with 
PC12 homogenates, and bound proteins were resolved by SDS-PAGE 
and immunoblotted for both Rin and GST. Left, Representative 
immunoblot. Right, Averaged data. Rin densities were normalized to total 
GST pulled down for each sample and are expressed as percentage ± 
SEM Rin isolated compared with wild-type GST–DAT. *p < 0.04, 
significantly different from wild-type GST–DAT (Student's t test; n = 5). 
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the PMA-induced increase in DAT/Rin interactions is PKC dependent.  In 
contrast, PMA treatment did not significantly increase Rin interactions with DAT 
587–590(4A) (Figure 4.5B), and pretreatment with BIM did not alter DAT 587–
590(4A)/Rin interactions.  Moreover, under basal conditions, DAT 587–590(4A) 
interactions with Rin were 300% of wild-type DAT/Rin interactions (Figure 4.5C). 
These results suggest that DAT residues 587–590 are required for PKC-induced 
increases in DAT/Rin interactions.  Additionally, these results suggest that 
DAT/Rin interactions increase in conditions were DAT internalization rates are 
accelerated either by PKC activation or mutating residues 587–590.  To further 
test this possibility, we performed GST pull downs using GST–DAT C terminus 
that encoded the 587–590(4A) mutation [GST–DAT(4A)]. GST–DAT(4A) isolated 
significantly more Rin than wild-type GST–DAT (164.6 ± 21.8% of wild-type 
levels) (Figure 4.5D), consistent with a role for residues 587–590 in modulating 
DAT/Rin interactions. 
 
Rin is required for PKC-mediated DAT trafficking 
We next asked whether DAT endocytosis requires Rin activity, under 
either basal or PKC-stimulated conditions.  To address this question, we used 
reversible biotinylation to measure relative DAT internalization rates in PC12 
cells coexpressing DAT with wild-type Rin, or constitutively active (Q78L) or 
dominant-negative (S34N) Rin mutants.  The results are shown in Figure 4.6. 
DAT internalized robustly under control conditions and PMA treatment 
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Figure 4.6.  PKC-induced 
D AT i n t e r n a l i z a t i o n 
requires Rin activity. 
Internalization assays. 
P C 1 2  c e l l s  w e r e 
cotransfected with DAT 
and the indicated Rin or 
control cDNAs and were 
assayed 48–72 h after 
transfection. Relative DAT 
internalization rates over 
10 min were measured by 
reversible biotinylation 
during treatment with or 
without 1 µM PMA, 37°C 
as described in Materials 
a n d M e t h o d s . To p , 
R e p r e s e n t a t i v e 
immunoblots showing total 
surface DAT at time 0 (T), 
strip controls (S), and 
internalized DAT under 
vehicle-treated (V) and 
P M A - t r e a t e d  ( P ) 
c o n d i t i o n s . B o t t o m , 
A v e r a g e d a t a . v e h , 
V e h i c l e .  D a t a  a r e 
expressed as percentage 
± SEM DAT internalized/10 
min compared with total 
surface DAT at t = 0. *p < 
0 . 0 0 1 , * * p < 0 . 0 5 , 
significantly different from 
vehicle-treated control 
(Student's t test; n = 4). 
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significantly increased the endocytic rate of DAT, both when DAT was 
coexpressed with empty vector or constitutively active RinQ78L.  In contrast, 
coexpressing DAT with either wild-type Rin or dominant-negative Rin S34N 
completely inhibited PMA-stimulated DAT endocytosis but had no effect on basal 
DAT internalization rates.  These results demonstrate that Rin activity is required 
for PKC stimulation of DAT endocytosis. 
We also visually examined DAT surface levels in response to PKC 
activation when DAT was coexpressed with either wild-type or mutant Rin 
constructs.  When DAT was coexpressed with either vector (data not shown) or 
CFP–Rin, we observed robust DAT and Rin surface expression under vehicle-
treated conditions (Figure 4.7).  PMA treatment for 30 min, 37°C resulted in 
marked DAT redistribution to intracellular puncta, whereas Rin dissociated from 
DAT remained at the plasma membrane after PKC activation (Fugure 4.7).  In 
cells that coexpressed DAT and Rin mutants, DAT and Rin were similarly 
expressed at the plasma membrane under vehicle conditions (Figure 4.7). 
However, although both wild-type Rin and Rin S34N inhibited PKC-stimulated 
DAT internalization when the global population was examined by biochemical 
means (i.e., reversible biotinylation; Figure 4.6), we still observed a 
subpopulation of cells that exhibit DAT intracellular sequestration in response to 
PKC activation.  In this subpopulation, and in contrast to control conditions, both 
RinQ78L and S34N failed to dissociate from DAT and internalized with DAT into 
intracellular puncta after PKC activation (Figure 4.7).  The majority of intracellular 
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Figure 4.7.  Guanyl nucleotide exchange is required for PKC-mediated Rin 
dissociation from DAT. Immunofluorescence. PC12 cells were cotransfected 
with DAT and the indicated Rin or control cDNAs and were assayed 48 h after 
transfection. Cells were treated with or without 1 µM PMA, 30 min, 37°C and 
were fixed, stained with anti-DAT or anti-GFP (to detect CFP–Rin) antibodies, 
and imaged as described in Materials and Methods. Planes through the cell 
center are shown and are representative of 12–16 cells imaged per condition in 
instances in which PMA-induced internalization was apparent (n = 4). 
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Rin puncta colocalized with DAT, although some DAT puncta were without Rin 
colocalization.  These results suggest that the ability of Rin to dissociate from 
DAT after PKC activation is dependent on its ability to exchange guanyl 
nucleotide. 
We further tested whether Rin was required for PKC-mediated DAT 
trafficking, using shRNAs targeted against human Rin mRNA to knockdown 
cellular Rin levels.  Three shRNAs were tested for their ability to reduce cellular 
Rin levels in HEK293 cells.  Of these, hRin228 significantly reduced Rin levels 
down to 68.6 ± 12.6% of that observed in vector-transfected cells, whereas a 
scrambled shRNA had no effect on Rin levels (Figure 4.8B, inset).  Using these 
Rin-directed shRNAs, we first asked whether Rin was required for PKC-induced 
DAT sequestration in the human neuroblastoma cell line SK-N-MC.  This line 
was chosen because it expresses the dopamine biosynthetic enzyme tyrosine 
hydroxylase and is compatible with commercially available human-targeted 
shRNAs. We coexpressed DAT encoding an extracellular HA epitope tag in the 
second extracellular loop with control or Rin-directed shRNA vectors and 
assessed PMA-induced DAT endocytosis by labeling surface DAT with anti-HA 
antibody.  In cells cotransfected with DAT and GFP-expressing vector, treatment 
with 1 µM PMA treatment, 15 min, 37°C resulted in robust DAT intracellular 
puncta in 79.8 ± 2.9% of cells (Figure 4.8).  Coexpressing DAT with scrambled 
shRNA had no significant effect on the number of cells exhibiting PMA-induced 
DAT internalization (73.0 ± 11.0% of cells).  In contrast, significantly fewer cells 
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Figure 4.8.  Rin is required for PKC-mediated DAT sequestration. 
hRin knockdown and antibody internalization assay. A. hRin knockdown. 
hRin-directed shRNAs were screened in HEK293 cells, 72 h after 
transfection. Top, Representative immunoblot showing Rin levels in 
vector-transfected, scrambled shRNA-transfected (scr), and hRin228-
transfected cells, with actin probed as a loading control. Bottom, 
Averaged data. Data are expressed as percentage Rin levels compared 
with vector-transfected cells (normalized to actin loading control). *p < 
0.05, significantly different from vector control (one-way ANOVA with 
Dunnett's post hoc analysis; n = 5). B, C. Antibody internalization assay. 
SK-N-MC cells cotransfected with EL2–HA–DAT and the indicated 
constructs were assayed 72 h after transfection. Cells were labeled with 
HA antibody, and DAT internalization was assessed for 15 min, 37°C in 
the presence of 1 µM PMA as described in Materials and Methods. Cells 
expressing shRNA constructs were identified by GFP coexpression. 
Optical z-stacks were collected and deconvolved as described in 
Materials and Methods. B. Averaged data. Data are expressed as 
percentage ± SEM cells exhibiting PMA-induced intracellular DAT puncta 
for each of the indicated transfection conditions. *p < 0.05, significantly 
different from vector-transfected control (one-way ANOVA with Dunnett's 
multiple comparison test; n = 3). C. Representative images. Planes 
through the cell center are shown for two cells per condition and are 
representative of 30–34 cells imaged per condition over three 
independent experiments. 
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exhibited PMA-induced DAT internalization when coexpressed with hRin228 
(37.2 ± 8.9% cells; p < 0.05, one-way ANOVA with Dunnett's post hoc analysis). 
Rin knockdown effects on DAT internalization were not attributable to global 
perturbation of the endocytic machinery, because TfR endocytosis was identical 
in vector- versus hRin228-transfected cells, as assessed by Alexa Fluor 594–
transferrin uptake (data not shown).  These results demonstrate that Rin is 
absolutely essential for PKC-induced DAT sequestration. 
Given that Rin is required for PKC-induced DAT sequestration, we used 
the hRin228 shRNA to ask whether Rin was required for PKC-mediated DAT 
functional downregulation.  We measured robust [3H]DA uptake in cells 
cotransfected with DAT and vector, and PKC activation significantly decreased 
DA uptake to 42.6 ± 11.1% of vehicle-treated cells (p < 0.03, Student's t test; n = 
4; Figure 4.9).  In contrast, PKC activation had no significant effect on DA uptake 
in cells cotransfected with DAT and hRin228 (106.3 ± 13.7% of vehicle-treated 
cells; p = 0.72, Student's t test; n = 4; Figure 4.9), consistent with the inability of 
DAT to sequester in a Rin-depleted environment. 
 
DISCUSSION 
In the current study, we sought to identify proteins that interacted with 
DAT residues 587–596 and were central to PKC-induced DAT sequestration. 
Using the hSOS rescue yeast two-hybrid approach, we determined that the 
neuronal GTPase Rin (Rit2) interacts with DAT residues 587–596 
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Figure 4.9.  Rin is required for PKC-induced DAT functional 
downregulation. [3H]DA uptake assays. SK-N-MC cells were cotransfected 
with DAT and the indicated constructs, and [3H]DA uptake was assessed 
72 h after transfection. Cells were treated with or without 1µM PMA, 30 min, 
37°C, followed by addition of [3H]DA as described in Materials and 
Methods. Averaged data are shown and are expressed as percentage 
±SEM uptake of vehicle-treated cells. *p < 0.03, significantly different from 
vehicle-treated control (Student's t test; n = 4). 
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(FREKLAYAIA) and that Rin is absolutely required for PKC-induced DAT 
sequestration.  Rin, also known as Rit2, is a member of the Rit subfamily of Ras-
like small GTPases, which also includes the Drosophila homolog RIC [186]. 
These GTPases are highly conserved and are distinguished from other Ras-like 
GTPases in their lack of a C-terminal CaaX box for prenylation.  Recent evidence 
suggests that a polybasic charged domain conserved at their C termini facilitates 
their plasma membrane association [174].  Whereas Rit is ubiquitously 
expressed, Rin expression is reported to be limited to neurons [173], and a 
recent report suggests that Rin expression is particularly enriched in 
dopaminergic neurons [187].  A recent study also revealed that Rin exhibits 
significant copy number variation in schizophrenic patient populations [188] and 
that a 5.3 Mb deletion encompassing the Rin gene on chromosome 18q12.3 is 
present in two patients with profound speech delay [189].  Together, these 
results suggest that Rin may play a central role in the pathophysiology of 
neuropsychiatric disorders. 
What is known about the role of Rin in intracellular signaling, and how 
might that shed light onto downstream pathways that converge on DAT?  Rin 
activates atypical PKC via interactions with the Par6/cdc42 complex [92,93] and 
a recent screen for endocytic determinants in Caenorhabditis elegans revealed 
that the Par6/cdc42 complex is absolutely required for transferrin receptor 
endocytosis, as well as for MHCI endocytic recycling [190].  Additionally, the 
Par6/cdc42/aPKC complex is required for E-cadherin endocytosis in 
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Drosophila [191].  Our results linking Rin to regulated DAT internalization raise 
the possibility that Rin may be an upstream signaling step in Par6/cdc42-
dependent endocytosis.  Rin also reportedly binds to and activates calmodulin 
[173].  Given that CaMKII interacts with the DAT C terminus and is essential for 
amphetamine-mediated DA efflux through DAT [94], it is possible that Rin may 
serve as a means to activate DAT-bound CaMKII via calmodulin activation.  Rin 
is also required for nerve growth factor (NGF)-stimulated neurite extension [192-
194] and p38 MAP kinase activation in response to NGF signaling [195].  Several 
reports link the MAP kinase signaling pathway to DAT trafficking [84,196-198], 
potentially implicating Rin in this process as well. 
We detected Rin protein expression in striatal tissue and several 
dopaminergic cell lines, including SK-N-MC and PC12 (Figure 4.1A).  In addition, 
we detected Rin in non-neuronal tissues and cell lines (Figure 4.1D), whereas 
previous studies reported that Rin mRNA expression was limited to neuronal 
tissues as determined by Northern blot and RT-PCR approaches [173].  This 
inconsistency is not attributable to lack of specificity of the Rin antibody, because 
it did not cross-react with GFP–Rit (data not shown).  Moreover, we detected 
both Rit and Rin mRNA signals by RT-PCR in primary mouse embryonic kidney, 
PC12, and HeLa cells, as well as in whole brain and substantia nigra (data not 
shown).  Thus, the apparent discrepancy between our results and previous 
reports may reflect a lack in sensitivity in the available approaches used at the 
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time the previous studies were performed.  Alternatively, Rin may be ectopically 
expressed in transformed cell lines. 
We observed DAT/Rin associations via coimmunoprecipitation in rat 
striatal tissue (Figure 4.1) and PC12 cells (Figures 4.1, 4.5).  Additionally, 
colocalization studies revealed that the DAT/Rin interaction occurs at the plasma 
membrane in PC12 and HEK293 cell lines (Figures 4.2, 4.3, 4.6).  We also 
wanted to determine whether DAT and Rin colocalize in native dopaminergic 
neurons.  The commercially available Rin monoclonal antibody does not 
recognize Rin in situ, and our attempts at raising Rin-specific antisera were not 
successful, thwarting our ability to examine the DAT/Rin interaction in native 
preparations.  As an alternative, we attempted to express CFP–Rin in primary 
ventral midbrain (VM) neurons using lentiviral infection.  Despite successful 
generation of high-titer lentivirus, as determine by transduction of HEK293 cells, 
we were unable to reproducibly and efficiently transduce VM neurons in culture. 
Future studies will explore alternative gene delivery methods to further examine 
the DAT/Rin interaction in situ. 
DAT/Rin interactions were significantly enriched in membrane raft regions 
within the membrane (Figure 4.2B-D).  A recent report indicates that DAT 
localizes to both lipid raft and non-raft domains within the plasma membrane 
[177] and that DAT may be differentially regulated by PKC, depending on its 
microdomain localization.  Moreover, Cremona et al. [176] recently reported that 
the membrane raft protein flotilin-1 is absolutely required for DAT localization to 
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lipid microdomains and for PKC-stimulated DAT sequestration.  Thus, DAT/Rin 
interactions may occur in a specific lipid microdomain that facilitates enhanced 
endocytosis in response to PKC activation. 
We recently reported that the charged residues at hDAT positions E589 
and R590 contribute to a braking mechanism that dampens DAT endocytic rates 
under basal conditions but is released during PKC activation [90].  In agreement 
with our findings, Sorkina et al. [167] also recently confirmed the existence of a 
negative endocytic regulatory mechanism.  Interestingly, results from that study 
demonstrated that the negative endocytic regulatory mechanism requires the 
DAT N terminus.  The DAT N terminus is also the target of PKC-stimulated 
ubiquitination, and ubiquitination is required for PKC-mediated DAT 
internalization [168].  We observed increased DAT/Rin interactions in 
circumstances in which the DAT endocytic brake is released, either during PKC 
activation (Figure 4.5A) or when DAT residues 587–590 are mutated (Figure 
4.5C, D).  These results suggest that Rin plays a role in accelerating DAT 
endocytic rates.  It also raises the possibility that there is a synergistic interaction 
between the DAT N and C termini that regulates the DAT endocytic rate. 
A common approach to testing the role of small GTPases is the use of 
dominant-negative and constitutively active mutant GTPases, which are locked in 
the GTP-bound and GDP-bound states, respectively, and are unable to either 
hydrolyze GTP (constitutively active) or exchange GDP for GTP (dominant 
negative).  Rin Q78L and S34N mutants have been described previously to 
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perturb Rin function in response to growth factor stimulation [195,199].  The Rin 
S34N mutant inhibited PKC-mediated DAT sequestration (Figure 4.6), consistent 
with a requisite role for Rin in PKC regulated DAT endocytosis.  Interestingly, 
overexpression of wild-type Rin also inhibited PKC-stimulated DAT endocytosis. 
Overexpressed GTPases can have an inhibitory effect, because they can 
mislocalize and potentially sequester important factors required for vesicle 
trafficking [200].  Cellular imaging revealed that both of the Rin mutants fail to 
dissociate from DAT during internalization (Figure 4.7).  Together with our 
coimmunoprecipitation results, these data suggest that Rin binds to the DAT C 
terminus to promote increased DAT internalization rates and then dissociates 
from DAT during guanyl nucleotide exchange.  Rab GTPases are reported to 
function in a similar manner, with guanyl nucleotide exchange dictating Rab 
movement between membrane-bound compartments [201]. 
Rin depletion significantly inhibited PKC-mediated DAT sequestration 
(Figure 4.8).  However, we should note that we did see PKC-induced DAT 
internalization in a population of cells with either high DAT expression or 
relatively low shRNA expression (correlated to GFP signal intensity).  This is 
consistent with our previous report in which we observed that PKC-mediated 
DAT trafficking is highly sensitive to DAT expression levels [83], suggesting a 
readily saturable cellular process. Indeed, we also observed that excessively 
high DAT expression levels in HEK293 cells resulted in a loss of PKC-induced 
DAT sequestration (unpublished results).  Surprisingly, Rin knockdown also 
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abolished PKC-mediated DAT functional downregulation (Figure 4.9).  Foster et 
al. [177] recently reported both trafficking-dependent and -independent modes of 
PKC-mediated DAT downregulation, in contrast with our findings.  The 
differences in our results may be attributable to different cell lines used (LLC-PK1 
vs SK-N-MC) or may indicate that Rin is also required for trafficking-independent 
forms of PKC-mediated DAT downregulation.  One possibility is that distinct PKC 
isoforms may participate in trafficking-dependent and -independent DAT 
regulatory mechanisms.  A recent report suggests that PKCβ plays a central role 
in DAT trafficking [202].  In addition, previous studies demonstrated that multiple 
PKC isoforms are capable of functional DAT downregulation [203].  Because 
phorbol ester treatment activates multiple PKC isoforms, simultaneously, we 
cannot conclude whether or not specific PKC isoforms underlie the trafficking-
dependent and -independent forms of DAT downregulation.  However, future 
studies exploring the role of specific PKC isoforms in Rin-mediated DAT 
trafficking should be illuminating in this regard. 
Recent studies have revealed a central role for biogenic amine transporter 
function in neuropsychiatric disorders, including ADHD [164] and autism [204]. 
Given the eminent role that transporters play, both as addictive and therapeutic 
drug targets, as well as in the pathophysiology of neuropsychiatric diseases, 
modulation of transporter availability by membrane trafficking is likely to have a 
significant impact on both normal and aberrant neurotransmission.  The 
identification of Rin as a critical modulator of DAT trafficking and as a potentially 
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important link between DAT, CaMKII, and MAP kinase signaling will undoubtedly 
shed additional light on the mechanisms governing dopamine levels and 
plasticity in the brain.  Moreover, these studies raise the possibility that Rin may 
play a larger role in synaptic endocytic trafficking. 
 
EXPERIMENTAL PROCEDURES 
Antibodies and reagents – Monoclonal rat anti-DAT antibodies were from 
Millipore Bioscience Research Reagents and mouse anti-Rin antibodies (clone 
27G2) were from ExAlpha Biologics or Millipore.  Rabbit anti-DAT polyclonal 
antibody was a generous gift from Dr. Roxanne Vaughan (University of North 
Dakota, Grand Forks, ND). cDNAs encoding HA–RinQ78L and HA–RinS34N 
(Spencer et al., 2002a) were kindly provided by Dr. Doug Andres (University of 
Kentucky, Lexington, KY). Mouse anti-green fluorescent protein (GFP) antibody 
and rat anti-HA antibody (clone 3F10) were from Roche, and mouse anti-actin 
antibody was from Santa Cruz Biotechnology.  Mouse anti-HA (HA.11) antibody 
was acquired from Covance.  Horseradish peroxidase (HRP)-conjugated 
secondary antibodies were from either Millipore Bioscience Research Reagents 
(anti-mouse) or Santa Cruz Biotechnology (anti-rat), and goat anti-mouse Fc 
fragment coupled to horseradish peroxidase was from Jackson 
ImmunoResearch.  Fluorescently conjugated secondary antibodies and 
transferrin were from Invitrogen. [3H]DA (dihydroxyphenylethylamine 3,4-[ring-
2,5,6,-3H]) was from PerkinElmer Life and Analytical Sciences, and sulfo-NHS-
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SS-biotin was from Pierce.  Phorbol 12-myristate 13-acetate (PMA) and 
GBR12909 (1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-[3-
phenylpropyl]piperazine) were from Tocris Cookson.  All other chemicals and 
reagents were from Sigma-Aldrich and Thermo Fisher Scientific and were of the 
highest grade available. 
 
Yeast two-hybrid screen – A bait encoding human DAT amino acids 587–596 
was constructed by amplifying hDAT cDNA region 1778–1807 with primers 
containing NotI and BglII sites and was cloned in-frame into the pSOS vector 
(Stratagene) at the NotI/BglII sites.  The pSOS–DAT(586–597) bait was used to 
screen a CytoTrap XR substantia nigra cDNA library cloned into the pMyr vector 
(Stratagene).  Positive interactions rescue Ras activity and permit yeast growth 
at the restrictive temperature.  Positive clones were picked and underwent 
secondary and tertiary screening to rule out false positives attributable to 
temperature reversion.  Plasmid DNA was isolated from tertiary positive clones, 
transformed into DH5αE bacteria (Invitrogen), amplified in liquid culture, and 
purified, and sequences were determined (Genewiz). 
 
Cell culture and transfections – PC12 cells were maintained at 37°C, 10% CO2 in 
DMEM (high glucose), 5% horse serum (Hyclone), and 5% bovine calf serum 
(Invitrogen) supplemented with 2 mM glutamine, 102 U/ml penicillin/streptomycin. 
Stably transfected PC12 cells expressing wild-type and 587–590(4A) DAT were 
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maintained as described previously [83,90,205] under selective pressure with 0.2 
mg/ml G418 (Invitrogen).  HEK293 cells were grown in DMEM, 10% fetal bovine 
serum, 2 mM glutamine, and 102 U/ml penicillin/streptomycin, 37°C, 5% CO2. 
The human neuroblastoma cell line SK-N-MC was obtained from American Type 
Culture Collection and was maintained in MEM supplemented with 10% fetal 
bovine serum, 2 mM glutamine, and 102 U/ml penicillin/streptomycin, 37°C, 5% 
CO2.  HEK293 cells were transiently transfected with Lipofectamine 2000, 
according to the instructions of the manufacturer, using 2 µg of total DNA/7 × 
105 cells, incubating with DNA/Lipofectamine complexes with cells 4 h for 
maximal cell viability. PC12 cells were transfected either by electroporation or 
using Lipofectamine 2000. For electroporation, 18.2 µg of DNA/1.1 × 107 PC12 
cells in 0.75 ml of electroporation buffer (in mM: 137 NaCl, 5.0 KCl, 0.7 
Na2HPO4, 6.0 glucose, and 20 HEPES, pH 7.05) was combined in 4 mm 
cuvettes and were electroporated using an exponential decay protocol at 300 V, 
500 µF.  Cells were resuspended in PC12 media supplemented with 3 mM EGTA 
and recovered 30 min, 37°C with occasional inversion.  Cells were collected by 
centrifugation, resuspended in PC12 media, and plated as indicated.  For 
Lipofectamine 2000 transfections, PC12 cells were seeded 1 d before 
transfection at 1 × 106 cells per well (six-well plates coated with 0.5 mg/ml poly-
D-lysine; biochemical assays) or 2.25 × 105 per well (glass coverslips coated with 
1.0 mg/ml poly-D-lysine for microscopy) in antibiotic-free PC12 media.  Cells 
were transfected with either 4 µg (six-well plates) or 0.8 µg (glass coverslips) 
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total DNA at a 2.5:1 Lipofectamine/DNA ratio, according to the instructions of the 
manufacturer.  Transfection solutions were replaced with fresh antibiotic-free 
media 16–24 h after transfection, and cells were assayed as described for each 
experiment. For SK-N-MC cells, 2.25 × 105 cells per well were plated 1 d before 
transfection in antibiotic-free media on either glass coverslips coated with 0.25 
mg/ml poly-D-lysine (microscopy) or in uncoated 24-well tissue cultureware 
plates (uptake assays).  Cells were transfected with 0.3 µg of total DNA per well 
at a 2:1 Lipofectamine/DNA ratio, according to the instructions of the 
manufacturer.  Transfection solutions were replaced with fresh, antibiotic-free 
media 4 h after transfection, and cells were assayed as described for each 
experiment. 
 
Coimmunoprecipitations – One × 106 PC12 or PC12 cells stably expressing 
either wild-type or 587–590(4A) DAT were seeded in poly-D-lysine-coated six-
well plates 1 d before experiments.  Cells were treated as indicated, lysed in 
coimmunoprecipitation (co-IP) buffer (50 mM Tris, pH 7.4, 100 mM NaCl, 1% 
Triton X-100, 10% glycerol, and 1 mM EDTA) containing protease inhibitors (1.0 
mM PMSF and 1.0 µg/ml each leupeptin, aprotinin, and pepstatin) and 
phosphatase inhibitors (10 mM sodium fluoride and 1 mM sodium 
orthovanadate), 30 min, 4°C with gentle shaking. Lysates were cleared by 
centrifugation (4°C), and protein concentrations were determined using the BCA 
Protein Assay (Pierce) with BSA standards.  Equivalent amounts of cellular 
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protein underwent immunoprecipitation (overnight, 4°C) using Protein A/G beads 
(Pierce) precoated with the indicated antibodies.  Supernatants were 
concentrated with Milliporespin filtration columns (10 kDa molecular weight 
cutoff), and beads were washed three times with co-IP buffer. Proteins were 
eluted by boiling in SDS-PAGE sample buffer containing 2 M urea (final 
concentration), and proteins were separated on 10% SDS-PAGE gels.  After 
transfer to nitrocellulose, immunoblots were blocked with 5% nonfat dry milk, 
0.1% Tween 20, and PBS, and proteins were detected with the indicated primary 
antibodies.  To avoid detecting mouse IgG light chain in the immunoprecipitation 
complex, immunoreactive Rin bands were detected with goat anti-mouse 
Fc fragment coupled to HRP.  Standard secondary antibodies conjugated to HRP 
were used to detect all other immunoreactive proteins.  HRP-positive bands were 
visualized by reacting with Dura West Substrate (Pierce) and imaging with a 
VersaDoc imaging system (Bio-Rad).  Nonsaturating bands were quantified using 
Quantity One software (Bio-Rad) and were normalized to the amount of DAT 
immunoprecipitated in the same reaction. 
 
Glutathione S-transferase pull downs – hDAT cDNA nucleotides 1778–1879, 
corresponding to DAT amino acids 587–617, were amplified by PCR, and the 
product was cloned into the pGEX-5x-1 vector (GE Healthcare) downstream of 
and in-frame with glutathione S-transferase (GST). The DAT 587–590(4A) 
mutation was generated using QuikChange Mutagenesis (Stratagene), and all 
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construct sequences were confirmed by dideoxy chain termination sequencing 
(Genewiz).  Plasmids were transformed into Escherichia coliBL21 and were 
cultured and induced with isopropyl-β-D-thiogalactopyranoside at 28°C to 
minimize fusion protein degradation, although some degradation was apparent in 
many of the assays.  Fusion proteins were purified with glutathione agarose 
according to the instructions of the manufacturer, and protein purification was 
monitored at each step by SDS-PAGE with Coomassie staining.  For pull downs, 
PC12 postnuclear supernatants were prepared with a ball-bearing cell 
homogenizer as described previously [205].  The indicated amount of cell 
homogenate was incubated with equivalent amounts of glutathione agarose 
bound to GST, GST–DAT 587–617, or GST–DAT 587–590(4A), 37°C, 1 h. 
Beads were washed three times with 50 mM Tris, pH 7.4, 150 mM NaCl, 1 
mM EDTA, 1% Triton X-100, and 10% glycerol and were boiled in SDS-PAGE 
sample buffer, 5 min to elute bound proteins.  Samples were resolved on SDS-
PAGE gels and were immunoblotted for Rin and GST (to confirm pull down). 
Nonsaturating Rin bands were imaged as described above for 
coimmunoprecipitations, normalizing to GST band densities (GST + GST–DAT in 
cases when degradation occurred). 
 
Fluorescence resonance energy transfer (FRET) – FRET [206] was measured 
with a Carl Zeiss Axiovert 200 epifluorescence microscope.  The “three-filter 
method” was performed as described previously [181].  Images were taken using 
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63× oil-immersion objectives and Ludl filter wheels allowing a rapid excitation and 
emission filter exchange.  We used HEK293 cells that were maintained and 
transiently transfected with plasmid cDNA (1.7 µg) by means of the calcium 
phosphate coprecipitation method as described previously [207].  The Ludl filter 
wheels were configured as follows: cyan fluorescent protein (CFP) (IDonor; 
excitation, 436 nm; emission, 480 nm; and dichroic mirror, 455 nm), yellow 
fluorescent protein (YFP) (IAcceptor; excitation, 500 nm; emission, 535 nm; and 
dichroic mirror, 515 nm), and FRET (IFRET; excitation, 436 nm; emission, 535 nm; 
and dichroic mirror, 455 nm).  Images were taken with a CCD camera 
(Coolsnap fx; Roper Scientific).  Background fluorescence was subtracted from 
all images.  We analyzed the images pixel by pixel using NIH ImageJ (version 
1.43b; Wayne Rasband, National Institutes of Health, Bethesda, MD) and the 
NIH ImageJ plug-in PixFRET (pixel-by-pixel analysis of FRET with NIH ImageJ, 
version 1.5.0; [180]) with which spectral bleed-through parameters for the donor 
bleed through (BT) and the acceptor BT were determined and normalized FRET 
image (NFRET) was calculated in the following 
way:  
The mean NFRET was measured at the plasma membrane (predefined as the 
region of interest) using the computed NFRET image.  The regions of interest were 
selected in the CFP (donor) or YFP (acceptor) image (to avoid bleaching-
associated bias) and transmitted to the NFRET image by the NIH ImageJ Multi 
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Measure Tool.  As negative control, we used the CFP-labeled form of DAT or Rin 
with a membrane-bound form of YFP [208] that was kindly provided by 
Viacheslav Nikolaev (University of Würzburg, Würzburg, Germany).  As positive 
controls for membrane proteins, we used the serotonin transporter (SERT) 
tagged with CFP and YFP on its cytoplasmic N and C termini, respectively (to 
yield C-SERT-Y; [209]).  We tagged DAT and Rin with CFP and YFP to reveal C-
DAT and Y-DAT [181] as well as C-Rin and Y-Rin to compare the FRET values 
in Rin and DAT (and rule out any bias introduced by the different tags, although 
they differ only in a few amino acids).  We also transfected HEK293 cells with 
combinations of C-DAT and Y-DAT as well as C-Rin and Y-Rin.  The statistical 
significance of differences between the experimental conditions was determined 
using one-way ANOVA followed by Tukey's multiple comparison test. 
 
Immunocytochemistry and microscopy – Cells were transfected with the 
indicated cDNAs at a 1:1 ratio and were assayed 48 h after transfection.  Cells 
were treated as indicated, rinsed in PBS, and fixed in 4% paraformaldehyde 
prepared in PBS, 10 min, 25°C.  Cells were blocked and permeabilized in 
blocking solution (PBS, 1% IgG/protease-free BSA, 5% goat serum, and 0.2% 
Triton X-100), 30 min, room temperature, followed by incubation with the 
indicated primary antibodies, 45 min, 25°C.  Cells were washed with PBS and 
incubated with Alexa Fluor 594-, Alexa Fluor 405-, and Alexa Fluor 488-
conjugated secondary antibodies (as indicated), 45 min, 25°C.  Cells were 
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washed with PBS, dried, and mounted on glass slides with ProLong Gold 
mounting medium (Invitrogen).  Immunoreactive cells were visualized as 
described previously [91] with a Carl Zeiss Axiovert 200M microscope using a 
63×, 1.4 numerical aperture oil-immersion objective, and 0.4 µm optical sections 
were captured through the z-axis with a Retiga-1300R cooled CCD camera 
(Qimaging) using Slidebook 5.0 software (Intelligent Imaging Innovations). z-
stacks were deconvolved with a constrained iterative algorithm using measured 
point-spread functions for each fluorescent channel.  All images shown are single 
0.4 µm planes through the center of each cell.  For CTX colocalization studies, 
before fixing and staining cells, cells were incubated with 2.0 µg/ml Alexa Fluor 
594-conjugated cholera toxin subunit B (CTX), 1 h, 4°C and were washed 
extensively in PBS2+ and 0.2% IgG/protease-free BSA.  To quantify the 
percentage of DAT that colocalized with Rin (by volume, i.e., counting voxels) in 
CTX-positive and CTX-negative regions, we assessed each z-stack over a broad 
range of threshold triplets (i.e., a threshold for each of the three channels).  
Given the inherent signal intensity variability among cells and to avoid biasing our 
analysis, a range of thresholds (picked manually while viewing three-dimensional 
images) was deliberately set to be somewhat wider than the likely range.  The 
lowest threshold allowed for some diffuse background fluorescence to remain; 
the highest threshold clearly was eroding the margins of labeled structures. 
Colocalization percentages were calculated at 10 equally spaced thresholds for 
each species, resulting in 1000 colocalization pairs for each cell.  For each cell, 
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we examined the sensitivity (to the threshold) of the raft and non-raft 
colocalization percentages by creating a surface plot for the two percentages.  A 
Wilcoxon's matched-pairs signed-rank test indicated significant difference across 
all thresholds.  Therefore, single measurements at the median threshold were 
chosen for statistical analysis and data presentation. 
 
Internalization assay – Relative initial internalization rates were measured using 
reversible biotinylation as described previously [83,90,91].  Cells were 
cotransfected with DAT and the indicated constructs at a 1:2 DAT/other cDNA 
ratio and were assayed 48–72 h after transfection.  Briefly, transfected cells were 
biotinylated twice, 15 min, 4°C with 2.5 mg/ml NHS-SS-biotin and were quenched 
twice, 15 min, 4°C with 100 mM glycine.  Cells were rapidly warmed to 37°C and 
incubated with or without 1 µM PMA, 10 min, 37°C, followed by rapidly cooling to 
4°C to stop internalization.  Residual surface biotin on internalization samples 
and stripping controls was stripped by reducing twice for 15 min, 4°C with 50 
mM tris(2-carboxyethyl)phosphine.  Cells were lysed, and biotinylated proteins 
were isolated with streptavidin agarose and analyzed by SDS-PAGE and 
immunoblotting for DAT.  Immunoblots were probed in parallel for GFP and HA to 
confirm cotransfection with CFP–Rin (wild-type) and HA-tagged Rin mutants. 
Internalization rates were calculated as the percentage DAT internalized over 10 
min compared with total surface protein labeled at time 0.  Assays were only 
included if stripping efficiencies were >90%. 
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Short hairpin studies – Short hairpin RNAs (shRNAs) targeting 29 nt spans of the 
human Rin mRNA cloned into the pGFP-V-RS vector, which coexpresses turbo 
GFP, were purchased from Origene.  hRin shRNA sequences were as follows: 
hRin228, GGTCCAGAGAGTACAAGGTGGTAATGCTG. hRin knockdown 
efficiencies were assessed in HEK293T cells, taking advantage of their relatively 
high transfection efficiency.  Two × 105 cells were seeded into six-well culture 
plates 1 d before transfection. Cells were transfected using Lipofectamine 2000 
(Invitrogen), using 4.0 µg of plasmid DNA per well and a Lipofectamine/DNA ratio 
of 2.5:1.  Media was changed 4 h after transfection, and at 72 h after 
transfection, GFP-positive cells were enriched by flow cytometry (University of 
Massachusetts Medical School Flow Cytometry Core Facility).  Cells were 
collected by centrifugation and lysed in RIPA buffer, and Rin levels were 
measured by quantitative immunoblotting equivalent amounts of cell lysate, 
normalizing to actin as a loading control.  For knockdown experiments, SK-N-MC 
cells were transfected with Lipofectamine 2000 as described above, with equal 
amounts of DAT and the indicated plasmids, and were plated on either poly-D-
lysine-coated glass coverslips (immunofluorescence) or 24-well tissue 
cultureware plates (uptake assays).  All studies were conducted 72 h after 
transfection, and shRNA expression was confirmed by detecting GFP 
coexpression, by microscopy or immunoblot. 
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Antibody internalization assays – SK-N-MC cells were cotransfected with hDAT 
encoding an HA epitope tag in the second extracellular loop (ELA–HA–DAT) [86] 
and the indicated control or shRNA cDNAs at a 1:1 ratio.  At 72 h after 
transfection, surface DAT was labeled with 2 µg/ml mouse anti-HA antibody, 30 
min, room temperature.  To monitor PKC-induced internalization, cells were 
extensively washed and rapidly warmed to 37°C in PBS2+ supplemented with 
0.2% IgG and protease-free BSA, 0.18% glucose, and 1 µM PMA and were 
incubated in the same solution, 15 min, 37°C. Cells were rapidly washed in cold 
PBS to inhibit additional endocytic trafficking and were fixed in 4% 
paraformaldehyde in PBS, 10 min, room temperature.  Residual surface HA 
antibody was blocked by incubating in 20 µg/ml goat anti-mouse secondary 
antibody in 5% normal goat serum and 1% IgG/protease-free BSA, 45 min, room 
temperature.  Cells were washed three times in PBS and were permeabilized in 
0.2% saponin in PBS containing 1% IgG and protease-free BSA, and 5% normal 
goat serum, 30 min, room temperature.  Internalized HA antibody was detected 
by probing cells with goat anti-mouse secondary antibody conjugated to Alexa 
Fluor 594 (1:5000), 45 min, room temperature.  Cells were washed three times in 
PBS, and coverslips were mounted in ProLong Gold.  Images of GFP-positive 
cells were captured as described above for microscopy, using identical exposure 
times for all cells.  For quantification, GFP-positive cells were scored blindly for 
PMA-induced DAT internalization, which was defined as the presence of multiple 
large (≥100 nm) intracellular puncta distinct from the plasma membrane and 
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visible in all three cell perspectives (x–y, x–z, and y–z axes).  The percentage 
GFP-positive cells exhibiting PMA-induced DAT internalization for each 
transfection condition was averaged across multiple experiments, and significant 
differences in PMA-induced internalization were determined by one-way ANOVA 
with Dunnett's post hoc analysis compared with vector-transfected cells. 
 
[3H]DA uptake assays – Transfected cells were seeded onto 24-well plates, and 
[3H]DA uptake was measured 48 h after transfection as reported previously 
[83,90].  Briefly, cells were rinsed and preincubated in KRH buffer (120 mM NaCl, 
4.7 mM KCl, 2.2 mM CaCl2, 1.2 mM MgSO4, 1.2 mM KH2PO4, 0.18% glucose, 
and 10 mM HEPES, pH 7.4) at for 37°C for 30 min with the indicated drugs. 
Uptake was initiated by adding 1.0 µM [3H]DA (PerkinElmer Life and Analytical 
Sciences) containing 10−5 M pargyline and 10−5 M ascorbic acid.  Assays 
proceeded for 10 min (37°C) and were terminated by rapidly washing cells with 
ice-cold KRH buffer.  Cells were solubilized in scintillation fluid, and accumulated 
radioactivity was determined by liquid scintillation counting in a Wallac Microbeta 
scintillation plate counter.  Nonspecific uptake was defined in the presence of 10 
µM GBR12909 and averaged <5% of total counts measured.  Data analysis was 
performed using Microsoft Excel and GraphPad Prism Software. 
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CHAPTER V 
 
DISCUSSION AND FUTURE STUDIES 
 
 The plasma membrane of eukaryotic cells contains all of the molecular 
machineries required to sense and respond to extracellular environmental cues. 
Endocytic sorting patterns can have profound effects on the organism as a whole 
and mammalian pathology has been reported in cases where normal protein 
sorting is disrupted.  Two examples of molecules with different fates following 
internalization are the glucose transporter 4 (GLUT4), and EGFR.  GLUT4, 
expressed in adipocytes and muscle cells, recycles to the plasma membrane 
following internalization.  The relative amount of GLUT4 on the plasma 
membrane increases in response to insulin which mobilizes the transporter to the 
plasma membrane and into a rapid recycling pathway, allowing it to maintain a 
high relative concentration at the plasma membrane [210,211].  Telltale signs of 
insulin resistance and Type II diabetes can be associated with abnormalities in 
GLUT4 trafficking [210,212,213].  The EGFR expressed in epithelial cells, upon 
EGF binding, undergoes rapid internalization and degradation.  Many types of 
cancers exhibit changes in EGFR levels that are brought about by disruption of 
the receptor’s normal degradative mechanism [11,12].  The cellular and 
molecular mechanisms by which proteins with distinct intracellular fates are 
sorted are not fully understood.  Insight into the molecular and cellular basis of 
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endocytosis requires experimental methods to detect the localization of multiple 
molecules within the 3-dimensional volume of the cell with high temporal and 
spatial resolution. 
Previous studies utilizing ligands for TfR and EGFR determined that the 
sorting of ligands begins at the plasma membrane [49].  Additionally, it was found 
that EGF rapidly and specifically associates with EEA1, and that expression of 
EEA1 is required for the lysosomal degradation of EGFR [49].  The aim of 
Chapter 2 was to determine whether different internalization mechanisms are 
associated with distinct endosome populations.  To address this question, I 
investigated whether Tf would be delivered from clathrin patches to specific 
endosome subpopulations.  Endocytic recycling is a dynamic process requiring 
real-time acquisition of data.  More importantly, in order to systematically 
visualize the internalization of Tf through clathrin and into a population of early 
endosomes we required an optical system equipped with three laser channels. 
Prior to the start of biological experiments, our collaborators in the 
Biomedical Imaging and Engineering group designed a high resolution imaging 
platform that integrates TIRF and ESL microscopy called TESM.  Importantly, 
TESM is equipped for the simultaneous visualization of three fluorophores 
allowing the systematic analysis of Tf cargo transferred from one cellular 
compartment to another in the early endocytic pathway.  An additional feature of 
TESM is the spatial resolution brought by combining TIRF and ESL imaging, 
allowing us to generate high resolution 3-dimensional maps of the position of 
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endosomes relative to the cell surface.  We developed not only a microscopy 
platform, but also analytical methodology to quantify the high resolution time 
lapse images generated.  Analytical methods employed allow both population-
based as well as single event-based analysis. 
Utilizing TESM in conjunction with standard biochemical and molecular 
biological tools, I was able to define the role of Rabenosyn-5 in TfR endocytic 
recycling.  Simultaneous imaging of clathrin, serving as the frame of reference, 
Tf, and various endosomal markers followed by quantitative image analysis and 
kinetic models determined that Rabenosyn-5 endosomes preferentially receive Tf 
immediately following entry through clathrin coated pits.  Combined TIRF and 
ESL imaging revealed that Rabenosyn-5 endosomes reside proximal to clathrin 
patches at the plasma membrane while EEA1 endosomes are more distal from 
the plasma membrane.  This provides a spatial and temporal framework for 
delivery of Tf into Rabenosyn-5 endosomes. 
Biochemical analysis of Rabenosyn-5 knockdown gave insight into the 
functional role or Rabenosyn-5 in TfR endocytic recycling.  Depletion of 
Rabneosyn-5 by siRNA led to an impairment in rapid TfR recycling in conjunction 
with an increase in TfR degradation, culminating in a marked reduction in TfR 
expression.  These results are consistent with the concept of early endosome 
specialization, where endosomes containing Rabenosyn-5 capture cargo 
destined for recycling, while endosomes containing EEA1 capture internalized 
cargo destined to lysosomes. 
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Data presented here indicate Rabenosyn-5 is a crucial component of the 
endocytic recycling system involved in determining the recycling versus 
degradative fate of cargo internalized through clathrin coated pits.  Like TfR, 
which requires Rabenosyn-5 for its proper expression and recycling, GLUT4 is 
internalized through clathrin coated pits and can recycle through the slow and 
fast endocytic recycling pathways.  Rabenosyn-5 is known to engage in 
multivalent interactions with Rab GTPases, EHD proteins, Vps45 and PI(3)P.  
Eathiraj et al. [120] found that Rabenosyn-5 also interacts with Rab14, a known 
target for the insulin regulated GTPase activating protein AS160.  Taken together 
with published data that Rabenosyn-5 binds EHD1 [70] and EHD1 has been 
shown to regulate GLUT4 recycling [214], the goal of future studies is to define 
and characterize the role of Rabenosyn-5 in constitutive and insulin-stimulated 
endocytic recycling of GLUT4. 
Improved axial resolution within the TIRF zone reveals that 
subpopulations of endosomes exist that contain only Rabenosyn-5, only EEA1, 
and also a mixed population of endosomes containing both proteins.  Further 
analysis is needed to understand what the functional roles are for these 
subpopulations and how they are generated.  Given that Rabenosyn-5 binds to 
Rab5, Rab4, and PI(3)P, the amount of EEA1 binding to a Rabenosyn-5 
endosomes may be dependent upon the concentration of PI(3)P and Rab5 on 
the endosomal membrane left unoccupied by Rabenosyn-5.  In this regard, 
internalized activated growth factor receptor tyrosine kinases, which increase the 
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activity of PI3-kinase, and activate Rab5, would be expected to promote binding 
of EEA1 to its vesicle.  Consistent with this are the published results of Nielsen el 
al. [32] in A431 cells transfected with Rab5 that showed extensive co-localization 
of EEA1 with Rabenosyn-5 on the same endosomal surface.  While our data 
revels distinct and overlapping populations of early endosomes, the morphology 
of these populations is still unknown.  Electron microscopy studies will provide 
insight into the structural identity of these endosomal regions.  Additionally, it is 
unknown what happens to endosomal morphology following siRNA-mediated 
depletion of effector proteins such as Rabenosyn-5 and EEA1. 
It was reported by Marsh et al. [215] that clustering of TfR reduced uptake.  
The multivalent Tf (Tf10) used in these studies was reported to traffic much 
slower, be selectively retained in endocytic recycling compartments, and have a 
higher proportion trafficked for degradation [215].  It is important to note that the 
Tf10 used in these studies was large, thus confounding the difference between 
surface protein clustering and endocytosis and alterations in cargo size and 
endocytosis.  The trafficking of oligomerized receptors through pathways that 
diverge from the less valent receptors may also be occurring at the plasma 
membrane.  However, alterations in endocytosis may be a direct result of 
valency.  For example, the clathrin coated pit is restricted in size.  If the valency 
exceeds the capacity of the clathrin coated pit, as we find with Tf linked to 1µm 
Dynabeads®, internalization can be inhibited or potentially brought about through 
an alternate mechanism.  Work by St. Pierre et al. [216] using fluorescent      
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anti-CD71, an antibody specific for the exofacial domain of TfR, also found 
increased colocalization of CD71 with late endosomal markers.  While these 
studies showed a greater proportion of CD71 trafficked for degradation, a caveat 
of these studies is that experiments did not verify whether or not internalized 
CD71 remained bound to the TfR.  It is possible that either 1) antibody binding of 
TfR, in the absence of multireceptor crosslinking, alters the receptor trafficking 
pathway or 2) following internalization of the antibody-receptor complex the 
antibody is released from the receptor and degraded while the receptor itself 
recycles normally. 
The results shown in Chapter 2 combined with those of Leonard et al.  [49] 
suggest that sorting of internalized cargo proceeds through the delivery of cargo 
from the plasma membrane into specialized endosome populations characterized 
by their topological organization relative to the plasma membrane.  This differs 
from the classical understanding in which sorting occurs following delivery of 
cargo into a common type of early endosome.  Testing this new model further will 
require the analysis of other types of cargo, such as LDL and platelet derived 
growth factor (PDGF), relative to specific endosome populations.  Further studies 
examining GFP-LDLR and LDL-Alexa568 will aid our understanding of endosomal 
proteins involved in sorting LDL from recycling LDLR. 
Surprisingly, in conjunction with the effect Rabenosyn-5 knockdown had 
on TfR, the dynamics of clathrin patches at the plasma membrane also appear to 
be altered.  The number, size, and intensity of clathrin regions are increased 
149
when Rabenosyn-5 is depleted.  It is possible that Rabenosyn-5 may affect the 
efficiency of budding or scission of clathrin-coated vesicles.  This data suggests a 
mechanistic link between Rabenosyn-5 and clathrin mediated endocytosis.  It is 
interesting to note that Bucci et al. [19] reported that dominant negative Rab5 
mutants impair Tf uptake and Rabenosyn-5 is a Rab5 effector with two Rab5 
binding domains.  Data presented here in conjunction with preliminary 
immunoprecipitation data suggest an association, direct or indirect, between 
Rabenosyn-5 and clathrin (Figure 5.1).  This interaction could be mediated 
through EHD1 which has been shown to associate with Rabenosyn-5 [70], 
clathrin and its adaptor protein AP2 [217], and membrane bound tubules [218].  
More extensive studies will determine if this interaction is specific, what protein(s) 
are involved, and what domains of Rabenosyn-5 are required. 
The endocytic pathway may be a common mechanism for the transport of 
dsRNA.  Drosophila S2 cells have been shown to utilize receptors to internalize 
dsRNA while in C. elegans the transmembrane protein SID-1 is required to 
import dsRNA from the environment.  In mammals, miRNAs can be transferred 
form one cell to another via secreted exosomes.  
The efficient intracellular uptake of RNAi compounds to tissues of interest 
remains a major hurdle in the development of RNAi as a therapeutic.  The goal of 
the study outlined in Chapter 3 was to determine how siRNA silencing is 
connected to endocytic trafficking.  In collaboration with RXi Pharmaceuticals 
with the use of patented sd-rxRNA, I discovered a pathway for siRNA transport 
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 Figure 5.1. Link between Rabenosyn-5 and clathrin mediated 
endocytosis.  A.  Model for association between Rabenosyn-5 and 
clathrin.  B.  GFP immunoprecipitations from COS-7 stably expressing 
GFP-Rabenosyn-5 immunoblotted for Clathrin, TfR, and Rabenosyn-5. 
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whereby endosomes containing both Rabenosyn-5 and EEA1 receive 
internalized sd-rxRNA.  While sd-rxRNA enters both endosomes, knockdown of 
EEA1 shows diminished silencing by the endocytosed sd-rxRNA.  Future studies 
are needed to better understand how antisense oligonucleotides are targeted to 
EEA1 endosomes. 
Antisense oligonucleotide activity is regulated by cargo sorting, but the 
sorting mechanism, which presumably would occur at the plasma membrane, is 
currently unknown.  A detailed understanding of the mechanism of siRNA uptake 
will allow for the development of strategies to significantly enhance the utilization 
of RNAi therapeutic compounds. 
Neurotransmitter transporters such as DAT traffic dynamically in a 
constitutive and regulated manner in response to stimuli and substrates.  Recent 
work has focused on elucidating the mechanisms involved in transporter 
trafficking to and from the membrane.  We previously defined the DAT 
internalization signal as a 10 amino acid stretch located in the protein C-
terminus.  The aim of Chapter 4 was to define molecular partners that interact 
with the DAT internalization signal.  The small GTPase Rin was found to 
specifically interact with the DAT internalization signal.  Interactions between 
DAT and Rin were confirmed by coimmunoprecipitations and 
immunofluorescence analysis revealed that this interaction occurs at the plasma 
membrane and is enriched in lipid rafts. 
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We previously reported that there exists an endocytic braking mechanism 
that attenuates DAT endocytic rates under basal conditions and this brake is 
released during PKC activation.  In Chapter 4 we observed that interactions 
between DAT and Rin increase in response to PKC activation, or when the 
braking mechanism is released through alanine mutations of the involved 
residues.  What this breaking mechanism is, and proteins or chemical 
modifications that it requires are still unknown and require further 
experimentation.  Rin activity is required for PKC-induced DAT internalization as 
both dominant negative Rin expression, as well as shRNA mediated Rin 
depletion, significantly inhibit this internalization process. 
I observed Rin, originally reported to be a neuronal specific GTPase, 
expression in neuronal and non-neuronal tissues and cell lines.  The requirement 
for Rin in DAT trafficking and its expression in all tissues analyzed may help to 
explain why DAT trafficking has been successfully studied in non-neuronal cell 
lines, such as HEK293. 
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APPENDIX 
 
INSERTION OF TETRACYSTEINE MOTIFS INTO DOPAMINE 
TRANSPORTER EXTRACELLULAR DOMAINS 
 
ABSTRACT 
The neuronal dopamine transporter (DAT) is a major determinant of 
extracellular dopamine (DA) levels and is the primary target for a variety of 
addictive and therapeutic psychoactive drugs.  DAT is acutely regulated by 
protein kinase C (PKC) activation and amphetamine exposure, both of which 
modulate DAT surface expression by endocytic trafficking.  In order to use live 
imaging approaches to study DAT endocytosis, methods are needed to 
exclusively label the DAT surface pool.  The use of membrane impermeant, 
sulfonated biarsenic dyes holds potential as one such approach, and requires 
introduction of an extracellular tetracysteine motif (tetraCys; CCPGCC) to 
facilitate dye binding.  In the current study, we took advantage of intrinsic proline-
glycine (Pro-Gly) dipeptides encoded in predicted DAT extracellular domains to 
introduce tetraCys motifs into DAT extracellular loops 2, 3, and 4.  [3H]DA uptake 
studies, surface biotinylation and fluorescence microscopy in PC12 cells indicate 
that tetraCys insertion into the DAT second extracellular loop results in a 
functional transporter that maintains PKC-mediated downregulation.  Introduction 
of tetraCys into extracellular loops 3 and 4 yielded DATs with severely 
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compromised function that failed to mature and traffic to the cell surface.  This is 
the first demonstration of successful introduction of a tetracysteine motif into a 
DAT extracellular domain, and may hold promise for use of biarsenic dyes in live 
DAT imaging studies. 
 
INTRODUCTION 
DA reuptake mediated by DAT is the primary means for clearing synaptic 
DA and terminating dopaminergic neurotransmission [82,219].  DAT is member 
of the Na+/Cl− -dependent SLC6 symporter gene family and is potently inhibited 
by addictive psychostimulants, such as amphetamine and cocaine, as well as by 
therapeutic agents such as the NDRI class of antidepressants and 
methylphenidate (Ritalin) [220-222].  Transgenic mouse studies indicate that 
DAT is critical in maintaining normal dopaminergic neurotransmission and 
synaptic tone, and that even a 50% reduction in DAT protein (DAT +/− mice) is 
sufficient to significantly alter DA signaling and synaptic stores [165,166].  Thus, 
cellular mechanisms that modulate DAT cell surface expression are likely to have 
a significant impact on DA availability and signaling in the brain. 
DAT is acutely downregulated by PKC activation [87,88] and 
amphetamine exposure [89,223,224], which markedly decrease DAT surface 
levels via endosomal trafficking.  While it is well established DAT surface levels 
are modulated by endocytic trafficking, the cellular mechanisms that mediate 
DAT trafficking are not well defined.  Live cellular imaging is a highly effective 
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means to reveal cellular trafficking mechanisms that are not detectable by fixed 
cell imaging or biochemical approaches [49,225].  Recent studies using GFP-
tagged DAT [27] and fluorescently-labeled cocaine analogs [226] have proved 
successful in achieving live DAT trafficking images; however, each approach has 
inherent limitations.  GFP-tagged DAT may not behave identically to the wildtype 
DAT, and has the disadvantage of labeling the entire cellular DAT population, 
limiting the ability to examine DAT surface dynamics specifically.  Use of cocaine 
analogs allows for exclusive labeling of the DAT surface pool, but may not reflect 
native DAT trafficking as cocaine binding has itself been reported to alter DAT 
surface expression [227,228]. 
The use of biarsenic dyes, such as FlAsH, ReAsH [229] and SplAsH [230], 
is another potential means to fluorescently label proteins for live imaging.  In 
particular, sulfonated versions of these dyes are membrane impermeant and may 
be suitable to exclusively label surface proteins [231].  Biarsenic dyes are not 
fluorescent in solution and bind with high affinity to tetracysteine (tetraCys) 
motifs, preferably flanking a proline-glycine (Pro-Gly) dipeptide (CCPGCC) [231]. 
Upon binding, they become highly fluorescent. In the current study, we 
engineered tetraCys motifs flanking existing extracellular Pro-Gly dipeptide 
residues encoded in human DAT (hDAT) at amino acid positions 194, 288 and 
387, to use as potential biarsenic dye labeling sites. Analysis of these DAT 
mutants reveals that inserting a tetraCys site into DAT extracellular loop 2 (EL2) 
is well tolerated by DAT, and yields a functional transporter that retains sensitivity 
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to PKC activation, whereas insertion of tetraCys into either extracellular loop 3 or 
4 (EL3, EL4) perturbs DAT biosynthesis and trafficking to the cell surface. 
 
RESULTS 
Protein labeling with biarsenic dyes requires the presence of a tetraCys 
motif, optimally flanking a Pro-Gly dipeptide.  As depicted in Figure A.1, DAT 
encodes three predicted extracellular Pro-Gly sequences at residues 194, 288 
and 387.  We took advantage of these intrinsic Pro-Gly residues and mutated the 
2 upstream and downstream residues to cysteines to generate three DAT 
constructs with CCPGCC sequences in either extracellular loops 2, 3 or 4 
(termed DAT EL2-CCPGCC, EL3-CCPGCC and EL4-CCPGCC, respectively). 
We first tested whether the mutant DATs retained DA transport function as 
compared to wildtype DAT.  As seen in Figure A.2A, all three tetraCys mutants 
exhibited significantly reduced DA uptake as compared to wildtype DAT (p<.01). 
However, DAT-EL2-CCPGCC retained 63.5% of wildtype activity, which was 
significantly greater than both DAT-EL3-CCPGCC and DAT-EL4-CCPGCC 
(p<.001).  We next tested whether any of the DAT tetraCys mutants were 
capable of undergoing PKC-mediated downregulation.  Following treatment with 
100 nM PMA, 30′, 37°C, wildtype DAT function decreased by 30.7±2.3% (Figure 
A.2B).  Similarly, PKC activation decreased DAT-EL2-CCPGCC activity by 29% 
(Not significantly different from wild type, p = 0.77, Student's t test, n = 3).  In 
contrast, PKC activation had no effect on either DAT-EL3-CCPGCC or DAT-EL4-
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Figure A.1. Schematic of DAT with target sites for tetracysteine 
mutagenesis.  Top: DAT model.  Asterisk indicate extracellular Pro-
Gly residues targeted for tetracysteine mutagenesis.  Bottom:  DAT 
sequences spanning across the Pro-Gly tetracysteine target sites.  
Pro-Gly dipeptides are highlighted in the shaded boxes. 
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Figure A.2. DA uptake and 
P K C - m e d i a t e d d o w n -
regulation are preserved 
when a tetracysteine motif 
is introduced into EL2, but 
not EL3 or EL4.  DA uptake 
a s s a y .   C e l l s w e r e 
transfected as described in 
Experimental Procedures 
and [3H]DA uptake was 
assessed 48 hours post 
transfection.  A. Introduction 
of te t racyste ine mot i fs 
decreases DA uptake.  Data 
are expressed as % wild-
type activity +/_ S.E.M.  
*Significantly different from 
wild-type (p<0.1, One-way 
ANOVA with Tukey’s multiple 
compar ison test , n=3), 
**Significantly different from 
E L 2 - C C P G C C  D A T 
(p<0.001, One-way ANOVA 
w i t h Tu k e y ’ s m u l t i p l e 
comparison test, n=3).  B.  
EL2-CC{GCC DAT is acutely 
downregulated by PKC 
activation, whereas EL3- and 
EL4-CCPGCC are not.  Cells 
were treated with either 
vehicle or 100nM PMA, 30 min, 37°C and [3H]DA uptake was measured.  
Data are expressed as % vehicle-treated DA uptake +/-S.E.M. for each 
construct.  *Significantly different from vehicle treated (p<0.05, Student’s t 
test, n=3), **Significantly different from vehicle treated (p<0.02, Student’s t 
test, n=3). 
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CCPGCC (Figure A.2B).  These data suggest that introduction of a tetraCys motif 
into the DAT EL2 results in a functional DAT that undergoes PKC-mediated 
downregulation, whereas conversion of residues in EL3 and EL4 is not well 
tolerated by DAT. 
We next used cell surface biotinylation to test whether the tetracysteine 
DATs exhibited maturation and cell surface expression comparable to wildtype 
DAT.  As seen in Figure A.3A, surface and intracellular proteins are readily 
detectable for both wildtype and EL2-CCPGCC DATs, and no significant 
difference between the %total mature DAT on the cell surface was detected 
(Figure A.3B, 48.1±6.7% (wildtype) vs. 49.0±5.4% (EL2-CCPGCC), p = .92, 
Student's t test, n = 4).  In contrast, neither EL3 nor EL4 were detected at the cell 
surface, nor was any mature protein detected, suggesting that these mutants fail 
to progress through the biosynthetic pathway (Figure A.3C).  We also measured 
the ratios of mature (90 kDa) to immature (56 kDa) DAT as an index of how 
readily EL2-CCPGCC DAT progresses through the biosynthetic pathway. 
Wildtype DAT exhibited mature:immature protein ratio of 1.66±0.22, whereas 
EL2-CCPGCC DAT had a trend for less mature:immature protein (0.99±.17), but 
which was not significantly different from wildtype (p = .07, Student's t test, n = 
4), suggesting that EL2-CCPGCC DAT is processed through the biosynthetic 
pathway comparably to wildtype DAT. 
We next used fluorescence microscopy to examine the cellular distribution 
of the tetracysteine-tagged DATs as compared to wildtype DAT in transiently 
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Figure A.3. The presence of a tetracysteine in DAT EL2 does not alter 
DAT maturation or surface expression.  Surface biotinylation assay.  Cells 
were transfected with the indicated DAT constructs and cell surface proteins 
were biotinylated and isolated from intracellular proteins as described in 
Experimental Procedures.  A.  Representative immunoblot displaying surface 
(S) and intracellular (I) wild-type and EL2-CCPGCC DAT.  Mature (90 kDa) 
and immature (56 kDa) species are indicated.  B.  Averaged data.  Data are 
expressed as % total mature DAT on cell surface +/-S.E.M. (n=4).  C.  
Representative immunoblot displaying surface (S) and intracellular (I) EL3-
CCPGCC and EL4-CC{GCC DAT.  Total lysates are displayed in the far right 
hand lanes.  Note that no mature protein is detected.  Immature species (56 
kDa) are indicated. 
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transfected PC12 cells.  Wildtype DAT staining presented as an intense ring at 
the cell perimeter, and PKC activation resulted in robust DAT redistribution to 
intracellular puncta (Figure A.4A).  Similarly, EL2-CCPGCC DAT staining was 
primarily at the cell perimeter (Figure A.4A), although some intracellular staining 
was apparent.  Moreover, PKC activation resulted in pronounced surface losses 
of EL2-CCPGCC DAT, similar to that observed for wildtype and consistent with 
our uptake results demonstrating functional downregulation of EL2-CCPGCC 
DAT.  We also expressed EL3, EL4 mutants and visualized their cellular 
distribution.  Neither EL3 nor EL4 were present at the cell perimeter, and a 
diffuse perinuclear signal was detected (Figure A.4B).  These results are 
consistent with our uptake and surface biotinylation results suggesting that EL3 
and EL4 fail to mature and traffic to the cell surface and that these mutations are 
not well tolerated by DAT. 
 
DISCUSSION 
In the current study, we aimed to introduce tetraCys residues in DAT 
extracellular domains that intrinsically encode Pro-Gly dipeptide sequences at 
DAT amino acid positions 194, 288 and 387. The CCPGCC sequence is the 
optimal sequence to facilitate biarsenic dye binding, and once bound confers the 
proper dye conformation for fluorescence emission [229,231].  Converting the 
four residues flanking the Pro-Gly at amino acid positions 194–195 yielded a 
DAT that retained DAT surface expression comparable to wildtype.  Moreover, 
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 Figure A.4. Cellular distribution of tetracysteine mutant DATs.  EL2-
CCPGCC DAT is robustly expressed at the cell surface and internalizes in 
response to PKC activation.  Immunofluorescence microscopy.  Cells 
were transfected with the indicated constructs and were fixed and stained 
with rat anti-DAT antibodies as described in Experimental Procedures.  A 
representative panel of deconvolved images is presented.  A single plane 
through each cell center is shown.  A.  Effect of PKC activation on EL2-
CCPGCC DAT.  Prior to fixation, cells were treated with either vehicle or 
1µM PMA (37°C, 30min).  B.  Cellular distribution of EL3-CCPGCC and 
EL4-CCPGCC DAT.  Note the lack of either protein at the cell surface. 
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EL2-CCPGCC DAT exhibit robust DA uptake, albeit somewhat reduced as 
compared to wildtype, and retained sensitivity to PKC-mediated downregulation, 
suggesting that this mutant may be amenable to labeling with biarsenic dyes for 
live imaging studies of DAT trafficking.  A recent study indicated that inserting a 
tetraCys motif at the DAT amino terminus and at position 511 were also well 
tolerated [232].  However, these are both located on intracellular domains that 
would require use of a membrane permeant biarsenic dye that would have 
access to the entire cellular DAT population and would not exclusively label the 
DAT surface residents.  It is also interesting to note that although we reproducibly 
observe PKC-mediated DAT downregulation in PC12 cells, a recent study by 
Ericksen et al reports lack of PKC-mediated downregulation in primary ventral 
midbrain neurons prepared from P2 rat pups [226].  This conflicts with previous 
studies that report PKC-mediated DAT downregulation in adult rat striatal 
synaptosomes [233], and suggests that either the developmental stage of the 
dopaminergic neuron or the primary culture environment may influence the ability 
of DAT to undergo PKC-mediated downregulation. 
While our data demonstrate that an extracellular tetracysteine-tag is well 
tolerated by DAT, they do not demonstrate whether this DAT construct can be 
labeled with biarsenic dyes.  We made several attempts to label EL2-CCPGCC 
DAT using Lumio brand (Invitrogen) FlAsH reagent, using both standard 
approaches as well as modified protocols that use extended washes with BAL 
reagent to reduce non-specific FlAsH binding.  All of our labeling attempts 
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resulted in a high degree of non-specific labeling of non-transfected cells, as well 
as cells expressing either wildtype or EL2-CCPGCC DAT (not shown).  Problems 
with non-specific FlAsH binding have been described [234,235] and particular 
issues have been raised regarding the utility and specificity of the commercially 
available Lumio form of FlAsH [236].  Thus, while our EL2-CCPGCC DAT is a 
viable DAT form, advances in FlAsH labeling may be required in order to 
determine the utility of this mutant in future trafficking studies. 
DAT residues 192–197 are located between the second and third 
glycosylation sites of the large second extracellular loop of the protein.  This 
region appears to tolerate amino acid substitution well, as previous studies 
reported that an extracellular HA epitope was successfully engineered across 
residues 193–203 [86].  The HA epitope at this locus is accessible for 
extracellular antibody labeling, suggesting that the much smaller biarsenic dye 
would also have access to this DAT region.  Cysteine conversion of EL3 and EL4 
residues flanking the Pro-Gly at positions 288–289 and 387–388, respectively, 
yielded CCPGCC DAT mutants that were not highly functional.  Interestingly, a 
previous mutagenesis study in which a cysteine-depleted DAT was generated 
indicated that mutating an existing cysteine in EL3 at position 306, just 
downstream of the EL3-CCPGCC DAT, resulted in the expression of mature DAT 
protein [237] that is fully functional [182].  Cys306 is positioned close to the sixth 
transmembrane segment, suggesting that this region may be more tolerable to 
structural perturbation. 
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In summary, we have characterized a functional DAT mutant that encodes 
a tetraCys motif on the extracellular DAT domain EL2.  The ability to introduce 
cysteines at this locus may have future utility both for NTSEA reagent labeling, 
as well as for biarsenic dye labeling for live imaging studies.  Future studies will 
directly examine the capacity of this mutant to bind to biarsenic dyes. 
 
EXPERIMENTAL PROCEDURES 
Constructs and Mutagenesis - TetraCys motifs flanking existing extracellular Pro-
Gly residues were engineered into EL2, EL3 or EL4 DAT extracellular loops by 
mutating the two residues upstream and downstream of the Pro-Gly residues into 
cysteines.  The amino acids mutated to cysteines were:  EL2: 192–193/196–197; 
EL3: 286–287/290–291; EL4 385–386/389–390. hDAT pcDNA3.1(+) was 
mutated using the QuikChange Mutagenesis kit (Stratagene).  The following 
mutagenic primers spanning the indicated hDAT cDNA regions were used: 
EL2-CCPGCC (577–627) 
5′CCCCAACTGCTCGGATTGCTGTCCTGGTTGCTGCAGTG
GAGACAGCTCGG3′ (sense), 
5′CCGAGCTGTCTCCACTGCAGCAACCAGGACAGCAATCC
GAGCAGTTGGGG3′(antisense); 
EL3-CCPGCC (860–907) 
5′CTCCTGCGTGGGGTCTGCTGCCCTGGATGCTGTGACGG
CATCAGAGCA3′ (sense), 
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5′TGCTCTGATGCCGTCACAGCATCCAGGGCAGCAGACCC
CACGCAGGAG3′(antisense); 
EL4-CCPGCC (1156–1205) 
5′ CGGGGACGTGGCCAAGTGCTGCCCAGGGTGCTGCTTCATC
ATCTACCCGG3′ (sense), 
5′CCGGGTAGATGATGAAGCAGCACCCTGGGCAGCACTTG
GCCACGTCCCCG3′(antisense). 
Mutations were confirmed by sequencing (UMASS Medical School Nucleic Acid 
Facility) and mutagenic regions were subcloned back into the parental hDAT 
cDNA using the following restriction enzymes:  PflMI/BstEII (EL2-CCPGCC), 
PflMI/ClaI (EL3-CCPGCC), BstEII/ClaI (EL4-CCPGCC). 
 
Cell culture and transfection - PC12 cells were from ATCC as previously 
described [205] and were cultured at 10% CO2 in high glucose DMEM 
supplemented with 5% horse serum, 5% bovine calf serum, 2 mM glutamine and 
102 U/ml penicillin-streptomycin.  Cells were removed from the cultureware by 
spraying media directly onto the growth surface and triturating.  Cells were 
transiently transfected either with Lipofectamine 2000 (Invitrogen), according to 
the manufacture's instructions, or by electroporation as previously described [90]. 
Briefly, 1.2×107 cells were collected by centrifugation and resuspended in 0.75 ml 
electroporation buffer (137 mM NaCl, 5.0 mM KCl, 0.7 mM Na2HPO4, 6.0 mM 
glucose, 20 mM HEPES, pH 7.05) and were mixed with 18.2 µg of the indicated 
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plasmids.  Cells were electroporated at 300 mV, 500 µF, with an exponential 
decay protocol, using a GenePulser Xcell unit (Biorad, Hercules, CA) with a CE 
module and 4.0 mm cuvettes.  Following 30 min recovery in PC12 media 
containing 3 mM EGTA, cells were plated onto poly-D-lysine coated plates as 
indicated.  All transfected cells were assayed 48 hrs post-transfection. 
 
Surface Biotinylation and Immunoblotting - Cells were seeded in 6 well plates 
coated with 0.5 mg/ml poly-D-lysine 48 hours prior to performing assays.  For 
surface biotinylation, cells were washed with phosphate buffered saline 
supplemented with 1.5 mM MgCl2, 0.2 mM CaCl2 (PBS2+) and surface proteins 
were covalently labeled biotin by incubating 2×15 min, 4°C with freshly prepared 
1.0 mg/ml sulfo-NHS-SS-biotin (Pierce) prepared in PBS2+. Residual biotinylation 
reagent was quenched by washing cells with and incubating 2×15′, 4°C in PBS2+, 
100 mM glycine.  Cells were lysed in RIPA buffer (10 mM Tris, pH 7.4, 150 mM 
NaCl, 1.0 mM EDTA, 0.1% SDS, 1.0% Triton X 100, 1.0% sodium deoxycholate) 
containing protease inhibitors (1.0 mM PMSF, 1.0 µg/ml each leupeptin, aprotinin 
and pepstatin), 20 min, 4°C, cellular debris was cleared by centrifugation and 
protein concentrations were determined with the BCA protein assay (Pierce). 
Surface (biotinylated) proteins were separated from intracellular (non-
biotinylated) proteins by streptavidin batch affinity chromatography using 
streptavidin-coupled agarose beads (Pierce), incubating overnight, 4°C with 
rotation. Non-biotinylated proteins in the supernatants were removed and 
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concentrated by spin filtration using columns with 30 kDa molecular weight cutoff 
(Millipore).  Beads bound to biotinylated proteins were washed three times with 
RIPA buffer and bound proteins were eluted in 2x Laemmli sample buffer by 
rotating 30 min, 25°C. Samples were separated on 10% SDS-PAGE gels and 
were transferred onto nitrocellulose for 1 hour, 100 V, 4°C.  Blots were blocked 
with 5% nonfat dry milk in PBS/0.1% Tween-20 (PBS-T), 45 min, 25°C, and 
incubated with rat anti-DAT antibody (MAB369, Chemicon, 1:1000) overnight, 
4°C.  Blots were washed with PBS-T and incubated with HRP-conjugated goat 
anti-rat antibody (Santa Cruz, 1:5000), 45′, 25°C, following by washing in PBS-T. 
Blots were developed with Supersignal Dura (Pierce) and immunoreactive bands 
were detected with a VersaDoc imaging station (Bio-Rad).  Non-saturating bands 
were quantified using Quantity One software and results were analyzed using 
GraphPad Prism software.  Mature:immature protein ratios were calculated by 
summing mature band (90 kDa) densities in surface and intracellular fractions, 
and dividing by the immature band (56 kDa) density in the intracellular fraction. 
 
Immunocytochemistry and Microscopy - Transfected cells were seeded on glass 
coverslips coated with 1.0 mg/ml poly-D-lysine 48 hours prior to fixation and 
labeling. Cells were treated as indicated, rinsed in PBS and fixed in 4% 
paraformaldehyde prepared in PBS, 10 min, 25°C.  Cells were blocked and 
permeabilized by incubating in blocking solution (PBS, 1% IgG/Protease-free 
BSA, 5% goat serum, 0.2% Triton-X-100), 30′, 25°C, followed by incubation with 
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rat anti-DAT antibody (1:2000 in blocking solution), 45 min, 25°C.  Cells were 
washed with PBS and incubated with Alexa594-conjugated goat anti-rat antibody 
(1:5000, Molecular Probes), 45 min, 25°C.  Cells were washed with PBS, dried 
and mounted on glass slides with ProLong Gold (Molecular Probes). 
Immunoreactive cells were visualized as previously described [91] with a Zeiss 
Axiovert 200 M microscope using a 63X, 1.4 N.A. oil immersion objective and 0.4 
µm optical sections were captured through the z-axis with a Retiga-1300R cooled 
CCD camera (Qimaging) using Slidebook 4.0 software (Intelligent Imaging 
Innovations).  Z- stacks were deconvolved with a constrained iterative algorithm 
using measured point spread functions for each fluorescent channel using 
Slidebook 4.0 software.  All images shown are single 0.4 µm planes through the 
center of each cell. 
 
(3H)DA Uptake Assays - Transfected cells were seeded onto 24 well plates 
coated with 0.5 mg/ml poly-D-lysine and (3H)DA uptake was measured 48 hours 
post transfection as previously reported [83,90].  Briefly, cells were rinsed and 
pre-incubated in KRH buffer (120 mM NaCl, 4.7 mM KCl, 2.2 mM CaCl2, 1.2 mM 
MgSO4, 1.2 mM KH2PO4, 0.18% glucose, 10 mM HEPES, pH 7.4) at either for 
37°C for 30 min with the indicated drugs.  100 nM desipramine was included in 
all wells to block endogenous NET activity.  Uptake was initiated by adding 1.0 
µM (3H)DA (dihydroxyphenylethylamine 3,4-(ring-2,5,6,-3H), Perkin Elmer) 
containing 10−5 M pargyline and 10−5 M ascorbic acid.  Assays proceeded for 10 
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min (37°C) and were terminated by rapidly washing cells with ice-cold KRH 
buffer.  Cells were solubilized in scintillation fluid and accumulated radioactivity 
was determined by liquid scintillation counting in a Wallac Microbeta scintillation 
plate counter.  Non-specific uptake was defined in the presence of 10 µM 
GBR12909 and averaged <5% of total counts measured.  Data analysis was 
performed using Microsoft Excel and GraphPad Prism Software. 
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